Drug_NDC|Drug_cpa_name|Drug_cpa_description|Drug_cpa_EffDate|Drug_cpa_EndDate
00002143380|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00002143380|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00002143480|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00002143480|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00002144509|CE:CYC-TALT|Cytokine and CAM Antagonists|03/27/2018|
00002144511|CE:CYC-TALT|Cytokine and CAM Antagonists|03/27/2018|
00002144527|CE:CYC-TALT|Cytokine and CAM Antagonists|03/27/2018|
00002322730|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002322830|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002322930|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002323030|CE:APY-SGA|Antipsychotics|04/10/2016|
00002323130|CE:APY-SGA|Antipsychotics|04/10/2016|
00002323330|CE:APY-SGA|Antipsychotics|04/10/2016|03/31/2021
00002323430|CE:APY-SGA|Antipsychotics|04/10/2016|03/31/2021
00002323830|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002323930|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002325030|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002325130|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00002411230|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
00002411230|CE:APY-SGA|Antipsychotics|04/10/2016|
00002411530|CE:APY-SGA|Antipsychotics|04/10/2016|
00002411530|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
00002411630|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
00002411630|CE:APY-SGA|Antipsychotics|04/10/2016|
00002411730|CE:APY-SGA|Antipsychotics|04/10/2016|
00002411730|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
00002418230|CE:CYC-OLU|Cytokine and CAM Antagonists|06/25/2019|
00002418402|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
00002418430|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
00002441530|CE:APY-SGA|Antipsychotics|04/10/2016|
00002442030|CE:APY-SGA|Antipsychotics|04/10/2016|
00002445385|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
00002445385|CE:APY-SGA|Antipsychotics|04/10/2016|
00002445485|CE:APY-SGA|Antipsychotics|04/10/2016|
00002445485|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
00002445585|CE:APY-SGA|Antipsychotics|04/10/2016|
00002445685|CE:APY-SGA|Antipsychotics|04/10/2016|
00002473230|CE:CYC-OLU|Cytokine and CAM Antagonists|06/25/2019|
00002733511|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|09/30/2021
00002759701|CE:APY-SGA|Antipsychotics|04/10/2016|
00002763511|CE:APY-SGA|Antipsychotics|04/10/2016|
00002763611|CE:APY-SGA|Antipsychotics|04/10/2016|
00002763711|CE:APY-SGA|Antipsychotics|04/10/2016|
00002771459|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00002772401|CE:CYC-TALT|Cytokine and CAM Antagonists|03/27/2018|
00002772411|CE:CYC-TALT|Cytokine and CAM Antagonists|03/27/2018|
00002775205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00002814701|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00002814801|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00002814901|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00003089321|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003089331|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003089421|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003089431|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003089470|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003218811|CE:CYC-OREN|Cytokine and CAM Antagonists|03/27/2018|
00003218851|CE:CYC-OREN|Cytokine and CAM Antagonists|03/27/2018|
00003281411|CE:CYC-OREN|Cytokine and CAM Antagonists|03/27/2018|
00003281811|CE:CYC-OREN|Cytokine and CAM Antagonists|03/27/2018|
00003376474|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00003517805|CE:DUP-STN|Duplicate Therapy|02/04/2016|10/31/2021
00003517805|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|10/31/2021
00003519410|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|10/31/2021
00003519410|CE:DUP-STN|Duplicate Therapy|02/04/2016|10/31/2021
00004005801|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00004005801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004005801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004005801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004006801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004006801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004006801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004006801|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00004009801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004009801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004009801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00004009801|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00006000530|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00006003330|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00006007861|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006007862|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006007882|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008061|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008062|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008082|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008131|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008154|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006008182|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006011231|CE:STG-JNVA50|Sitagliptan (Januvia)|01/31/2011|
00006011231|CE:DRO-SITAG50|Drug Regimen Optimization|01/31/2011|
00006011231|CE:DPP-STG50|DPP-4 Inhibitors|09/25/2018|
00006011254|CE:STG-JNVA50|Sitagliptan (Januvia)|01/31/2011|
00006011254|CE:DPP-STG50|DPP-4 Inhibitors|09/25/2018|
00006011254|CE:DRO-SITAG50|Drug Regimen Optimization|01/31/2011|
00006022131|CE:STG-JNVA25|Sitagliptan (Januvia)|01/31/2011|
00006022131|CE:DRO-SITAG25|Drug Regimen Optimization|01/31/2011|
00006022131|CE:DPP-STG25|DPP-4 Inhibitors|09/25/2018|
00006022154|CE:DPP-STG25|DPP-4 Inhibitors|09/25/2018|
00006022154|CE:DRO-SITAG25|Drug Regimen Optimization|01/31/2011|
00006022154|CE:STG-JNVA25|Sitagliptan (Januvia)|01/31/2011|
00006027728|CE:DPP-STG100|DPP-4 Inhibitors|09/25/2018|
00006027728|CE:STG-JNVA100|Sitagliptan (Januvia)|01/31/2011|
00006027731|CE:STG-JNVA100|Sitagliptan (Januvia)|01/31/2011|
00006027731|CE:DPP-STG100|DPP-4 Inhibitors|09/25/2018|
00006027754|CE:STG-JNVA100|Sitagliptan (Januvia)|01/31/2011|
00006027754|CE:DPP-STG100|DPP-4 Inhibitors|09/25/2018|
00006027782|CE:STG-JNVA100|Sitagliptan (Januvia)|01/31/2011|
00006027782|CE:DPP-STG100|DPP-4 Inhibitors|09/25/2018|
00006032530|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00006033530|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00006046102|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00006046106|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|08/26/2020
00006046405|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|10/31/2020
00006046410|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00006054331|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006054354|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006057561|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006057562|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006057582|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006057761|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006057762|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006057782|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006071731|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006071731|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
00006071731|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006071754|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006071754|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
00006071754|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006073531|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
00006073531|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006073554|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006073554|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
00006074031|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
00006074031|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006074054|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006074054|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
00006074531|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006074531|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006074554|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006074554|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006074731|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006074731|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006074754|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00006074754|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006074931|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
00006074931|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006074954|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00006074954|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
00006095154|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006095154|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
00006095231|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
00006095231|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006095254|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006095254|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
00006096031|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006096054|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00006171131|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00006307402|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
00006384130|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00006386203|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00006536703|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006536706|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006536803|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006536806|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00006911731|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00006911754|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00006927531|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00007337013|CE:DRO-CARVCR10|Drug Regimen Optimization|01/31/2011|05/13/2021
00007337113|CE:DRO-CARVCR20|Drug Regimen Optimization|01/31/2011|
00007337213|CE:DRO-CARVCR40|Drug Regimen Optimization|01/31/2011|
00007365022|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00007365030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00008083321|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
00008083322|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
00008083721|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00008083722|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00008084381|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
00008112312|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00009001201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009001201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009002201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009002201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009002901|CE:ALP-ALP|Alprazolam|05/28/2015|
00009002901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002902|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002902|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002902|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009002902|CE:ALP-ALP|Alprazolam|05/28/2015|
00009003101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009003101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009004401|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009004401|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009005501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005501|CE:ALP-ALP|Alprazolam|05/28/2015|
00009005501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005503|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005503|CE:ALP-ALP|Alprazolam|05/28/2015|
00009005503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005602|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009005602|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009005604|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009005604|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009005707|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005707|CE:ALP-ALP|Alprazolam|05/28/2015|
00009005707|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005707|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005907|CE:ALP-ALP|Alprazolam|05/28/2015|
00009005907|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005907|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009005907|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006607|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006607|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006607|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006607|CE:ALP-ALP|Alprazolam|05/28/2015|
00009006807|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006807|CE:ALP-ALP|Alprazolam|05/28/2015|
00009006807|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009006807|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009007301|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009007301|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009009001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009001|CE:ALP-ALP|Alprazolam|05/28/2015|
00009009001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009004|CE:ALP-ALP|Alprazolam|05/28/2015|
00009009004|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009004|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009004|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00009009401|CE:ALP-ALP|Alprazolam|05/28/2015|
00009017601|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00009017601|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00009027101|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00009519001|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00009519002|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00009519003|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00013215036|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00013262681|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013264681|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013264902|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265002|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265102|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265202|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265302|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265402|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265502|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265602|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265702|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00013265802|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00023350730|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00023601460|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00023601460|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023601460|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023601460|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00023601460|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00023601560|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00023601560|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00023601560|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023601560|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00023601560|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023601960|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00023601960|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00023601960|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023601960|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00023601960|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023602205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00023602205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023602205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00023602205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00023602205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00024540131|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00024542131|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00024550131|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00024552131|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00024574502|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00024574502|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00024574702|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00024574702|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00024576105|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00024576105|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00024585090|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
00024585090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00024585130|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
00024585130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00024585230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00024585530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00024585530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00024585630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00024585630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00024590102|CE:PCS-PRA|PCSK9 Inhibitors|01/04/2017|
00024590202|CE:PCS-PRA|PCSK9 Inhibitors|01/04/2017|
00024590801|CE:CYC-KEVZ|Cytokine and CAM Antagonists|03/27/2018|
00024591001|CE:CYC-KEVZ|Cytokine and CAM Antagonists|03/27/2018|
00024591401|CE:DPX-DPX|Dupixent|10/31/2017|
00024591801|CE:DPX-DPX|Dupixent|10/31/2017|
00024592001|CE:CYC-KEVZ|Cytokine and CAM Antagonists|03/27/2018|
00024592201|CE:CYC-KEVZ|Cytokine and CAM Antagonists|03/27/2018|
00025101131|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00025102131|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00025138131|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00025141160|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00025141190|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00025142160|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00025151501|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025151501|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152031|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152031|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152034|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152034|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152051|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152051|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152531|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152531|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152534|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152534|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025152551|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00025152551|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025153002|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00025153002|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00037200101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00037200101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00037200101|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
00037225010|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
00037225010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00037225010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00037601030|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00037605030|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00046074905|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046087221|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110081|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110091|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110181|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110281|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110291|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110381|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110481|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110491|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110511|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110611|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110711|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00046110811|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00049005260|CE:APY-SGA|Antipsychotics|04/10/2016|
00049005460|CE:APY-SGA|Antipsychotics|04/10/2016|
00049005660|CE:APY-SGA|Antipsychotics|04/10/2016|
00049005860|CE:APY-SGA|Antipsychotics|04/10/2016|
00049017001|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
00049275066|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
00049276066|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
00049277066|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
00049392083|CE:APY-SGA|Antipsychotics|04/10/2016|
00049396060|CE:APY-SGA|Antipsychotics|04/10/2016|08/23/2020
00049490030|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
00049490041|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
00049496030|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
00052010530|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|09/20/2021
00052010630|CE:DRO-MIRODT15|Drug Regimen Optimization|01/31/2011|
00052436401|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
00054001720|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001720|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001725|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001725|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001729|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001729|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001820|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001820|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001825|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001825|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001829|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001829|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001920|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054001920|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001925|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054001925|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054006344|CE:APY-ARI|Antipsychotics|04/10/2016|
00054008425|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054008525|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054008813|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
00054008826|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
00054012322|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054012322|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
00054014308|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|08/31/2021
00054014387|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|08/31/2021
00054017613|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00054017613|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054017613|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054017713|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054017713|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054017713|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00054018813|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054018813|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054018813|CE:SUB-SUBOX|Suboxone|04/23/2013|
00054018913|CE:SUB-SUBOX|Suboxone|04/23/2013|
00054018913|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054018913|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054022031|CE:APY-SGA|Antipsychotics|04/10/2016|
00054022125|CE:APY-SGA|Antipsychotics|04/10/2016|
00054022225|CE:APY-SGA|Antipsychotics|04/10/2016|
00054022321|CE:APY-SGA|Antipsychotics|04/10/2016|
00054022931|CE:APY-SGA|Antipsychotics|04/10/2016|
00054023025|CE:APY-SGA|Antipsychotics|04/10/2016|
00054023525|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023525|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023525|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054023525|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023525|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023625|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023625|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023625|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023625|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023625|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054023749|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023749|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023749|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023749|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054023749|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023763|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054023763|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023763|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023763|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023763|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023849|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023849|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054023849|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023849|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023849|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023863|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054023863|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023863|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054023863|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054023863|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054024324|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054024424|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024424|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054024424|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054024424|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024424|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054024425|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024425|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054024425|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054024425|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054024425|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024525|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054024525|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054024525|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024525|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054024525|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054025413|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054025413|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054025422|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054025422|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054025513|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054025513|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054025522|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054025522|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054026424|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054026424|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054026424|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054026424|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054026424|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054026425|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054026425|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054026425|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054026425|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054026425|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054026525|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054026525|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054026525|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054026525|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054026525|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054028325|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054028325|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054028325|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054028325|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054028325|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054028425|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054028425|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054028425|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054028425|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054028425|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054028813|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|06/30/2021
00054028822|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|06/30/2021
00054028913|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|06/30/2021
00054028922|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|06/30/2021
00054029513|CE:GIM-ALO|GI Motility|01/18/2017|
00054029613|CE:GIM-ALO|GI Motility|01/18/2017|
00054038663|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054038663|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054038663|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054038663|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054038663|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054038925|CE:ADD-IRMETHAM|ADD/ADHD Agents|02/13/2014|
00054039041|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039041|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054039041|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054039041|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039041|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054039063|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054039063|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054039063|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039063|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039063|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054039168|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039168|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054039168|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039168|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054039168|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054039268|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054039268|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054039268|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054039268|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054039268|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040441|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054040441|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054040441|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040441|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054040441|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040444|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054040444|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040444|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054040444|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054040444|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040450|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040450|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054040450|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054040450|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054040450|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054046823|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
00054046923|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
00054051741|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054051741|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054051741|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054051741|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051741|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051744|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054051744|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051744|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051744|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054051744|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054051750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054051750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054051750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054051750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054054318|CE:DUP-ARB|Duplicate Therapy|02/05/2013|09/16/2020
00054054318|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|09/16/2020
00054054518|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054054518|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054054618|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054054618|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054054718|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00054054718|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00054055125|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00054055125|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00054055125|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054055125|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|02/28/2021
00054055125|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|02/28/2021
00054055129|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00054055129|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054055129|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|02/28/2021
00054055129|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|02/28/2021
00054055129|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00054306844|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054306844|CE:ALP-ALP|Alprazolam|05/28/2015|
00054306844|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054306844|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054309036|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054309036|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054309036|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054309036|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054309036|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054317644|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054317644|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054317757|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054317757|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054317763|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054317763|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054318544|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054318544|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054318544|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054318544|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054318863|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054318863|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054318863|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054318863|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054353244|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054353244|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054353244|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054353244|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054354563|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054354563|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054354563|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054354563|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054354563|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054355344|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054355344|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054355344|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355344|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355344|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054355563|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054355563|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054355563|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355563|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054355563|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355663|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054355663|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355663|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054355663|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054355663|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054372144|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054372144|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054372250|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054372250|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054372263|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054372263|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054417925|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054417925|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418025|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418025|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418125|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418125|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418225|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418225|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418325|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418325|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418425|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418425|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054418625|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054418625|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054421925|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/10/2020
00054421925|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00054421925|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/10/2020
00054421925|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00054421925|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
00054421925|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
00054453825|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054453825|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054453825|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054453825|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054453825|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054457025|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054457025|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054457025|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054457025|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054457025|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054457125|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054457125|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054457125|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054457125|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054457125|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054457125|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054472825|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054472825|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054472831|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054472831|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054474125|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054474125|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054474131|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054474131|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054474225|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054474225|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054485825|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485825|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485825|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485825|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054485925|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485925|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485925|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054485925|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485929|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485929|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485929|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054485929|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00054817425|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054817425|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054817525|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054817525|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054817625|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054817625|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054817925|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054817925|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054818025|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054818025|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054818125|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054818125|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054818325|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054818325|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054855324|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054855324|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054855324|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054855324|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054855324|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054855424|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00054855424|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00054855424|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00054855424|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00054855424|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054855424|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00054872425|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054872425|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054873925|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00054873925|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054874025|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00054874025|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00056016870|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/31/2020
00056016970|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|11/30/2020
00056016975|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/26/2020
00056017070|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|10/31/2020
00056017075|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/26/2020
00056017270|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|09/30/2020
00056017275|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|12/31/2020
00056017370|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/31/2020
00056017470|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/26/2020
00056017670|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|10/31/2020
00056017675|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/26/2020
00056018870|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|10/31/2020
00056018875|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/26/2020
00056018970|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/31/2020
00056018975|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|08/31/2020
00069019502|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069019602|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069020602|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069021702|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069022002|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069022302|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069022802|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069023201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00069033621|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00069033621|CE:SDF-REVSUSP|Sildenafil (Revatio)|09/01/2015|
00069050130|CE:CYC-XELJ|Cytokine and CAM Antagonists|03/27/2018|
00069100101|CE:CYC-XELJ|Cytokine and CAM Antagonists|03/27/2018|
00069100201|CE:CYC-XELJ|Cytokine and CAM Antagonists|03/27/2018|
00069130501|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130510|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130601|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130610|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130701|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130710|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130801|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130810|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130901|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069130904|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
00069152068|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
00069153068|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
00069153072|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
00069215030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069216030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069217030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069218030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069219030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069225030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069226030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069227030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00069265066|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
00069265072|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
00069322066|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00069323066|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00069419068|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00069541066|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00069542066|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00071015523|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00071015523|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00071015623|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00071015623|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00071015723|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00071015723|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00071015823|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00071015873|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00071022023|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00071022223|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00071022323|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00071040124|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00071080324|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00071080524|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00071080624|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00071201223|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/22/2021
00071201244|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00074006702|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074012403|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074024302|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074055402|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074061602|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074081702|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074153903|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074204202|CE:CYC-SKY|Cytokine and CAM Antagonists|11/04/2019|
00074230630|CE:CYC-RIN|Cytokine and CAM Antagonists|03/03/2020|
00074254003|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074262528|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
00074305413|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
00074305413|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/10/2020
00074305413|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
00074305413|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00074305413|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00074309328|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
00074326590|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
00074379902|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074382611|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00074382613|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00074433902|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074433906|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074433907|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074634702|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00074937402|CE:CYC-HUMI|Cytokine and CAM Antagonists|03/27/2018|
00075062040|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075062160|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075062280|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075062300|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075062430|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075062603|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075291201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00075291501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00078031434|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00078031434|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078031534|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078031534|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00078034345|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078034445|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078034542|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078034545|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078034642|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078034645|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078035105|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00078035205|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00078035405|CE:DUP-STN|Duplicate Therapy|02/04/2016|02/28/2021
00078035415|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00078035834|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
00078035834|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078035934|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
00078035934|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078036034|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078036542|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078036545|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00078037005|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00078037005|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00078037105|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00078037205|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00078038005|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
00078038105|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
00078038205|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
00078038334|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078038334|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00078042315|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078042405|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00078042405|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00078043005|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078043005|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00078043105|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078043105|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00078043205|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078043305|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078043405|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078043905|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00078044005|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00078044105|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00078047134|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078047134|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00078047234|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078047234|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00078048815|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078048915|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078049015|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078049115|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078049305|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078060805|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078060905|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00078063941|CE:CYC-COSE|Cytokine and CAM Antagonists|03/27/2018|
00078063968|CE:CYC-COSE|Cytokine and CAM Antagonists|03/27/2018|
00078063997|CE:CYC-COSE|Cytokine and CAM Antagonists|03/27/2018|
00078063998|CE:CYC-COSE|Cytokine and CAM Antagonists|03/27/2018|
00078065920|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078065967|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078066419|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00078069620|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078069667|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078073461|CE:CYC-ILAR|Cytokine and CAM Antagonists|03/27/2018|
00078077720|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00078077767|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00085113204|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00085126401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00085134101|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085134102|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085134107|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085146102|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085433301|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085433401|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00085461001|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00085720601|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00093005001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093005001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093005001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093005001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093005801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093005801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093005801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005805|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093005805|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093005805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093005805|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093007301|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093007401|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093015001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093015001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093015001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093015001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093015001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093015010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093015010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093015010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093015010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093015010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093030801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093031401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093031401|CE:KET-KET|Ketorolac|05/25/2012|
00093035001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093035001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093035001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093035001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093035005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093035005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093035005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093035010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093035010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093035010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093057610|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093057610|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
00093071101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093071105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075506|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093075705|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093077198|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
00093077198|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093083201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/31/2022
00093083201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/31/2022
00093083201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/31/2022
00093083201|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|03/31/2022
00093092401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093092405|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093092606|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
00093092606|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093092610|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
00093092610|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093092810|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093094801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093094805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093100501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093100505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093100601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093100605|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093111801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093112201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093171201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171210|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171301|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171310|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171401|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171410|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171601|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093171801|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093172001|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093172101|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093172110|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093172301|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00093206301|CE:APY-SGA|Antipsychotics|04/10/2016|
00093206801|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
00093206901|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
00093207001|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
00093308601|CE:APY-SGA|Antipsychotics|04/10/2016|07/30/2021
00093308684|CE:APY-SGA|Antipsychotics|04/10/2016|
00093308701|CE:APY-SGA|Antipsychotics|04/10/2016|07/30/2021
00093308784|CE:APY-SGA|Antipsychotics|04/10/2016|07/30/2021
00093309056|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00093309256|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00093309356|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00093309456|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00093312242|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093312298|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093317431|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00093321201|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093321201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093321201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093321201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093321305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093321305|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093321305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093321305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093322308|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093322397|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093322555|CE:DUP-NSD|Duplicate Therapy|02/05/2013|05/01/2021
00093323001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093323001|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00093323101|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093323201|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093333406|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00093354143|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093354256|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354356|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354456|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354556|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354656|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354756|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093354856|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093360782|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00093360882|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00093360982|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00093365640|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365640|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365640|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093365640|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093365640|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093365740|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093365740|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093365740|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365740|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093365740|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365840|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093365840|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093365840|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365840|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365940|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093365940|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093365940|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093365940|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093365940|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093414556|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00093414656|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00093414756|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00093414856|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00093435901|CE:APY-SGA|Antipsychotics|04/10/2016|
00093435905|CE:APY-SGA|Antipsychotics|04/10/2016|
00093435993|CE:APY-SGA|Antipsychotics|04/10/2016|
00093440401|CE:APY-SGA|Antipsychotics|04/10/2016|
00093440405|CE:APY-SGA|Antipsychotics|04/10/2016|
00093440505|CE:APY-SGA|Antipsychotics|04/10/2016|
00093440593|CE:APY-SGA|Antipsychotics|04/10/2016|
00093482210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093482210|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093482210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093482210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093500256|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093500256|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093500356|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093500356|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093500456|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093500456|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093500556|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093500556|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093500656|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093500656|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093504501|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093504601|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093505698|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00093505698|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093505798|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093505898|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093505898|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00093505998|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00093505998|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093506001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506005|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506105|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093506205|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093520601|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|07/29/2020
00093524565|CE:APY-SGA|Antipsychotics|04/10/2016|
00093524565|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
00093524665|CE:APY-SGA|Antipsychotics|04/10/2016|
00093524665|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
00093524765|CE:APY-SGA|Antipsychotics|04/10/2016|
00093524865|CE:APY-SGA|Antipsychotics|04/10/2016|
00093526801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|09/03/2020
00093526901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|09/03/2020
00093529201|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093529301|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093529501|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00093529501|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093529601|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00093529601|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093529701|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093529801|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093534601|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00093534601|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093534701|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093534801|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00093540189|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
00093541601|CE:APY-SGA|Antipsychotics|04/10/2016|
00093541701|CE:APY-SGA|Antipsychotics|04/10/2016|
00093541784|CE:APY-SGA|Antipsychotics|04/10/2016|
00093541901|CE:APY-SGA|Antipsychotics|04/10/2016|
00093541984|CE:APY-SGA|Antipsychotics|04/10/2016|
00093545528|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093545542|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00093550356|CE:APY-SGA|Antipsychotics|04/10/2016|
00093550456|CE:APY-SGA|Antipsychotics|04/10/2016|
00093550556|CE:APY-SGA|Antipsychotics|04/10/2016|
00093550656|CE:APY-SGA|Antipsychotics|04/10/2016|
00093550756|CE:APY-SGA|Antipsychotics|04/10/2016|
00093551798|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00093553756|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093553801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093553901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00093555001|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093555001|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00093555101|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093555101|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00093555201|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093555301|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093555401|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093556201|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00093573101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093573101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093573101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573101|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00093573101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093573201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093573201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573201|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093573201|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00093573201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093573201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573301|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093573301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573301|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00093573301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093573301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093573401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093573401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093573401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573401|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00093573401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093573401|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00093576801|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|08/10/2020
00093576801|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093576810|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093576810|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|08/10/2020
00093576856|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|08/10/2020
00093576856|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093576901|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093576901|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|08/10/2020
00093577001|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|08/10/2020
00093577001|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093577101|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093577110|CE:APY-SGA|Antipsychotics|04/10/2016|08/10/2020
00093585001|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
00093585005|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
00093585101|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
00093596001|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093596101|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093596301|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093596401|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00093645056|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00093645098|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00093681573|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00093681673|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00093681773|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00093702898|CE:DUP-ARB|Duplicate Therapy|02/05/2013|07/31/2020
00093715310|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/31/2020
00093715310|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|08/31/2020
00093716305|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00093716356|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00093716398|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00093716501|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093716501|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093716505|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093716505|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093716601|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093716601|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093716605|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093716605|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093717006|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093717006|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093717201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00093720110|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
00093720110|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093720198|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
00093720198|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093720210|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093720210|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
00093720298|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093720298|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
00093727010|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093727098|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093727105|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727156|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727198|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727205|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727256|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727298|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727305|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727356|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093727398|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00093729001|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
00093729056|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
00093730606|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00093730606|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00093735056|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00093736710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736710|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
00093736756|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
00093736756|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736756|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736798|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736798|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
00093736798|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736856|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736856|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736898|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736898|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736910|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736910|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736956|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736956|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093736998|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093736998|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093738001|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|04/30/2021
00093738456|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00093738498|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00093738556|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
00093738598|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
00093739286|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
00093742456|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093742498|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093742556|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093742598|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093742656|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093742698|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093744201|CE:DRO-FLUVA20|Drug Regimen Optimization|01/31/2011|
00093744201|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093744256|CE:DRO-FLUVA20|Drug Regimen Optimization|01/31/2011|
00093744256|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093744301|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093744301|CE:DRO-FLUVA40|Drug Regimen Optimization|01/31/2011|
00093744356|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093744356|CE:DRO-FLUVA40|Drug Regimen Optimization|01/31/2011|
00093744501|CE:DUP-OCS|Duplicate Therapy|02/04/2016|03/09/2021
00093744501|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|03/09/2021
00093744601|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093744656|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00093748756|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00093761556|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093761556|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093761656|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093761656|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093761698|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093761698|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093761756|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093761756|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093770198|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00093777201|CE:APY-SGA|Antipsychotics|04/10/2016|
00093777205|CE:APY-SGA|Antipsychotics|04/10/2016|
00093777293|CE:APY-SGA|Antipsychotics|04/10/2016|
00093786565|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093786565|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786565|CE:ACT-ACTIQ200|Actiq Lozenges|01/31/2011|
00093786565|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093786565|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786565|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093786665|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786665|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093786665|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00093786665|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093786665|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093786665|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786765|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786765|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00093786765|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093786765|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093786765|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093786765|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786865|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786865|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093786865|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093786865|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786865|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00093786865|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093786965|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786965|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093786965|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093786965|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093786965|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093786965|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00093787065|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093787065|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00093787065|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00093787065|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00093787065|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00093787065|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00093816201|CE:APY-SGA|Antipsychotics|04/10/2016|
00093816301|CE:APY-SGA|Antipsychotics|04/10/2016|
00093816401|CE:APY-SGA|Antipsychotics|04/10/2016|
00093816501|CE:APY-SGA|Antipsychotics|04/10/2016|
00093816601|CE:APY-SGA|Antipsychotics|04/10/2016|
00093823256|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093823256|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093823298|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093823298|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093823856|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093823856|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093823898|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00093823898|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00093914801|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00095008735|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/26/2020
00095008735|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/26/2020
00095008851|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/26/2020
00095008851|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/26/2020
00095008921|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/26/2020
00095008921|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/26/2020
00095086006|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|08/10/2020
00095086006|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00113005705|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113016626|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113046162|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113057826|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00113057826|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00113060471|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113060478|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113060490|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113061239|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00113061265|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00113066026|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113089726|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113089734|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00113091555|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
00115127701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115127701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115127701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115127701|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115127701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115127801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115127801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115127801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115127801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115127801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115127901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115127901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115127901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115127901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115127901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115128001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115128001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115128001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115128101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115128101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115128201|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115128201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115128201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115128201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115143613|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00115143613|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115143613|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115143713|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115143713|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00115143713|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115147901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115147901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115147901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115147901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115147901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115148361|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00115148601|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115148601|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
00115148701|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
00115148701|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115148801|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
00115148801|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115148901|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115149001|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115149101|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00115151866|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00115155601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115155601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155601|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115155601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115155601|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115155601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115155701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155701|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115155701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115155701|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115155801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115155801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115155801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115155801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155801|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115155801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155901|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115155901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115155901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115155901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115155901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115156001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115156001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115156001|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115156001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115156101|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115156101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115156101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115156101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115156101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115156201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00115156201|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00115156201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00115156201|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00115165701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|10/31/2020
00115165703|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/08/2020
00115165801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|10/31/2020
00115165803|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/08/2020
00115167102|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/08/2020
00115168774|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00115168974|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00115169606|CE:DUP-OCS|Duplicate Therapy|02/04/2016|03/23/2021
00115169606|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|03/23/2021
00115169701|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|04/07/2021
00115169701|CE:DUP-OCS|Duplicate Therapy|02/04/2016|04/07/2021
00115170001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|06/23/2021
00115170001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|06/23/2021
00115170210|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|08/08/2020
00115170310|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|08/08/2020
00115170410|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|08/08/2020
00115170901|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115171001|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115173601|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115173601|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00115173701|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115173701|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00115173801|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115173901|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115174001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115174101|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00115174501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115174501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115174801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115174801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115175701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00115180001|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00115180101|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00115180201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00115180301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00115180302|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00115180401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00115180402|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00115201101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115201101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115201102|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115201102|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00115532201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00115681108|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00115681110|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00115691101|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|08/08/2020
00115691102|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|08/08/2020
00115991801|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00115991801|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115991901|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00115991901|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115992001|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115992101|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115992201|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00115992710|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00115992810|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00115992910|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00115993078|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00115993178|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00115993278|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00121050404|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121050404|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121050404|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121050404|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121050416|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121050416|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121050416|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121050416|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121058104|CE:APY-FGA|Antipsychotics|04/10/2016|
00121065304|CE:APY-FGA|Antipsychotics|04/10/2016|
00121065402|CE:APY-FGA|Antipsychotics|04/10/2016|
00121075908|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00121075908|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00121077204|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077204|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121077204|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00121077204|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121077204|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077216|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121077216|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077216|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121077216|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077216|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00121077308|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00121077308|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00121077504|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00121077504|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077504|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121077504|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077504|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121077508|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121077508|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077508|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121077508|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00121077508|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077516|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00121077516|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00121077516|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077516|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00121077516|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00121077708|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00121077708|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00143129005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2022
00143129005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2022
00143129201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
00143129201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
00143129205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2022
00143129205|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2022
00143310701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/10/2020
00143310801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/10/2020
00143970001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00143970001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00168041630|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168041660|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168041699|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168041730|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168041760|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168041799|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00168043224|CE:IMI-IMIQ5|Imiquimod|07/16/2012|
00168084401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00169291115|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169291115|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00169406012|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169406012|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00169406013|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169406013|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00169413212|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169413212|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00169413602|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00169413602|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169430313|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169430713|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169431413|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00169517603|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00169517604|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00169770321|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00169770421|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00169770521|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00169770821|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00172208360|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00172208380|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00172208960|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00172208980|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00172392560|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392560|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392560|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392560|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392570|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392570|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392570|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392570|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392660|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392660|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392670|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392670|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392670|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392670|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392680|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392680|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392680|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392680|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392760|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392760|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392760|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392760|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392770|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392770|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392770|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392770|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392780|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00172392780|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392780|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00172392780|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00173052100|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
00173060002|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173060102|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173060202|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173068220|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00173068224|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00173069500|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173069600|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173069700|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071520|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071522|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071620|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071622|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071720|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071722|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173071820|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173071920|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173072020|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173085910|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173085914|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173086118|CE:TZD-ROSIGLIT|Hypoglycemics  TZD|01/31/2011|
00173086313|CE:TZD-ROSIGLIT|Hypoglycemics  TZD|01/31/2011|
00173086910|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00173087410|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173087610|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00173088210|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173088408|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
00173088710|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173088714|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00173088810|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00185002201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185002201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185002210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185002210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185007201|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/26/2020
00185007201|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|08/26/2020
00185007210|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
00185007210|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00185007260|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|08/26/2020
00185007260|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/26/2020
00185007401|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/26/2020
00185007460|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/26/2020
00185014101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00185014501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|07/31/2020
00185014505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|07/31/2020
00185014601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|07/31/2020
00185021101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00185023601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00185027701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00185032501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00185044801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185044801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00185061501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00185061505|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00185067401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00185067405|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00185067501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00185067510|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00185068701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00185083101|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00185084201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00185085301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00185086401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00186037020|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00186037220|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00186038230|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|02/01/2022
00186038290|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00186091612|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00186091706|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00186198804|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00186198904|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00186199004|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00186502031|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00186502054|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00187000402|CE:CYC-SILI|Cytokine and CAM Antagonists|03/27/2018|
00187014601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00187065820|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00187065920|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00187073030|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00187073090|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00187510001|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00187510102|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00187510203|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00228202710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202710|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202750|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202750|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202796|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202796|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202796|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202796|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202910|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202950|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202950|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202950|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202950|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202996|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202996|CE:ALP-ALP|Alprazolam|05/28/2015|
00228202996|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228202996|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203110|CE:ALP-ALP|Alprazolam|05/28/2015|
00228203110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203150|CE:ALP-ALP|Alprazolam|05/28/2015|
00228203150|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203150|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203150|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203196|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203196|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203196|CE:ALP-ALP|Alprazolam|05/28/2015|
00228203196|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203910|CE:ALP-ALP|Alprazolam|05/28/2015|
00228203910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228203910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206710|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228206710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206910|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228206910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228206910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207310|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228207610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207610|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228207610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207650|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207650|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207650|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228207710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228207710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207750|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228207750|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00228207750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228234810|CE:PTU-PTU|Propylthiouracil|04/18/2011|
00228255006|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228255011|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228255096|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228255106|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228255111|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228255196|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00228263611|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00228263650|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00228263711|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00228263750|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00228282011|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00228285011|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00228285111|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00228285311|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00228285511|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00228287611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00228287611|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
00228287611|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
00228287611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
00228287611|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/10/2020
00228287811|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/23/2021
00228287811|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|03/23/2021
00228287811|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|03/23/2021
00228287811|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228287811|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/23/2021
00228287911|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00228287911|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228287911|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|02/28/2021
00228287911|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|02/28/2021
00228287911|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
00228300511|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/09/2021
00228300511|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|04/09/2021
00228300511|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/09/2021
00228300511|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/09/2021
00228305911|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
00228305911|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228306011|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228306111|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228306211|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228306211|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
00228306311|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228306311|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
00228306411|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00228308306|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308306|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308306|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308306|CE:ALP-ALP|Alprazolam|05/28/2015|
00228308406|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308406|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308406|CE:ALP-ALP|Alprazolam|05/28/2015|
00228308406|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308606|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308606|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308606|CE:ALP-ALP|Alprazolam|05/28/2015|
00228308606|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308706|CE:ALP-ALP|Alprazolam|05/28/2015|
00228308706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308706|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228308706|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309011|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309011|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228309011|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228309011|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228309011|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309111|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228309111|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228309111|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228309111|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309111|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309211|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228309211|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228309211|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228309211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309311|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309311|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228309311|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228309311|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228309311|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228311611|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228311611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228311611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228311611|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228311611|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228311711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228311711|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228311711|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228311711|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228311711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315303|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00228315303|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315303|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315403|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315403|CE:SUB-SUBOX|Suboxone|04/23/2013|
00228315403|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315473|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/13/2021
00228315473|CE:SUB-SUBOX|Suboxone|04/23/2013|02/13/2021
00228315473|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/13/2021
00228315503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315503|CE:SUB-SUBOX|Suboxone|04/23/2013|
00228315503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315567|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315567|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315567|CE:SUB-SUBOX|Suboxone|04/23/2013|
00228315573|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/13/2021
00228315573|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/13/2021
00228315573|CE:SUB-SUBOX|Suboxone|04/23/2013|02/13/2021
00228315603|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315603|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228315603|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00228348211|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/26/2020
00228350106|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350106|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350106|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350106|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350106|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350206|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350206|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350206|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350206|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350206|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350306|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350306|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350306|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350306|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350306|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350406|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350406|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350406|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350406|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350406|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350506|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350506|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350506|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350506|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350506|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350606|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350606|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350606|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350606|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350606|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350706|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228350706|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228350706|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228350706|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228350706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228401911|CE:ALP-ALP|Alprazolam|05/28/2015|
00228401911|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228401911|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228401911|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402211|CE:ALP-ALP|Alprazolam|05/28/2015|
00228402211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402211|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402411|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402411|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402411|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402411|CE:ALP-ALP|Alprazolam|05/28/2015|
00228402511|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402511|CE:ALP-ALP|Alprazolam|05/28/2015|
00228402511|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402511|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228402911|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228402911|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
00228402911|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
00228402911|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/30/2021
00228402911|CE:DUP-NSD|Duplicate Therapy|02/05/2013|04/30/2021
00228424106|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
00228427011|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228427011|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228427011|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228427011|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228427011|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228427111|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228427111|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228427111|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228427111|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228427111|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228431111|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228431111|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228431111|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228431111|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228431111|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228432311|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228432311|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228432311|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228432311|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00228432311|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228434711|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00228434711|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00228434711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228434711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00228434711|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00254100752|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00254203501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/31/2020
00254203501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
00254203501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/31/2020
00254203501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
00254203501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/31/2020
00254203601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00254203601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/03/2021
00254203601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/03/2021
00254203601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|02/03/2021
00254203601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|02/03/2021
00254302002|CE:ENZ-NOR|Enzymes|11/20/2019|
00254302102|CE:ENZ-NOR|Enzymes|11/20/2019|
00254302202|CE:ENZ-NOR|Enzymes|11/20/2019|
00310027110|CE:APY-SGA|Antipsychotics|04/10/2016|
00310027210|CE:APY-SGA|Antipsychotics|04/10/2016|
00310027460|CE:APY-SGA|Antipsychotics|04/10/2016|
00310027510|CE:APY-SGA|Antipsychotics|04/10/2016|
00310027810|CE:APY-SGA|Antipsychotics|04/10/2016|
00310027910|CE:APY-SGA|Antipsychotics|04/10/2016|
00310028060|CE:APY-SGA|Antipsychotics|04/10/2016|
00310028160|CE:APY-SGA|Antipsychotics|04/10/2016|
00310028260|CE:APY-SGA|Antipsychotics|04/10/2016|
00310028360|CE:APY-SGA|Antipsychotics|04/10/2016|
00310028460|CE:APY-SGA|Antipsychotics|04/10/2016|
00310075190|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
00310075190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00310075290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00310075290|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
00310075430|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00310075590|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00310075590|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
00310196930|CE:GIM-MOV|GI Motility|01/18/2017|
00310197030|CE:GIM-MOV|GI Motility|01/18/2017|
00310460012|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00310460039|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00310610030|CE:DPP-SAX2|DPP-4 Inhibitors|09/25/2018|
00310610090|CE:DPP-SAX2|DPP-4 Inhibitors|09/25/2018|
00310610530|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310610590|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310612560|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00310613530|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00310614530|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00310651201|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310651201|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00310652401|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310652401|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00310653004|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00310653004|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310654004|CE:DPP-SAX5|DPP-4 Inhibitors|09/25/2018|
00310654004|CE:GLP-GLP|GLP-1 Receptor Agonists|09/25/2018|
00310661502|CE:HIM-SYMLIN|Hypoglycemics  Incretin Mimetics/Enhancers|01/31/2011|
00310662702|CE:HIM-SYMLIN|Hypoglycemics  Incretin Mimetics/Enhancers|01/31/2011|
00310678030|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00310737020|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00310737220|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00310828360|CE:APY-SGA|Antipsychotics|04/10/2016|12/01/2020
00310828460|CE:APY-SGA|Antipsychotics|04/10/2016|02/01/2021
00378003001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378003001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378003001|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378003001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378003005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378003005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378003005|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378003005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004001|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378004001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004005|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378004005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378004201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378007001|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378007001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378007001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378007001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378007301|CE:APY-FGA|Antipsychotics|04/10/2016|
00378008101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378008301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378008401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378008601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378015001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|09/06/2020
00378016201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|09/06/2020
00378021401|CE:APY-FGA|Antipsychotics|04/10/2016|
00378021410|CE:APY-FGA|Antipsychotics|04/10/2016|
00378025701|CE:APY-FGA|Antipsychotics|04/10/2016|
00378025710|CE:APY-FGA|Antipsychotics|04/10/2016|
00378027101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027101|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378027101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027105|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378027105|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378031301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378032701|CE:APY-FGA|Antipsychotics|04/10/2016|
00378032710|CE:APY-FGA|Antipsychotics|04/10/2016|
00378033001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378033005|CE:APY-FGA|Antipsychotics|04/10/2016|
00378033401|CE:APY-FGA|Antipsychotics|04/10/2016|
00378033501|CE:APY-FGA|Antipsychotics|04/10/2016|
00378034501|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378034501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034505|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378034505|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378034701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378035101|CE:APY-FGA|Antipsychotics|04/10/2016|
00378035110|CE:APY-FGA|Antipsychotics|04/10/2016|
00378035301|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
00378040301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378042401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378042701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378043401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378044201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378044205|CE:APY-FGA|Antipsychotics|04/10/2016|
00378044501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378046001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378046401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378047101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/31/2020
00378047201|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00378047205|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00378047277|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00378047701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378047701|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378047701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378047701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378047705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378047705|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378047705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378047705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378050701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378053101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378057401|CE:APY-FGA|Antipsychotics|04/10/2016|
00378057405|CE:APY-FGA|Antipsychotics|04/10/2016|
00378057701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378057705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378061201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378061401|CE:APY-FGA|Antipsychotics|04/10/2016|
00378061601|CE:APY-FGA|Antipsychotics|04/10/2016|
00378061801|CE:APY-FGA|Antipsychotics|04/10/2016|
00378064001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378064001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378064010|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378064010|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378064101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378064101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378064110|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378064110|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378071101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378071201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378072301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378073101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378075101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378075101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378075101|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00378075110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378075110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378075110|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00378076101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378076101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378076101|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00378077101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378077101|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00378077101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378078191|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00378078293|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00378081001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378081005|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378082501|CE:APY-SGA|Antipsychotics|04/10/2016|
00378086001|CE:APY-SGA|Antipsychotics|04/10/2016|
00378086005|CE:APY-SGA|Antipsychotics|04/10/2016|
00378092393|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378092393|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00378092393|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378092493|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378092493|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
00378092493|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378097201|CE:APY-SGA|Antipsychotics|04/10/2016|
00378097301|CE:APY-SGA|Antipsychotics|04/10/2016|
00378100101|CE:APY-FGA|Antipsychotics|04/10/2016|
00378101201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00378107593|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378107693|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378107793|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378107893|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378113401|CE:KET-KET|Ketorolac|05/25/2012|
00378113401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378135201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378135205|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378135501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378135505|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378145201|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145205|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145401|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145405|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145801|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145805|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378145877|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378165777|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00378172193|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378172293|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378172393|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378172493|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378200201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378200393|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
00378215001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378226001|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|
00378226801|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|
00378235093|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
00378240101|CE:APY-FGA|Antipsychotics|04/10/2016|
00378240201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378240501|CE:APY-FGA|Antipsychotics|04/10/2016|
00378241001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378247401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378253701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378253710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378292093|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378292093|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
00378300001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378300177|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378300177|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378300205|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378300205|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378300277|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378300277|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378300377|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378300377|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378300501|CE:APY-FGA|Antipsychotics|04/10/2016|
00378311001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378311001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378311001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378311001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378322477|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378322477|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
00378322493|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378322493|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
00378322577|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378322577|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
00378322593|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378322593|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
00378323177|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378323177|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
00378323193|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
00378323193|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378323277|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378323293|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378334999|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378335099|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378335199|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378335299|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378336099|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378336199|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378343193|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00378343293|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00378343393|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00378350205|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|08/10/2020
00378350205|CE:APY-ARI|Antipsychotics|04/10/2016|08/10/2020
00378350291|CE:APY-ARI|Antipsychotics|04/10/2016|08/10/2020
00378350291|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|08/10/2020
00378350505|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|09/30/2020
00378350505|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378350591|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378350591|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|09/30/2020
00378351105|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351105|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|09/30/2020
00378351191|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351191|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|09/30/2020
00378351205|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|09/30/2020
00378351205|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351291|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351291|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|09/30/2020
00378351305|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351391|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351491|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
00378351501|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
00378351593|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
00378363501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00378363501|CE:DRO-CERTIR5|Drug Regimen Optimization|01/31/2011|
00378363701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00378363705|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00378395005|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395005|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00378395077|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00378395077|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395105|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00378395177|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00378395177|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395205|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00378395277|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395277|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00378395305|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378395377|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378397893|CE:APY-SGA|Antipsychotics|04/10/2016|
00378397993|CE:APY-SGA|Antipsychotics|04/10/2016|
00378398093|CE:APY-SGA|Antipsychotics|04/10/2016|
00378398193|CE:APY-SGA|Antipsychotics|04/10/2016|
00378400105|CE:ALP-ALP|Alprazolam|05/28/2015|
00378400105|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400305|CE:ALP-ALP|Alprazolam|05/28/2015|
00378400305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400505|CE:ALP-ALP|Alprazolam|05/28/2015|
00378400505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400505|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400701|CE:ALP-ALP|Alprazolam|05/28/2015|
00378400701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378400701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378401005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401005|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378401005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401077|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401077|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401077|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378401077|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378402101|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
00378402201|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
00378402401|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
00378408001|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378408001|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00378408101|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378408101|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00378408201|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378408301|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378408401|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378408501|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00378415101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378415101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378415101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00378415105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00378415105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378415105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378415105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415293|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378415293|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415293|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415293|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378415293|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378415393|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378415393|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378415393|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378415393|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378415393|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378441501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378441501|CE:ASH-FLURAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378441501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378441501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378443001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378443001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378443001|CE:ASH-FLURAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378443001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378451493|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00378451593|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00378451793|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00378451893|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00378451993|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
00378461926|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378462026|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378462126|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378462226|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378462326|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378464026|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378464126|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378464226|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378464326|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378464426|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378471022|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378471022|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378471522|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378471522|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378472501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378473022|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378473022|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378473501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378474501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378477501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378501001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378505001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378505001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505005|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378505005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505077|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378505077|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505077|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378505077|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378520001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378520905|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|08/31/2020
00378520977|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|07/31/2020
00378527001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378527101|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378527201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00378535001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378535101|CE:APY-FGA|Antipsychotics|04/10/2016|
00378535201|CE:APY-FGA|Antipsychotics|04/10/2016|
00378535301|CE:APY-FGA|Antipsychotics|04/10/2016|
00378551093|CE:APY-SGA|Antipsychotics|04/10/2016|
00378551093|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
00378551193|CE:APY-SGA|Antipsychotics|04/10/2016|
00378551193|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
00378551293|CE:APY-SGA|Antipsychotics|04/10/2016|
00378551393|CE:APY-SGA|Antipsychotics|04/10/2016|
00378557305|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00378557305|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00378557393|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00378557393|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00378557505|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00378557505|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00378557593|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00378557593|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00378580793|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378581377|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
00378581377|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378581477|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
00378581477|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378581577|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378623101|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
00378623105|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
00378623201|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
00378623205|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
00378632105|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632105|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632177|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632177|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632277|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632277|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632305|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632305|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632377|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632377|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632477|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632477|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632505|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632505|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378632577|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00378632577|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378662993|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00378668877|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
00378668899|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
00378697193|CE:TDF-TDF|Tadalafil 5mg|11/04/2019|
00378697691|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00378699152|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378699252|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378699393|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378700110|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
00378700193|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
00378700210|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
00378700293|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
00378700501|CE:APY-FGA|Antipsychotics|04/10/2016|
00378701001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378701293|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378702501|CE:APY-FGA|Antipsychotics|04/10/2016|
00378705001|CE:APY-FGA|Antipsychotics|04/10/2016|
00378711277|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
00378711277|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378711293|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378711293|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
00378712477|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378712493|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00378715501|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00378715501|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00378729453|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378729553|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378801593|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00378802077|CE:DRO-FLUVA20|Drug Regimen Optimization|01/31/2011|
00378802077|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378802093|CE:DRO-FLUVA20|Drug Regimen Optimization|01/31/2011|
00378802093|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378802177|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378802177|CE:DRO-FLUVA40|Drug Regimen Optimization|01/31/2011|
00378802193|CE:DRO-FLUVA40|Drug Regimen Optimization|01/31/2011|
00378802193|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00378808801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378808801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378808801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00378808801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378808801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378808805|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00378808805|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378808805|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378808805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378808805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378815501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00378815501|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
00378815601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00378815601|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
00378815701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00378815801|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00378820001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378827052|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378875006|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378875559|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00378876516|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876516|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876516|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876593|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876593|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876593|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876616|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876616|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876616|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876693|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876693|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876693|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876716|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876716|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876716|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876793|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876793|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876793|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876816|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876816|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876816|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876893|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378876893|CE:SUB-SUBOX|Suboxone|04/23/2013|
00378876893|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378877035|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00378911998|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378911998|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378911998|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378911998|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378911998|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378911998|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912198|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912198|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912198|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912198|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912198|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912198|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912298|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912298|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912298|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912298|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912298|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912298|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912398|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912398|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912398|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912398|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912398|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912398|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912498|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912498|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912498|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912498|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912498|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912498|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912598|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912598|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912598|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912598|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912598|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912598|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912698|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912698|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378912698|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912698|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912698|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912698|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912798|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00378912798|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912798|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378912798|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378912798|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00378912798|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378932032|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00378932132|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00378932232|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
00378963943|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00378963943|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00378963943|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00378963943|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378963943|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00378969052|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378969152|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00378969252|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00406012301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012310|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012310|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012362|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012362|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012362|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012362|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012362|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012410|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012410|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012410|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012462|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012462|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012462|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012462|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012462|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012505|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012510|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012562|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406012562|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012562|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406012562|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406012562|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406012701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00406012701|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
00406013601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00406015401|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00406037601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037705|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037705|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037705|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406037805|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406037805|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406037805|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406037805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048410|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048410|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048410|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048462|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048462|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048462|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048462|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048462|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406048505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406048505|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406048505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406048505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406051201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406051201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406051201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406051201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406051201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406051205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406051205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406051205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406051205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406051205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406052201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406052201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406052201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406052205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406052205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406052205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406052301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406052301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406052305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406052305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406052305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406052305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406052710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406052710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406052710|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406052710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406054034|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406054034|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406054034|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406054034|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406054034|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406055201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406055201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406055201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406055201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406055201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406114201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00406114401|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00406114601|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00406144501|CE:ADD-ERMETHYL|ADD/ADHD Agents|02/13/2014|
00406144501|CE:DRO-MPHTB10|Drug Regimen Optimization|01/31/2011|
00406147301|CE:ADD-ERMETHYL|ADD/ADHD Agents|02/13/2014|
00406181001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406181001|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00406182001|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00406182001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406183001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406184001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406185001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406186001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00406192303|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406192303|CE:SUB-SUBOX|Suboxone|04/23/2013|
00406192303|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406254001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406254001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406254001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406254001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406254001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406324301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406324301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406324301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406324401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406324401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406324401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406324401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406324901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406324901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406324901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406575501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406575501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406575501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406575501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406575501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406577101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406577101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406577101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406577101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406577101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406577101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800312|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406800312|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406800312|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800312|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406800312|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800315|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406800315|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406800315|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406800315|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800315|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800324|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800324|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800324|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406800324|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406800324|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406800330|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406800330|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800330|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406800330|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800330|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406800503|CE:SUB-SUBOX|Suboxone|04/23/2013|
00406800503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406800503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406802003|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406802003|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406802003|CE:SUB-SUBOX|Suboxone|04/23/2013|
00406831501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406831501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406831501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406831501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406831501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406832001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406832001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406832001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406832001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406832001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406833001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406833001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406833001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406833001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406833001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406838001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406838001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406838001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406838001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406838001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406839001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406839001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406839001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406839001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406839001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406851501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406851501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406851501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406851501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406851501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406851562|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406851562|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406851562|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406851562|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406851562|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406853001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406853001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406853001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406853001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406853001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406853062|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406853062|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406853062|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406853062|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406853062|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406855605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406855605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406855605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406855605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406855605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406855730|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406855730|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406855730|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406855730|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406872510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406872510|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406872510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406872510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406872510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406895801|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
00406895901|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
00406896001|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00406896101|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00406896201|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
00406900076|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406900076|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406900076|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406900076|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406900076|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00406900076|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406901276|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406901276|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406901276|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406901276|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00406901276|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406901276|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406902576|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406902576|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406902576|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406902576|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00406902576|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406902576|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406905076|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406905076|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406905076|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406905076|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00406905076|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406905076|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406907576|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406907576|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406907576|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00406907576|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406907576|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406907576|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
00406920230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920230|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406920230|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406920230|CE:ACT-ACTIQ200|Actiq Lozenges|01/31/2011|
00406920230|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406920230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920430|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00406920430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920430|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406920430|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406920430|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406920630|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406920630|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406920630|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406920630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920630|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00406920830|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406920830|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00406920830|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406920830|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406920830|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406920830|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406921230|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406921230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406921230|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406921230|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00406921230|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406921230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406921630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406921630|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
00406921630|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00406921630|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00406921630|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00406921630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991403|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406991403|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991403|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991403|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991501|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406991501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991503|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991503|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406991503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991601|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406991601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406991701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406991701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406995903|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406995903|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406995903|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406995903|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406996001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00406996001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406996001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00406996001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409113403|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409113403|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409113403|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409113403|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409113405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409113405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409113405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409113405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409118130|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409118130|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00409118130|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409118130|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409118130|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409120120|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409120120|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409120120|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409120120|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409120120|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00409120301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|07/02/2021
00409120301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409120301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/02/2021
00409120301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409120301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409125301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/02/2021
00409125301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|07/02/2021
00409125301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/02/2021
00409125401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409125401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|07/02/2021
00409125401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409125601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/02/2021
00409125601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/02/2021
00409125601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|07/02/2021
00409146301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409146301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00409146301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409146301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409146301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409146701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00409146701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409146701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409146701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409146701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409189001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409189001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409189001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409189101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409189101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409189201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409189301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409189301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00409189301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00409189301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409321312|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00409379601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00409379601|CE:KET-KETINJ|Ketorolac|05/25/2012|
00409592201|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
00409677802|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409677802|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409677802|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00409677802|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409678002|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00409678002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409678002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00409678002|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00430017015|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|05/31/2021
00430072024|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00430072124|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00430072224|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00430375414|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00456120130|CE:GIM-LIN|GI Motility|01/18/2017|
00456120230|CE:GIM-LIN|GI Motility|01/18/2017|
00456120330|CE:GIM-LIN|GI Motility|01/18/2017|
00456200501|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
00456201001|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
00456240260|CE:APY-SGA|Antipsychotics|04/10/2016|
00456240560|CE:APY-SGA|Antipsychotics|04/10/2016|
00456240563|CE:APY-SGA|Antipsychotics|04/10/2016|
00456241060|CE:APY-SGA|Antipsychotics|04/10/2016|
00456241063|CE:APY-SGA|Antipsychotics|04/10/2016|
00456401001|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
00456402001|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
00472052794|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00472103016|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00472103016|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00472103016|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00472103016|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00472103016|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00472176094|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472176098|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472176194|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472176394|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472176494|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472178310|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00472200294|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00485008001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485008001|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485009816|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485015516|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485015516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485017116|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485017116|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485017116|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
00485017116|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
00485020216|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485020216|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00485020404|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485020404|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485020404|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
00485020404|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
00485020416|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
00485020416|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485020416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485020416|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
00485020616|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485020616|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00485020816|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00485021001|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|08/22/2020
00485021001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/22/2020
00485024001|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485024001|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
00485024001|CE:DXO-DEXK|Dextromethorphan Overutilization|07/16/2012|
00485024001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00485025401|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00485025401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00487020101|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00487020103|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00487020160|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00487030101|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487950101|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487950103|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487950125|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487950160|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487990130|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487990401|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00487990425|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00517042001|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00517044001|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00517176701|CE:MAK-MAK|Makena|06/12/2015|
00517420125|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00527131201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527131201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00527131201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00527131201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527131201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00527135301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00527135301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00527135301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00527135301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527135301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527135401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00527135401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00527135401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00527135401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527135401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527135501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527135501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00527135501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00527135501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00527135501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527139401|CE:APY-FGA|Antipsychotics|04/10/2016|
00527139501|CE:APY-FGA|Antipsychotics|04/10/2016|
00527139601|CE:APY-FGA|Antipsychotics|04/10/2016|
00527139701|CE:APY-FGA|Antipsychotics|04/10/2016|
00527143501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527143501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00527163201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00527163210|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00527178801|CE:APY-FGA|Antipsychotics|04/10/2016|
00527178901|CE:APY-FGA|Antipsychotics|04/10/2016|
00527179001|CE:APY-FGA|Antipsychotics|04/10/2016|
00527179005|CE:APY-FGA|Antipsychotics|04/10/2016|
00527179101|CE:APY-FGA|Antipsychotics|04/10/2016|
00527179105|CE:APY-FGA|Antipsychotics|04/10/2016|
00527217037|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00527293037|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293037|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293043|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293043|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293137|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293137|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293237|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293237|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293243|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293243|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293337|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293337|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293341|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293341|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293437|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293437|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293441|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527293441|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293537|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00527293537|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00527331037|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
00527331037|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00527331137|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00527331137|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
00527331237|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00527331337|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
00527457937|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527457937|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00527458037|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00527458037|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527458137|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527458237|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527458337|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527458437|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00527530264|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00527530264|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00527530264|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00527530270|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00527530270|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00527530270|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00527810637|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00527810637|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527810737|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00527810737|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527810837|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527810937|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527811037|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527811137|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527811237|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00527811337|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00536100601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536100601|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536100610|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536100610|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536101001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536101506|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
00536101801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536101810|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536103413|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00536106834|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|
00536106834|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536108901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00536109301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00536109306|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00536109401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00536114419|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00536114492|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536114493|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00536114730|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00536116134|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536116134|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
00536116134|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536116137|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
00536116137|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536116137|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536116361|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536116361|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536117801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536117810|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536118285|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00536118297|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00536118485|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00536118485|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536118497|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00536118497|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536120521|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536120521|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536120536|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536120536|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00536121388|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00536121388|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
00536121429|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536123613|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00536123688|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00536124207|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536125775|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00536125859|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00548560100|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560200|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560300|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560400|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560500|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560600|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00548560700|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00555003302|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555003302|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555003302|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555003302|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555003305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555003305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555003305|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555003305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009496|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009496|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009496|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009496|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555009596|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009596|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555009596|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009596|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009696|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555009696|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009696|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009696|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009796|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009796|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009796|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009796|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555009896|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555009896|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009896|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555009896|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015802|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015802|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015802|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555015802|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015804|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015804|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555015804|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015804|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015902|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015902|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015902|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555015902|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015904|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00555015904|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015904|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555015904|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00555030202|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00555030204|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00555032302|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00555032304|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00555032402|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00555048302|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00555048305|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00555077502|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555077602|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555077702|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555078702|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|08/31/2020
00555078702|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|08/31/2020
00555078802|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|09/30/2020
00555078902|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|08/31/2020
00555079202|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|09/30/2020
00555088602|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00555088604|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00555088702|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00555088704|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00555089902|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00555095202|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
00555095302|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
00555097102|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555097202|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555097302|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00555097402|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
00574022701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00574022801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00574022901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00574024001|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00574024101|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00574024201|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00574087005|CE:DUP-HRT|Duplicate Therapy|02/05/2013|02/28/2022
00574087205|CE:DUP-HRT|Duplicate Therapy|02/05/2013|01/31/2022
00574110404|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00574110404|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00574110404|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00574110416|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00574110416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00574110416|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00574206727|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00574704012|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00574704012|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00574704012|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00574704012|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574704012|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574704512|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574704512|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00574704512|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00574704512|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574704512|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00574722406|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00574722406|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574722406|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00574722406|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00574985010|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|01/31/2022
00574985010|CE:DUP-OCS|Duplicate Therapy|02/04/2016|01/31/2022
00574985510|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00574985510|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591024001|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024005|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024010|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024101|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024105|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024105|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024110|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024201|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024205|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024205|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024210|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591024210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591024210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591034701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591034705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591034801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591034805|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591034810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591036901|CE:APY-FGA|Antipsychotics|04/10/2016|
00591037001|CE:APY-FGA|Antipsychotics|04/10/2016|
00591037101|CE:APY-FGA|Antipsychotics|04/10/2016|
00591037201|CE:APY-FGA|Antipsychotics|04/10/2016|
00591039501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591039501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591039501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591039501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00591039501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591039719|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591039760|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591039860|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591042401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591042405|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591074401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591074401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591074401|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591074401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591074501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591074501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591074501|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00591074501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591079001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/31/2020
00591079001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/31/2020
00591079021|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591079021|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591084401|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
00591084410|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
00591086001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591086005|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591086101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591086105|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591086201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591086205|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591090030|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
00591234101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591234101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591246401|CE:DES-DESMO|Desmopressin|05/25/2012|
00591246501|CE:DES-DESMO|Desmopressin|05/25/2012|
00591252001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591252001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591252005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591252005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591264101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591264101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591264101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00591264101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591269301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591269301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591269301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591269301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591269301|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00591269301|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00591270801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591270801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591270801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00591270801|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
00591270801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591270801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591292754|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591294430|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00591294460|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00591294487|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
00591299239|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|05/11/2021
00591322001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591322001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00591322001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591322001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591322001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591325601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591325601|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00591325601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591333001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591333001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591333001|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00591333105|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00591333119|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00591333130|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00591335401|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00591335501|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
00591346753|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591346853|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591349901|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00591349901|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00591349930|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00591349930|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00591350001|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00591350001|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00591350030|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
00591350030|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
00591354601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591354601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591354601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591354601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00591354601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591354605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00591354605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00591354605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00591354605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591354605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591355101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/05/2020
00591355101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/05/2020
00591355101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/05/2020
00591355101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/05/2020
00591355101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/05/2020
00591367001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591367005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591367101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591367105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591369230|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369319|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369330|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369419|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369430|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369519|CE:APY-SGA|Antipsychotics|04/10/2016|
00591369530|CE:APY-SGA|Antipsychotics|04/10/2016|
00591379730|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591379760|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591379783|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
00591398260|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00591398260|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00591398301|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00591398301|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00591398305|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00591398305|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00591398401|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00591398401|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00591398405|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00591398405|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00591410101|CE:APY-FGA|Antipsychotics|04/10/2016|
00591410201|CE:APY-FGA|Antipsychotics|04/10/2016|
00591410301|CE:APY-FGA|Antipsychotics|04/10/2016|
00591410401|CE:APY-FGA|Antipsychotics|04/10/2016|
00591437530|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|05/31/2021
00591505201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591505201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591505210|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591505210|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591530701|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00591530710|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00591531901|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00591544201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591544205|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544205|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591544210|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544210|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591544301|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591544301|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544305|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544305|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591544310|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00591544310|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00591551301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591551301|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
00591551301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591551305|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
00591551305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591551305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591551310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591551310|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
00591551310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565801|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00591565801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565805|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00591565805|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565810|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
00591565810|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591565810|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00591566001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591566005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591566101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591566105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00591578201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591578301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00591588201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00591588301|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00591588401|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
00597002402|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00597002901|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00597002901|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
00597002901|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
00597003001|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
00597003001|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00597003937|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
00597003937|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004037|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004037|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
00597004137|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004237|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004237|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00597004337|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004337|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00597004437|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00597004437|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00597014030|CE:DPP-LIN5|DPP-4 Inhibitors|09/25/2018|
00597014090|CE:DPP-LIN5|DPP-4 Inhibitors|09/25/2018|
00597014618|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597014660|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597014718|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597014760|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597014818|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597014860|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597015531|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|07/31/2021
00597015561|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00597015570|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
00597016430|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597016490|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597018230|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597018239|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597018290|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597019261|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
00597027073|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597027094|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597027533|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597027581|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
00597035509|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00597035556|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00597036055|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00597036082|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00603158658|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|08/08/2020
00603158658|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|08/08/2020
00603158658|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|08/08/2020
00603158658|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|08/08/2020
00603158658|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/08/2020
00603233721|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603233721|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233721|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603233721|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603233721|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233821|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233821|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603233821|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233821|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603233821|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603233832|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233832|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603233832|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603233832|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233832|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603233921|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233921|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603233921|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233921|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603233921|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603233928|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233928|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603233928|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603233928|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603233928|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603255321|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603255321|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603255321|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603255321|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603255321|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603358121|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
00603358128|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
00603358221|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
00603358228|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
00603358421|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603358421|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603358421|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603358421|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603358421|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00603358421|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603358621|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603358621|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603358621|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603358621|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603358621|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00603358621|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603388728|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603388728|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603388728|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603388728|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603388728|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603388732|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603388732|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603388732|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603388732|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603388732|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389028|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389028|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389028|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389028|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603389028|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389032|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603389032|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389032|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389032|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389032|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389128|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389128|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603389128|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389128|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389128|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389132|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389132|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389132|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389132|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389132|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603389721|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389721|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603389721|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00603389721|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389721|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389721|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389728|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603389728|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389728|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603389728|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00603389728|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603389728|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603459315|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603459315|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603459321|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603459321|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603497821|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497821|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603497821|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603497821|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497821|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603497921|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603497921|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603497921|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497921|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603497921|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497928|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603497928|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497928|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603497928|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603497928|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603498221|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603498221|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603498221|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603498221|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603498221|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603498228|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603498228|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603498228|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603498228|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603498228|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603499821|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603499821|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603499821|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603499821|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603499821|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603499828|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603499828|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00603499828|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00603499828|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00603499828|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00603506021|CE:APY-FGA|Antipsychotics|04/10/2016|
00603506121|CE:APY-FGA|Antipsychotics|04/10/2016|
00603506128|CE:APY-FGA|Antipsychotics|04/10/2016|
00603506221|CE:APY-FGA|Antipsychotics|04/10/2016|
00603506228|CE:APY-FGA|Antipsychotics|04/10/2016|
00603506321|CE:APY-FGA|Antipsychotics|04/10/2016|
00603533521|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533521|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533532|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533532|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533621|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533621|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533715|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533715|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533721|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533721|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533731|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533731|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533732|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533732|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533815|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533815|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533821|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533821|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533828|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533828|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533831|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533831|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533832|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533832|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533921|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533921|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533928|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533928|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00603533932|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00603533932|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00641092821|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641092825|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641092921|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641092925|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641094931|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641094935|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641149535|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641149635|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00641605225|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00641605225|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00641605225|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605225|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00641605225|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605325|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00641605325|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605325|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00641605325|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605325|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00641605425|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605425|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00641605425|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00641605425|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00641605425|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00641608425|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00703001801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703001801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00703001801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00703001801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00703001801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703011003|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00703011003|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703011003|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703011003|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00703011003|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00703011303|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703011303|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00703011303|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00703011303|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00703011303|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00703219104|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|08/26/2020
00703220104|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|08/26/2020
00703505103|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
00703505401|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
00703797103|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00703797301|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00703851021|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703851023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703853023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703854023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703856023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703858021|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703858023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703861023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00703868023|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00713013212|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00713052612|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00713053612|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00781106101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106101|CE:ALP-ALP|Alprazolam|05/28/2015|
00781106101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106105|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106105|CE:ALP-ALP|Alprazolam|05/28/2015|
00781106105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781106110|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107701|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107705|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107710|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107901|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107905|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107905|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107910|CE:ALP-ALP|Alprazolam|05/28/2015|
00781107910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781107910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108901|CE:ALP-ALP|Alprazolam|05/28/2015|
00781108901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108905|CE:ALP-ALP|Alprazolam|05/28/2015|
00781108905|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781108905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781183001|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00781183010|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00781183201|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00781205101|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|
00781205105|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|07/31/2020
00781205301|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|
00781205305|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|07/31/2020
00781207401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00781207410|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00781208102|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
00781214710|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00781214731|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
00781216460|CE:APY-SGA|Antipsychotics|04/10/2016|
00781216660|CE:APY-SGA|Antipsychotics|04/10/2016|
00781216760|CE:APY-SGA|Antipsychotics|04/10/2016|
00781216860|CE:APY-SGA|Antipsychotics|04/10/2016|
00781232106|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781232151|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781232246|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781232268|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781232368|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781232901|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781232901|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
00781233501|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
00781233501|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781234301|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
00781234301|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781235201|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781236101|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
00781236101|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00781236201|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00781236201|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
00781236301|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00781236401|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
00781236801|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781237101|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
00781268201|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
00781268201|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268301|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
00781268301|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268401|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268501|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268601|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268701|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268801|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781268901|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
00781278501|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|08/01/2020
00781278510|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|08/01/2020
00781278531|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|08/01/2020
00781279001|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|08/01/2020
00781286810|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
00781286831|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
00781286892|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
00781300107|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00781300407|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00781313363|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|04/30/2021
00781315972|CE:APY-SGA|Antipsychotics|04/10/2016|
00781322464|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|05/31/2021
00781335666|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|02/28/2021
00781342868|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|01/31/2021
00781350069|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|01/31/2021
00781361268|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|04/30/2021
00781365569|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|02/28/2021
00781400436|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
00781406336|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
00781501701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/31/2020
00781502201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00781502201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00781502207|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
00781502207|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
00781506701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781506705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781507701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|09/30/2020
00781520410|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781520410|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781520431|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781520431|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781520492|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781520492|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781520610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781520610|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|08/10/2020
00781520610|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00781520631|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00781520631|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|08/10/2020
00781520631|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781520692|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781520692|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|08/10/2020
00781520692|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00781520710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781520710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781520731|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781520731|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/10/2020
00781520792|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/26/2020
00781520792|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781527664|CE:DRO-DONEODT5|Drug Regimen Optimization|01/31/2011|
00781531501|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781531601|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781531701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781531710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781531801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781531810|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00781534201|CE:APY-SGA|Antipsychotics|04/10/2016|
00781534301|CE:APY-SGA|Antipsychotics|04/10/2016|
00781534401|CE:APY-SGA|Antipsychotics|04/10/2016|
00781534601|CE:APY-SGA|Antipsychotics|04/10/2016|
00781534701|CE:APY-SGA|Antipsychotics|04/10/2016|
00781534801|CE:APY-SGA|Antipsychotics|04/10/2016|
00781538192|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00781538192|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781538292|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00781538292|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781538492|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781538492|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00781538892|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781540092|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
00781540092|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781540192|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781540192|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
00781540292|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781540292|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
00781540331|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781542010|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542031|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542092|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542110|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542131|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542192|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542210|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542231|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781542292|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
00781552810|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00781552831|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
00781555431|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00781555492|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00781555531|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00781555592|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00781556701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781556701|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|11/30/2020
00781556701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781556701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781556705|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|10/31/2020
00781556705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/31/2020
00781556705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/31/2020
00781556705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/31/2020
00781556710|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|11/30/2020
00781556710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781556710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781556710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
00781562660|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|11/30/2020
00781562760|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|01/31/2021
00781562831|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781564331|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781570010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781570010|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|08/26/2020
00781570092|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781570092|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|08/10/2020
00781570110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781570110|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
00781570131|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|08/26/2020
00781570131|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781570192|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|08/10/2020
00781570192|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781570210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781570231|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/26/2020
00781570292|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
00781591301|CE:APY-FGA|Antipsychotics|04/10/2016|
00781591401|CE:APY-FGA|Antipsychotics|04/10/2016|
00781591501|CE:APY-FGA|Antipsychotics|04/10/2016|
00781591601|CE:APY-FGA|Antipsychotics|04/10/2016|
00781591701|CE:APY-FGA|Antipsychotics|04/10/2016|
00781593631|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781593631|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
00781593731|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781593731|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
00781593831|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781593831|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
00781593892|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
00781593892|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781593931|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781593992|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00781598901|CE:APY-SGA|Antipsychotics|04/10/2016|06/30/2021
00781599201|CE:APY-SGA|Antipsychotics|04/10/2016|06/30/2021
00781710454|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781711954|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781712254|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781712983|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781713354|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781713454|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781713654|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781713883|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781714483|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781715683|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781716783|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
00781721606|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781721606|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781721606|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781721664|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781721664|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781721664|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781722706|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781722706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781722706|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781722764|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781722764|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781722764|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781723806|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781723806|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781723806|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781723864|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781723864|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781723864|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781724906|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781724906|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781724906|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781724964|CE:SUB-SUBOX|Suboxone|04/23/2013|
00781724964|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781724964|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00781751587|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00781751687|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00781751787|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
00781801701|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781801731|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00781802801|CE:APY-FGA|Antipsychotics|04/10/2016|
00781802931|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00781803201|CE:APY-FGA|Antipsychotics|04/10/2016|
00781803401|CE:APY-FGA|Antipsychotics|04/10/2016|
00781803601|CE:APY-FGA|Antipsychotics|04/10/2016|
00781803731|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00781804531|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00781804601|CE:APY-FGA|Antipsychotics|04/10/2016|
00781804701|CE:APY-FGA|Antipsychotics|04/10/2016|
00781804801|CE:APY-FGA|Antipsychotics|04/10/2016|
00781804901|CE:APY-FGA|Antipsychotics|04/10/2016|
00781805331|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
00781910572|CE:APY-SGA|Antipsychotics|04/10/2016|
00832022500|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022500|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832022500|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832022500|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022500|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832022600|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832022600|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022600|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832022600|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832022600|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022700|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832022700|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022700|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832022700|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832022700|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022800|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022800|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832022800|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832022800|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022800|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832022900|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832022900|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022900|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832022900|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832022900|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832023000|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832023000|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832023000|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832023000|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832023000|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832023300|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832023300|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00832023300|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00832023300|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00832023300|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00832030000|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030100|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030110|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030200|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030210|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030300|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030310|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030400|CE:APY-FGA|Antipsychotics|04/10/2016|
00832030410|CE:APY-FGA|Antipsychotics|04/10/2016|
00832035611|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
00832035711|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
00832048311|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00832048411|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00832048511|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
00832049411|CE:APY-FGA|Antipsychotics|04/10/2016|
00832049511|CE:APY-FGA|Antipsychotics|04/10/2016|
00832049611|CE:APY-FGA|Antipsychotics|04/10/2016|
00832049711|CE:APY-FGA|Antipsychotics|04/10/2016|
00832077760|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
00832121100|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121101|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121110|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121200|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121210|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121300|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121301|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121310|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121400|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121401|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121410|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121500|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121510|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121600|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121601|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121700|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121701|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121710|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121800|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121801|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121850|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121900|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121901|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832121950|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00832151011|CE:APY-FGA|Antipsychotics|04/10/2016|
00832152011|CE:APY-FGA|Antipsychotics|04/10/2016|
00832154011|CE:APY-FGA|Antipsychotics|04/10/2016|
00832155011|CE:APY-FGA|Antipsychotics|04/10/2016|
00832156011|CE:APY-FGA|Antipsychotics|04/10/2016|
00904001280|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904001280|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904025024|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904025024|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904025059|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904025059|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904530624|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904530660|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904530680|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904530780|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904530909|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904530920|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904535196|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00904535196|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904535196|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904552261|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
00904552361|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
00904552461|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
00904557720|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904567661|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
00904567761|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
00904568461|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|11/20/2020
00904572872|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/09/2020
00904572887|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|10/11/2020
00904572889|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|02/28/2021
00904576444|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|12/12/2020
00904578624|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|
00904579252|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904583112|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00904583315|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904583348|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904585246|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00904585340|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585360|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585440|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585461|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585540|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585560|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585561|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904585961|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/03/2020
00904585961|CE:ALP-ALP|Alprazolam|05/28/2015|09/03/2020
00904585961|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/03/2020
00904585961|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/03/2020
00904586061|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904586061|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904586061|CE:ALP-ALP|Alprazolam|05/28/2015|
00904586061|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904588061|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904588061|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904588061|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904588061|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904589161|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
00904589161|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904589261|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
00904589261|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904589361|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904589361|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
00904600760|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600760|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600760|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600760|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600761|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600761|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600761|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600761|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600860|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600860|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600860|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600860|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600861|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600861|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600861|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600861|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600960|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600960|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600960|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600960|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600961|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600961|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904600961|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904600961|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904608261|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904608461|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
00904608561|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
00904621640|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904621740|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904626908|CE:APY-SGA|Antipsychotics|04/10/2016|
00904627008|CE:APY-SGA|Antipsychotics|04/10/2016|
00904627108|CE:APY-SGA|Antipsychotics|04/10/2016|
00904627208|CE:APY-SGA|Antipsychotics|04/10/2016|
00904628361|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
00904628361|CE:APY-SGA|Antipsychotics|04/10/2016|
00904628606|CE:APY-SGA|Antipsychotics|04/10/2016|
00904628661|CE:APY-SGA|Antipsychotics|04/10/2016|
00904628706|CE:APY-SGA|Antipsychotics|04/10/2016|
00904628761|CE:APY-SGA|Antipsychotics|04/10/2016|
00904629061|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904629061|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
00904629161|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
00904629161|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904629261|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
00904629261|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904629304|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904631256|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904631256|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904631256|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
00904635761|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
00904635761|CE:APY-ARI|Antipsychotics|04/10/2016|
00904635861|CE:APY-ARI|Antipsychotics|04/10/2016|
00904635861|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
00904635961|CE:APY-ARI|Antipsychotics|04/10/2016|
00904635961|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
00904636061|CE:APY-ARI|Antipsychotics|04/10/2016|
00904636061|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
00904636161|CE:APY-ARI|Antipsychotics|04/10/2016|
00904636261|CE:APY-ARI|Antipsychotics|04/10/2016|
00904636345|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00904636361|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
00904636561|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904636561|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904636561|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904636561|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904636561|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904636961|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
00904637061|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
00904637661|CE:APY-SGA|Antipsychotics|04/10/2016|
00904637661|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
00904637761|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
00904637761|CE:APY-SGA|Antipsychotics|04/10/2016|
00904638961|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00904639061|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|04/13/2021
00904639061|CE:DUP-ARB|Duplicate Therapy|02/05/2013|04/13/2021
00904639161|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
00904639161|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
00904642661|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
00904643604|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643604|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904643604|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643604|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643660|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643660|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00904643660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643761|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643761|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643761|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904643761|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904643761|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904643861|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904643861|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904643861|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643861|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643861|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904643961|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643961|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904643961|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904643961|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904643961|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904644461|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|09/11/2020
00904644461|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/11/2020
00904644461|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/11/2020
00904644461|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/11/2020
00904644461|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904646161|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
00904646220|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904646220|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904646320|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
00904646320|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
00904646320|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904646320|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904646420|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904646420|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00904646861|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
00904646961|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
00904647761|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
00904650261|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00904650261|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00904650361|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
00904650361|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
00904650904|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651006|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651006|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
00904651061|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651061|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
00904651106|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
00904651106|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651161|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
00904651161|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651204|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
00904651204|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651304|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651404|CE:APY-ARI|Antipsychotics|04/10/2016|
00904651661|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904651761|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904651961|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
00904653061|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904653061|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904653061|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904653061|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904653061|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904653061|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00904653720|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904653720|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00904654606|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|08/30/2020
00904654661|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|08/20/2020
00904655761|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00904655761|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655761|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904655761|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904655761|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655861|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655861|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904655861|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655861|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00904655861|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904655961|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655961|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00904655961|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904655961|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904655961|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904656061|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904656061|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904656061|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904656061|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904656061|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
00904656460|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
00904656461|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
00904657004|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
00904657006|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
00904657061|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
00904658661|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00904659204|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
00904659961|CE:APY-FGA|Antipsychotics|04/10/2016|
00904660061|CE:APY-FGA|Antipsychotics|04/10/2016|
00904660161|CE:APY-FGA|Antipsychotics|04/10/2016|
00904661761|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904661861|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904663861|CE:APY-SGA|Antipsychotics|04/10/2016|
00904663961|CE:APY-SGA|Antipsychotics|04/10/2016|
00904664061|CE:APY-SGA|Antipsychotics|04/10/2016|
00904664161|CE:APY-SGA|Antipsychotics|04/10/2016|
00904664261|CE:APY-SGA|Antipsychotics|04/10/2016|
00904664361|CE:APY-SGA|Antipsychotics|04/10/2016|
00904664604|CE:LTMC-ZAF|Leukotriene Modifiers - Clinical|12/15/2015|04/23/2021
00904665640|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
00904665640|CE:APY-ARI|Antipsychotics|04/10/2016|
00904665760|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
00904666561|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00904666661|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00904666761|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
00904666825|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
00904667104|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
00904667840|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904667840|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904667840|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
00904667840|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
00904667840|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
00904671110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671146|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671152|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00904671189|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
00904671740|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671741|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671743|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671746|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671760|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671761|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671772|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671786|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904671839|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904671839|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00904674724|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904674740|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904674751|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904674759|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904674770|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904674780|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904675816|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904675816|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00904675859|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904675859|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00904676130|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904676316|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904676320|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904676520|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904676720|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904677861|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904677861|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
00904678061|CE:DUP-STN|Duplicate Therapy|02/04/2016|
00904678061|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
00904679344|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|10/31/2020
00904680361|CE:APY-SGA|Antipsychotics|04/10/2016|
00904680561|CE:APY-SGA|Antipsychotics|04/10/2016|
00904680861|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
00904681546|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904681552|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
00904681646|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904681646|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
00904681652|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904681652|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
00904683106|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904683106|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
00904685207|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904685260|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904685261|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904685272|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904685289|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904690804|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
00904697940|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904697960|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904698516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904698520|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904698640|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
00904698640|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904699544|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|
00904700635|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904701320|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
00904701320|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
00904705040|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904705060|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
00904765151|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
00904791251|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904791451|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904791459|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
00904791480|CE:DUP-NSD|Duplicate Therapy|02/05/2013|12/31/2020
00904791551|CE:DUP-NSD|Duplicate Therapy|02/05/2013|07/31/2020
00904791559|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/20/2020
00944417910|CE:ENZ-CEP|Enzymes|11/20/2019|
00955100310|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955100410|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955100610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955100810|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955101010|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955101210|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955101510|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955101601|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
00955170210|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
00955170310|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
10147068501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
10147068501|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
10147068601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
10147068701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
10147068801|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
10147068801|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
10147076100|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|07/31/2020
10147095103|CE:APY-SGA|Antipsychotics|04/10/2016|
10147095201|CE:APY-SGA|Antipsychotics|04/10/2016|
10147095203|CE:APY-SGA|Antipsychotics|04/10/2016|
10147095301|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2021
10147095303|CE:APY-SGA|Antipsychotics|04/10/2016|
10147095401|CE:APY-SGA|Antipsychotics|04/10/2016|
10147095403|CE:APY-SGA|Antipsychotics|04/10/2016|
10370010103|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
10370010150|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
10370011610|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
10370011710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
10370017009|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|02/28/2021
10370017011|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|02/28/2021
10370022111|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10370022111|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10370022111|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
10370022211|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10370022211|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
10370022211|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10370022311|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10370022311|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10370022311|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
10370025702|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
10370025702|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
10370051010|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|08/07/2021
10370051050|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|08/07/2021
10370074501|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
10702000201|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
10702000301|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
10702000310|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
10702000401|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
10702000601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000601|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000610|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000650|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000650|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000701|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000710|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000750|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
10702000750|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702000801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702000801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702000850|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000850|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702000850|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000850|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702000850|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702000901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702000901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702000901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702000950|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000950|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702000950|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702000950|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702000950|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702001001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001050|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001150|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001250|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
10702001601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
10702001606|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
10702001610|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
10702001650|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
10702001801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702001801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702001801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702001801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702001801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702001850|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702001850|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702001850|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702001850|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702001850|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702002301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702002301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702002301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702002301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702002301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005501|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
10702005503|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
10702005503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005503|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005503|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702005601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005650|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005650|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702005650|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005650|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702005701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702005750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702005750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702005750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702005750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702006501|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
10702006601|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
10702007001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702007001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702007001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702007001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007006|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702007006|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007006|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702007006|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007006|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702007101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702007101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702007101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702007101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007106|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702007106|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702007106|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007106|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702007106|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702007501|CE:DRO-MPHTB10|Drug Regimen Optimization|01/31/2011|
10702007501|CE:ADD-ERMETHYL|ADD/ADHD Agents|02/13/2014|
10702007601|CE:ADD-ERMETHYL|ADD/ADHD Agents|02/13/2014|
10702010001|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
10702010101|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
10702010201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
10702010601|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
10702010701|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
10702010801|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
10702015016|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
10702015016|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702015016|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702015016|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702015016|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702016350|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
10702016450|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
10702018401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702018401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702018401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702018701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702018701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702018701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702018750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702018750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702018750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702018750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702019001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702019001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702019001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702019001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702019010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702019010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702019010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019050|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019050|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702019050|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019050|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702019050|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702019101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702019101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702019101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702019101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
10702019101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702034301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702034401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702034401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
10702034501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
10702034501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
10702034501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
12496009001|CE:APY-SGA|Antipsychotics|04/10/2016|
12496012001|CE:APY-SGA|Antipsychotics|04/10/2016|
12496120201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120201|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120203|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120401|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120403|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120403|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120403|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120801|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120803|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496120803|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496120803|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496121201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496121201|CE:SUB-SUBOX|Suboxone|04/23/2013|
12496121201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496121203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496121203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
12496121203|CE:SUB-SUBOX|Suboxone|04/23/2013|
12830076216|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
12830076216|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
12830081616|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
12830081616|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
12830081616|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
13107000105|CE:DRO-MIRTA7.5|Drug Regimen Optimization|01/31/2011|
13107000130|CE:DRO-MIRTA7.5|Drug Regimen Optimization|01/31/2011|
13107000401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107000401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
13107000401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107000401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107000401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107000401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107000501|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
13107000505|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
13107000601|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
13107000605|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
13107001901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107001901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107001901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107001901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107001901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107001905|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107001905|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107001905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107001905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107001905|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107002001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107002001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107002001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107002005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107002005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107002005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107002101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107002101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107002101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107002101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107002105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107002105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107002105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002199|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002199|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107002199|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107002199|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107002199|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107003105|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
13107003130|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
13107003134|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
13107003501|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
13107003601|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
13107004401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107004401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107004405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107004501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004505|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107004601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107004601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107004605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107004605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107004605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107005501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107005701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107005801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107005999|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107005999|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107005999|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107005999|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107005999|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107006001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107006001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107006005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107006005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107006005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107006099|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006099|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107006099|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107006099|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107006099|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107006801|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
13107007001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
13107007201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
13107007301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
13107007401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
13107008305|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13107008305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008405|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13107008405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008501|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13107008501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13107008801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107008801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107008901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13107008901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107008901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107008901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107008901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107010301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107010301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107010401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107010701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107010701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107010801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107010801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107010801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107010901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107010901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107010901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107011905|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
13107011905|CE:APY-ARI|Antipsychotics|04/10/2016|
13107012105|CE:APY-ARI|Antipsychotics|04/10/2016|
13107012105|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
13107012360|CE:APY-ARI|Antipsychotics|04/10/2016|
13107015405|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
13107015430|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
13107015490|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
13107015505|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
13107015530|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
13107015590|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
13107015599|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
13107021101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107021101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107021105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107021201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107021301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13107021301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13107021305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13107021305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13107021305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13668000701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000705|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000805|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000810|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
13668000901|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
13668000905|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
13668000909|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
13668001001|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
13668001005|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
13668001006|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
13668001830|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
13668001930|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
13668001990|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
13668003505|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
13668003505|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003560|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003560|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
13668003605|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
13668003605|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003660|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003660|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
13668003705|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003705|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
13668003760|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003760|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
13668003805|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
13668003805|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003860|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
13668003860|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003905|CE:APY-ARI|Antipsychotics|04/10/2016|
13668003960|CE:APY-ARI|Antipsychotics|04/10/2016|
13668004005|CE:APY-ARI|Antipsychotics|04/10/2016|
13668004060|CE:APY-ARI|Antipsychotics|04/10/2016|
13668006730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668006890|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
13668006890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668006990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668006990|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
13668007090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668007905|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668007930|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668007990|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668008005|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668008030|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668008090|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668008190|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668008630|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
13668008630|CE:APY-SGA|Antipsychotics|04/10/2016|
13668008830|CE:APY-SGA|Antipsychotics|04/10/2016|
13668008830|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
13668008930|CE:APY-SGA|Antipsychotics|04/10/2016|
13668009030|CE:APY-SGA|Antipsychotics|04/10/2016|
13668009605|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
13668009690|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
13668010210|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
13668010230|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
13668010240|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
13668010290|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
13668011310|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
13668011310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011390|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
13668011390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011590|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011610|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
13668011610|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011630|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
13668011630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011690|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011690|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
13668011710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011790|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668011830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668011905|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668011930|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668011990|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668012005|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668012030|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668012090|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668013201|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
13668013210|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
13668013301|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
13668013310|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
13668013501|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
13668013505|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
13668013510|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
13668013601|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
13668013605|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
13668013610|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
13668014005|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668014030|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668014090|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668015410|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
13668015430|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
13668015490|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
13668015630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668015630|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
13668015730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668015730|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
13668015830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668015930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668015930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668016030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668016030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668016130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668016130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668016630|CE:APY-SGA|Antipsychotics|04/10/2016|
13668016630|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
13668016730|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
13668016730|CE:APY-SGA|Antipsychotics|04/10/2016|
13668016830|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
13668016830|CE:APY-SGA|Antipsychotics|04/10/2016|
13668016930|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
13668016930|CE:APY-SGA|Antipsychotics|04/10/2016|
13668017030|CE:APY-SGA|Antipsychotics|04/10/2016|
13668017130|CE:APY-SGA|Antipsychotics|04/10/2016|
13668017905|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668017905|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
13668017990|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
13668017990|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668018090|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
13668018090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668018190|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
13668018190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668018205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668018230|CE:DUP-STN|Duplicate Therapy|02/04/2016|
13668018590|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
13668018905|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
13668018930|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
13668018990|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
13668020230|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|
13668020290|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|
13668021630|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021690|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021730|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021730|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
13668021790|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
13668021790|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021830|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
13668021830|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021890|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021890|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
13668021930|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
13668021930|CE:APY-ARI|Antipsychotics|04/10/2016|
13668021990|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
13668021990|CE:APY-ARI|Antipsychotics|04/10/2016|
13668022030|CE:APY-ARI|Antipsychotics|04/10/2016|
13668022090|CE:APY-ARI|Antipsychotics|04/10/2016|
13668022130|CE:APY-ARI|Antipsychotics|04/10/2016|
13668022190|CE:APY-ARI|Antipsychotics|04/10/2016|
13668024830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668024890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668024930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668024930|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
13668024990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668024990|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
13668025030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668025190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668025230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668025230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668025290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025330|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668025330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668025390|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668028033|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668028060|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668028133|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668028160|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
13668031130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668031190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668031230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668031290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668031330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668031390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668032430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668032490|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668034330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668034430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668034530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668034630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668038230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668038230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668038530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668038530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668038630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668038630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668039730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
13668039730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668040910|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
13668040910|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668040930|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
13668040930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668040990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
13668040990|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
13668044101|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
13668044101|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
13668053194|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
13668057710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
13668057710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13668057710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13668057710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13668057710|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
13668058130|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
13668058906|CE:APY-ARI|Antipsychotics|04/10/2016|
13668059607|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
13811068930|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811068930|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811068930|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811068930|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811068930|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13811069030|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811069030|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811069030|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811069030|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13811069030|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811069130|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13811069130|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811069130|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811069130|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811069130|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811070110|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811070110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070110|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811070210|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13811070210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070210|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811070210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070210|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811070310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070310|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811070310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811070410|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
13811070410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070410|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
13811070410|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
13811070410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
13811070610|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
13811070610|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
13811070710|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
13811070710|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
13811070810|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
13811070910|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
13913000419|CE:GAB-GRAL|Anticonvulsant Agents (Gabapentin)|02/06/2018|
13913000519|CE:GAB-GRAL|Anticonvulsant Agents (Gabapentin)|02/06/2018|
13925016604|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
13925016604|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
14539067301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
14539067306|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
14539067401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
14539067405|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
14539067501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
14539067505|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
15054104005|CE:MLC-INCRELEX|Mecasemin (Increlex)|01/31/2011|
15370013010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
15370017030|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020106|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020110|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020111|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020150|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020206|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020210|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020211|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571020310|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16571040110|CE:DRO-CERTIR5|Drug Regimen Optimization|01/31/2011|
16571040110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16571040210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16571040250|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714000610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714001610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714002610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714003610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714004610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714005610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714006610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
16714008110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008111|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008211|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008212|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008310|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714008311|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714012401|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
16714012401|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
16714012501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
16714012501|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
16714012601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
16714012701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
16714022101|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|12/31/2020
16714022130|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|12/31/2020
16714022132|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|12/31/2020
16714022401|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022402|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022402|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022501|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022502|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022502|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022504|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022504|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022601|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022601|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|12/31/2020
16714022602|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022602|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|12/31/2020
16714022602|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022604|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
16714022604|CE:DUP-ARB|Duplicate Therapy|02/05/2013|12/31/2020
16714022604|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|12/31/2020
16714027102|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
16714027103|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
16714033001|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714033002|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714033201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714033202|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714045201|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045202|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045301|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045302|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045401|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045402|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045501|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045601|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714045701|CE:APY-SGA|Antipsychotics|04/10/2016|12/31/2020
16714046901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714046901|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/26/2020
16714046901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714046901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/26/2020
16714048101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/26/2020
16714048101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/26/2020
16714048102|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048102|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/26/2020
16714048102|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048102|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/26/2020
16714048102|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/26/2020
16714048103|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/26/2020
16714048103|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048103|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
16714048103|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/26/2020
16714048103|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/26/2020
16714048201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
16714048202|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|10/31/2020
16714048203|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
16714048401|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
16714049701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714049702|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714049801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714049802|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714049901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714049902|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714050301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|04/30/2021
16714050302|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|05/31/2021
16714050401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|11/30/2020
16714050402|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|05/31/2021
16714050501|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|04/30/2021
16714050502|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|04/30/2021
16714061101|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061104|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061105|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061106|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061201|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061204|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061205|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|12/31/2020
16714061206|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|12/31/2020
16714062101|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|12/31/2020
16714062102|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|12/31/2020
16714062201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|12/31/2020
16714062202|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|12/31/2020
16714065601|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
16714066101|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714066102|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714066201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714066202|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714066301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|05/31/2021
16714066302|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
16714068101|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068101|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068102|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068102|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068201|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068201|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068202|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068202|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068203|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068203|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068301|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068301|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068302|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068302|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068303|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068303|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068401|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068401|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068402|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068402|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068403|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068403|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|12/31/2020
16714068501|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068502|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714068503|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
16714070601|CE:DRO-MIRTA7.5|Drug Regimen Optimization|01/31/2011|02/28/2021
16714070701|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|04/30/2021
16714073101|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073101|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073201|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073201|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073202|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073202|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073301|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073301|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073302|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073302|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073401|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
16714073401|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
16714073501|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|09/30/2021
16714073502|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|11/30/2021
16714074701|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|11/30/2021
16714074702|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|10/31/2021
16714074703|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|12/31/2021
16714075501|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714075601|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714075701|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714075801|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714075901|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714076001|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
16714077801|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714077802|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714077901|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714077902|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714078001|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714078002|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714078101|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714078102|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
16714078301|CE:APY-ARI|Antipsychotics|04/10/2016|
16714078401|CE:APY-ARI|Antipsychotics|04/10/2016|
16714078401|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
16714078501|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
16714078501|CE:APY-ARI|Antipsychotics|04/10/2016|
16714078601|CE:APY-ARI|Antipsychotics|04/10/2016|
16714078601|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
16714078701|CE:APY-ARI|Antipsychotics|04/10/2016|
16714078801|CE:APY-ARI|Antipsychotics|04/10/2016|
16714079901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714079902|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714079903|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714079904|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714080201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080501|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080601|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080701|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714080801|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714082101|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
16714082201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
16714082301|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
16714082901|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
16714082901|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
16714083901|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|09/30/2020
16714086601|CE:APY-SGA|Antipsychotics|04/10/2016|
16714086701|CE:APY-SGA|Antipsychotics|04/10/2016|
16714086801|CE:APY-SGA|Antipsychotics|04/10/2016|
16714086901|CE:APY-SGA|Antipsychotics|04/10/2016|
16714087401|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087401|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
16714087402|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
16714087402|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087403|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
16714087403|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087501|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087501|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
16714087502|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
16714087502|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087503|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087503|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
16714087601|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
16714087601|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087602|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087602|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
16714087603|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
16714087603|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087701|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087702|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714087703|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714088301|CE:DES-DESMO|Desmopressin|05/25/2012|
16714088401|CE:DES-DESMO|Desmopressin|05/25/2012|
16714089101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714089801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714089802|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714089803|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714089901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714089902|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
16714090301|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
16714090302|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
16714090401|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
16714090402|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
16714093601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16714093701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16714094801|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714094901|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714095001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714095201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714095301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714095401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
16714097601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
16714097901|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
16714097902|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
16714098801|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714098801|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
16714098901|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
16714098901|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714099001|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16714099001|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
16714099101|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000415|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000415|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
16729000417|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000417|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
16729000515|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000515|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
16729000517|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
16729000517|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000615|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000615|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
16729000617|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
16729000617|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000715|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000717|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000815|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
16729000815|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000816|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000816|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
16729000915|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
16729000915|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000916|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
16729000916|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000917|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729000917|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
16729001015|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729001015|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
16729001016|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
16729001016|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729001017|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729001017|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
16729001115|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729001116|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729002010|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002015|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002016|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002110|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002115|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002116|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002210|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002215|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729002216|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
16729004417|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
16729004417|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729004517|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729004517|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
16729004617|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729004617|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
16729004716|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729009512|CE:APY-SGA|Antipsychotics|04/10/2016|
16729009612|CE:APY-SGA|Antipsychotics|04/10/2016|
16729009712|CE:APY-SGA|Antipsychotics|04/10/2016|
16729010912|CE:APY-SGA|Antipsychotics|04/10/2016|
16729011910|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
16729011915|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
16729013212|CE:APY-SGA|Antipsychotics|04/10/2016|
16729013600|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013600|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013600|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013600|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013616|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013616|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013616|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013616|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013700|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013700|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013700|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013700|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013716|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013716|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013716|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013716|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013800|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013800|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013800|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013800|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013816|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013816|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729013816|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
16729013816|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
16729014101|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014116|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014201|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014216|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014501|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014517|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014601|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014617|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014701|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014717|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014801|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014817|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014912|CE:APY-SGA|Antipsychotics|04/10/2016|
16729014917|CE:APY-SGA|Antipsychotics|04/10/2016|
16729015001|CE:APY-SGA|Antipsychotics|04/10/2016|
16729015016|CE:APY-SGA|Antipsychotics|04/10/2016|
16729015615|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
16729015615|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729016801|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
16729016901|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
16729018201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729018217|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729018301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729018317|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729018401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729018417|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
16729021101|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
16729021301|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
16729021510|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
16729021615|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
16729021616|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
16729027801|CE:APY-ARI|Antipsychotics|04/10/2016|
16729027810|CE:APY-ARI|Antipsychotics|04/10/2016|
16729027901|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
16729027901|CE:APY-ARI|Antipsychotics|04/10/2016|
16729027910|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
16729027910|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028001|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
16729028001|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028010|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028010|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
16729028101|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028101|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
16729028110|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028110|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
16729028201|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028210|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028301|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028310|CE:APY-ARI|Antipsychotics|04/10/2016|
16729028415|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
16729028415|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028417|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028417|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
16729028515|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028515|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
16729028517|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028517|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
16729028615|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
16729028615|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028617|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
16729028617|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028710|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028715|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729028717|CE:DUP-STN|Duplicate Therapy|02/04/2016|
16729031701|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
16729032110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729032110|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
16729032115|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
16729032115|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729032117|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729032117|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
16729032210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729032215|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729032217|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
16729041401|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
16729041417|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
16729042101|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729042110|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729042112|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729042201|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729042210|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729042212|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
16729044310|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
16729044315|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
16729044316|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
17478017224|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
17478017324|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
17478017424|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
18860010110|CE:APY-SGA|Antipsychotics|04/10/2016|11/30/2020
18860010410|CE:APY-SGA|Antipsychotics|04/10/2016|11/30/2020
18860010610|CE:APY-SGA|Antipsychotics|04/10/2016|08/31/2020
21724070105|CE:ADD-IRPROC|ADD/ADHD Agents|02/13/2014|
21922000909|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
23155000810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
23155000910|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
23155002101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
23155002201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
23155029251|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155031751|CE:APY-ARI|Antipsychotics|04/10/2016|
23155048901|CE:DES-DESMO|Desmopressin|05/25/2012|
23155049001|CE:DES-DESMO|Desmopressin|05/25/2012|
23155050001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050005|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050105|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155050205|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23155053102|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
23155060403|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
23155060403|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
23155060409|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
23155060409|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
23155060503|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
23155060503|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
23155060509|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
23155060509|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
23155062102|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
23155064409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064409|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
23155064410|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064410|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
23155064503|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
23155064503|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064509|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
23155064509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064510|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
23155064603|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064609|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23155064610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
23359003216|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
23359003216|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23359004016|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
23359004016|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
23359004016|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23359004016|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
23359004016|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23594010105|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
23594050501|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
23594050501|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
23594050521|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
23594050521|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
23594050548|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
23594050548|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
23594050550|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
23594050550|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
23635058110|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
23635058110|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
23635058110|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
23635058110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23635058110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23635058210|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
23635058210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23635058210|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
23635058210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
23635058210|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
24338002210|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
24338002210|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
24338002610|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
24338002610|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
24338085010|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085110|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085210|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085310|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085410|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085510|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24338085610|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
24385031034|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|08/10/2020
24385035926|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
24385035926|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
24385035934|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
24385035934|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
24385046378|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|10/31/2020
24385046378|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|10/31/2020
24385047199|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
24385053126|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
24385054662|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
24385060471|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
24385060478|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
24385064771|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
24385064778|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
24385099865|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
24385099875|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
24478007401|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478007501|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478007601|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478032102|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478032204|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478032305|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24478032406|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
24510005010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510005010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510005010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510005010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510005010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
24510005860|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510005860|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510005860|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510005860|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510005860|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510007510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510007510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510007510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510007510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510007510|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
24510010010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510010010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510010010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
24510010010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510010010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510011010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510011010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510011010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510011010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510011010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
24510011010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510011510|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
24510011510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510011510|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510011510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510011510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510011510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510011660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510011660|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510011660|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510011660|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510011660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510012010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510012010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510012010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
24510012010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510012010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510012010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510013010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
24510013010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510013010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510013010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510013010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510013010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510014010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
24510014010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510014010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510014010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510014010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510014010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510017460|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510017460|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510017460|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510017460|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510017460|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510023260|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510023260|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510023260|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510023260|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510023260|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510029160|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
24510029160|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24510029160|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
24510029160|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
24510029160|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24979001101|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
24979001112|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
24979003504|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24979003504|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
24979003504|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24979003604|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
24979003604|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24979003604|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
24979010102|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
24979010106|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
24979010107|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
24979053301|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
24979053401|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
24979053601|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
24979053801|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
25208020009|CE:DUP-STN|Duplicate Therapy|02/04/2016|10/01/2020
25208020109|CE:DUP-STN|Duplicate Therapy|02/04/2016|
25208020209|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27241000106|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000106|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
27241000150|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000150|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
27241000206|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000206|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
27241000250|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000250|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
27241000306|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
27241000306|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000350|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
27241000350|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000406|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000406|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
27241000450|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
27241000450|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000506|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000550|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000606|CE:APY-ARI|Antipsychotics|04/10/2016|
27241000650|CE:APY-ARI|Antipsychotics|04/10/2016|
27241001531|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001603|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001609|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001703|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001709|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001803|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001809|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241001890|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
27241005103|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005108|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005203|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
27241005203|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005208|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
27241005208|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005303|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005303|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
27241005308|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
27241005308|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005403|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005403|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
27241005408|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005408|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
27241005503|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005508|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005603|CE:APY-ARI|Antipsychotics|04/10/2016|
27241005608|CE:APY-ARI|Antipsychotics|04/10/2016|
27241008303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008403|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008503|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008603|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241008609|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
27241010806|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
27241012302|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
27241012403|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
27241012502|CE:RAN-RAN|Ranolazine|05/25/2012|
27241012602|CE:RAN-RAN|Ranolazine|05/25/2012|
27241015504|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
27241015508|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
27241017529|CE:SDF-REVSUSP|Sildenafil (Revatio)|09/01/2015|
27808003301|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
27808003501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003502|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003502|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003502|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003503|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003503|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003503|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003602|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003602|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003602|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003602|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003603|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003603|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003603|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003603|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003603|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003702|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003702|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003702|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003702|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808003702|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003703|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808003703|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003703|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808003703|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808003703|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808005801|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
27808005901|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
27808006502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808006502|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808006502|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
27808006502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808006502|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
27808006502|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
27808008201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808008201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808008201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808008201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008202|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808008202|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008202|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808008202|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808008202|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008501|CE:ADD-IRPROC|ADD/ADHD Agents|02/13/2014|
27808008601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808008601|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
27808008601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808008601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
27808008602|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
27808008602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008602|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
27808008602|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808008602|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808008602|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808009101|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
27808009201|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
27808009301|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
27808010201|CE:ADD-ERDYA|ADD/ADHD Agents|01/26/2017|
27808011401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011402|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011402|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011402|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011402|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011402|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011502|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011502|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011502|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011602|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
27808011602|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
27808011602|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
27808011602|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808011602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
27808015501|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
27808015501|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015503|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
27808015503|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015601|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015601|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
27808015603|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
27808015603|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015701|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015701|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
27808015703|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015703|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
27808015801|CE:DUP-STN|Duplicate Therapy|02/04/2016|
27808015803|CE:DUP-STN|Duplicate Therapy|02/04/2016|
28595080130|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
28595080208|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
28595080316|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
28595080316|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
28595080416|CE:DXO-DEXK|Dextromethorphan Overutilization|07/16/2012|
28595080416|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
28595080416|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
28595080416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
28595090060|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
28595090060|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
29033000101|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2020
29033000201|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
29033001201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
29033001301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
29033002602|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
29033020701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29033020701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29033020701|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
29300012401|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
29300012401|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
29300012401|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
29300012410|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
29300012410|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
29300012410|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
29300012501|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
29300012501|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
29300012510|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
29300012510|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
29300012801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300012810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300012901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300012910|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300013001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300013005|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300013010|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300013101|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
29300013201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
29300014701|CE:APY-SGA|Antipsychotics|04/10/2016|
29300014710|CE:APY-SGA|Antipsychotics|04/10/2016|
29300014801|CE:APY-SGA|Antipsychotics|04/10/2016|
29300014810|CE:APY-SGA|Antipsychotics|04/10/2016|
29300014901|CE:APY-SGA|Antipsychotics|04/10/2016|
29300015001|CE:APY-SGA|Antipsychotics|04/10/2016|
29300015101|CE:APY-SGA|Antipsychotics|04/10/2016|
29300015116|CE:APY-SGA|Antipsychotics|04/10/2016|
29300015201|CE:APY-SGA|Antipsychotics|04/10/2016|
29300018701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018713|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018805|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018813|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018905|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300018913|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
29300022010|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022013|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022019|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022110|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022113|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022119|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022210|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022213|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300022219|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
29300024105|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
29300024110|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
29300024119|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
29300024205|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
29300024210|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
29300024219|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
29300025087|CE:DRO-DONEODT5|Drug Regimen Optimization|01/31/2011|
29300025501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
29300025601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
29300025605|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
29300032813|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
29300032819|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
29300035501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29300035501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
29300035501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
29300035501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29300035505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29300035505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
29300035505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
29300035505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29300035510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
29300035510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
29300035510|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
29300035510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722017301|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722017401|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722017501|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722019101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722019101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722019101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722019205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722019205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722019205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722019205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722019301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722019301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722019301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722019305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722019305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722019401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722019401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722019401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722019401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722051010|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051010|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051090|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051090|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051110|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051110|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051190|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051190|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051210|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051210|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051290|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051290|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051310|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051310|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051390|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722051390|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|12/31/2020
31722051490|CE:DUP-STN|Duplicate Therapy|02/04/2016|12/31/2020
31722053301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722053405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722054201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
31722054301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
31722055190|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
31722056501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
31722056560|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
31722057210|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
31722057230|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
31722057290|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
31722060730|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
31722064730|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
31722065931|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
31722070005|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
31722070005|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070010|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
31722070010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070090|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
31722070090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070110|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
31722070130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070130|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
31722070190|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
31722070190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722070290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722071290|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
31722072610|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072630|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072690|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072730|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072790|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072830|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072890|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
31722072930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722072930|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
31722072990|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
31722072990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722073030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722073030|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
31722073090|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
31722073090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722073130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722073190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722073705|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
31722073730|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
31722073790|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
31722074530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722074690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722074690|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
31722074790|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
31722074790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722074890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
31722077605|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
31722077690|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
31722080236|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
31722080236|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|08/10/2020
31722080337|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
31722080337|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|08/10/2020
31722080437|CE:DUP-ARB|Duplicate Therapy|02/05/2013|08/10/2020
31722081930|CE:APY-ARI|Antipsychotics|04/10/2016|
31722082030|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
31722082030|CE:APY-ARI|Antipsychotics|04/10/2016|
31722082111|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
31722082211|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
31722082730|CE:APY-ARI|Antipsychotics|04/10/2016|
31722082730|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
31722082830|CE:APY-ARI|Antipsychotics|04/10/2016|
31722082830|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
31722082930|CE:APY-ARI|Antipsychotics|04/10/2016|
31722083030|CE:APY-ARI|Antipsychotics|04/10/2016|
31722088290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
31722088290|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
31722088390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
31722088390|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
31722088490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
31722088490|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
31722088530|CE:DUP-STN|Duplicate Therapy|02/04/2016|
31722091701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722091701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722091701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722091705|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722091705|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722091705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091705|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722091705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722091801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722091801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722091805|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722091805|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722091805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722091805|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722092601|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722092701|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722092801|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
31722092901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722092901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722092901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722092901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722092901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722093001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722093001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722093001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722093001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722093001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722093612|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
31722094101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094601|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
31722094601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094701|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
31722094701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722094901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722094901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722094901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722094901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722095005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722095005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722095101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722095101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722095101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722095101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
31722095105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
31722095105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
31722095105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
31722095201|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
31722095201|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
31722095301|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
31722095301|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
31722095401|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
31722095501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
31722095801|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
33342001510|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
33342002707|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
33342002710|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
33342002715|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
33342002907|CE:DRO-DONEODT5|Drug Regimen Optimization|01/31/2011|
33342002960|CE:DRO-DONEODT5|Drug Regimen Optimization|01/31/2011|
33342003611|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
33342003711|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
33342004707|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
33342004707|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342004710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342004710|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
33342004807|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
33342004807|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342004810|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
33342004810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342004907|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342004910|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342005407|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005410|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005415|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005507|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005510|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005515|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005607|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005610|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342005707|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342005707|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342005710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342005710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342005807|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342005807|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342005810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342005810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342006207|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342006310|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
33342006310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342006410|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342006410|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
33342006510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342006707|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
33342006707|CE:APY-SGA|Antipsychotics|04/10/2016|
33342006744|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
33342006744|CE:APY-SGA|Antipsychotics|04/10/2016|
33342006807|CE:APY-SGA|Antipsychotics|04/10/2016|
33342006807|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
33342006844|CE:APY-SGA|Antipsychotics|04/10/2016|
33342006844|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
33342006907|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
33342006907|CE:APY-SGA|Antipsychotics|04/10/2016|
33342006944|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
33342006944|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007007|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
33342007007|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007015|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
33342007015|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007107|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007115|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007207|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007215|CE:APY-SGA|Antipsychotics|04/10/2016|
33342007410|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007410|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007444|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007444|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007510|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007515|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007515|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007610|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007615|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007615|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007715|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007715|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342007810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007815|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342007815|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342008307|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
33342008307|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008311|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
33342008311|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008407|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
33342008407|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008411|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008411|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
33342008507|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008511|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008607|CE:APY-SGA|Antipsychotics|04/10/2016|
33342008611|CE:APY-SGA|Antipsychotics|04/10/2016|
33342009911|CE:APY-SGA|Antipsychotics|04/10/2016|
33342010011|CE:APY-SGA|Antipsychotics|04/10/2016|
33342010111|CE:APY-SGA|Antipsychotics|04/10/2016|
33342010207|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342010210|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342010215|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342010311|CE:APY-SGA|Antipsychotics|04/10/2016|
33342010511|CE:APY-SGA|Antipsychotics|04/10/2016|
33342011007|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342011010|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342011107|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342011110|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
33342011407|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342011407|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
33342011507|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342011507|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
33342011607|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342011607|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
33342011610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342011610|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
33342011707|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342011710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342012110|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
33342012207|CE:APY-ARI|Antipsychotics|04/10/2016|
33342012307|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
33342012307|CE:APY-ARI|Antipsychotics|04/10/2016|
33342012407|CE:APY-ARI|Antipsychotics|04/10/2016|
33342012407|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
33342012507|CE:APY-ARI|Antipsychotics|04/10/2016|
33342012507|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
33342012607|CE:APY-ARI|Antipsychotics|04/10/2016|
33342012707|CE:APY-ARI|Antipsychotics|04/10/2016|
33342013110|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342013110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013115|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013115|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342013210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013210|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342013215|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013215|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342013310|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342013310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013315|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342013315|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
33342014409|CE:APY-SGA|Antipsychotics|04/10/2016|
33342014509|CE:APY-SGA|Antipsychotics|04/10/2016|
33342014609|CE:APY-SGA|Antipsychotics|04/10/2016|
33342014709|CE:APY-SGA|Antipsychotics|04/10/2016|
33342015509|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
33342015509|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
33342015711|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
33342015711|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
33342015715|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
33342015715|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
33342015809|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
33342015809|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
33342017609|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342017657|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342017709|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342017757|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
33342017807|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342017907|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
33342017907|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342017910|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342017910|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
33342018007|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342018010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019007|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019107|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019207|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019307|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342019310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
33342020010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
33342020144|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
33342020144|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
33342020144|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
33342020144|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
33342020144|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
33342029907|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
33342030011|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
33342030111|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
35356055630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35356055630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35356055630|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
35573041302|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041302|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041304|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041304|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041402|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041402|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041404|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041404|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
35573041530|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
35573041630|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
35573041730|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
35573041830|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
35573041930|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
35573042030|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
39328004416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
41616075981|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
41616075983|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
41616076081|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
41616076083|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
42023011001|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42023011101|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42023011201|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42043016001|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
42043016001|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
42043016003|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
42043016003|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
42043016101|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
42043016101|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
42043016103|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
42043016103|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
42043016190|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
42043016190|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
42043021001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
42043021101|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
42043032003|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
42043032101|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
42043032201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
42043039002|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
42043039020|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
42043039021|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
42043040003|CE:APY-ARI|Antipsychotics|04/10/2016|
42043040103|CE:APY-ARI|Antipsychotics|04/10/2016|
42192060704|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
42192060704|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
42192060704|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42192060716|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
42192060716|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
42192060716|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42192060816|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
42195010090|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/05/2030
42195012106|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42195012106|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42195015110|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42195015110|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42195021010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
42195021010|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|08/10/2020
42195030809|CE:DUP-NSD|Duplicate Therapy|02/05/2013|12/05/2030
42195047101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42195084010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/15/2045
42195084010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/15/2045
42195084010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42195084010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/15/2045
42195084010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/15/2045
42291017430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42291017430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42291017430|CE:SUB-SUBOX|Suboxone|04/23/2013|
42291017530|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42291017530|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42291017530|CE:SUB-SUBOX|Suboxone|04/23/2013|
42292000916|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
42292002620|CE:APY-SGA|Antipsychotics|04/10/2016|
42292002720|CE:APY-SGA|Antipsychotics|04/10/2016|
42494040901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42494040901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42494040901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543000510|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
42543000590|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
42543011401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42543011501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42543014050|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42543014050|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42543014101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42543014101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42543014201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42543014201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42543043401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543043401|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
42543043401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070001|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
42543070005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070005|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
42543070005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42543070010|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
42543070205|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
42543070210|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
42543070230|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
42543070290|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
42543071290|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42571011010|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
42571011010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571011110|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
42571011110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571011210|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571011901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42571011901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42571011901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42571011901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42571011901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42571011905|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42571011905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42571011905|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42571011905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42571011905|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42571012290|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42571014260|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571014260|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014301|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571014301|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014305|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014305|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571014401|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014401|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571014405|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571014405|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014560|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
42571014560|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
42571017601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42571017701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42571022630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571022630|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
42571022730|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
42571022730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571022830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571023530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571023630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571023730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571023830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
42571025830|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42747072601|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
42799011101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42799011201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42799021701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42799021701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42799021701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42799021702|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42799021702|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42799021702|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42799081201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42799081201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42799081301|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42799081301|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42806000501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42806000501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42806000601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42806000601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42806000701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42806000701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42806000701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42806000801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42806000901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806000901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42806000901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42806000901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42806001101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42806001105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42806001201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806001210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806001401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806001410|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806001801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42806001805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
42806001901|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
42806001910|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
42806002001|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
42806002010|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
42806005505|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
42806005509|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
42806005510|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
42806005605|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
42806005609|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
42806005610|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
42806008701|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42806008801|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42806008901|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
42806015901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806015905|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806015910|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016005|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016105|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806016110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806033601|CE:APY-FGA|Antipsychotics|04/10/2016|
42806033701|CE:APY-FGA|Antipsychotics|04/10/2016|
42806033801|CE:APY-FGA|Antipsychotics|04/10/2016|
42806033901|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
42806034101|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
42806034301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
42806034401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
42806034501|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
42806034805|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
42806034809|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
42806034830|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
42806040001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
42806040001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
42806040021|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/10/2020
42806040021|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/10/2020
42806064801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806064810|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806064901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806064910|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
42806071401|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
42806071405|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
42806071501|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
42806071505|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
42858000101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858000101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858000101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858000101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858000201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858000201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858000201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858000301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858000301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858000401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858000401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858000401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858000401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858000501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858000501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858000501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858001101|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
42858004001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858004001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858004001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858004001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858004001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858005501|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
42858005501|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
42858007545|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858007645|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858007745|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858007845|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858007945|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858008045|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858008145|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858010201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858010250|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010250|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010250|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010250|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010250|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858010301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858010301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010350|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010350|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010350|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010350|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010350|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858010401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858010401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010450|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010450|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858010450|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858010450|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858010450|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858012201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858012201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858012201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858012201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858012201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858013901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858013901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858013901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858013901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858013901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858020101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858020101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858020101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858020150|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858020150|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858020150|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020150|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020150|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858020201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858020201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858020201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858020201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858020301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858020301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858020350|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020350|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858020350|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858020350|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858020350|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858021501|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
42858021501|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
42858022501|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
42858023401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858023401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858023401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858023401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858023401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858023450|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858023450|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858023450|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858023450|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858023450|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858023801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858023801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858023801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858023801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858023801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858030101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858030101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858030101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858030201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858030201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858030250|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030250|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858030250|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858030250|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030250|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858030301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858030301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858030301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858030416|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030416|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858030416|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858030416|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858030416|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858032501|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
42858033801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858033801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858033801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858033801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858033801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858035340|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858035340|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858035340|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858035340|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858040145|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040245|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040345|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040445|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040545|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040645|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858040745|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
42858041001|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
42858041616|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858041616|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858041616|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858041616|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858041616|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
42858049340|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858049340|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858049340|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858049340|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858049340|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858050103|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858050103|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858050103|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
42858050203|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
42858050203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858050203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858051501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858051501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858051501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858051501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858051501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858058640|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858058640|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858058640|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858058640|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858061001|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
42858061001|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
42858063101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858063101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858063101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858063101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858063101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858070101|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
42858070201|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
42858070303|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
42858072001|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
42858075040|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858075040|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858075040|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858075040|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858075040|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858076001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858076001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858076001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858076001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858076001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858079901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858079901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858079901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858079901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858079901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858080101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858080101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858080201|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858080201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858080201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858080301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858080301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858080301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080301|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858080401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080401|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858080401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858080401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858080501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858080501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858080501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858080501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858083940|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858083940|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858083940|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858083940|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858083940|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858090001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
42858090001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
42858090001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858090001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
42858090001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
42858093001|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43068010102|CE:APY-SGA|Antipsychotics|04/10/2016|
43068010202|CE:APY-SGA|Antipsychotics|04/10/2016|
43068010402|CE:APY-SGA|Antipsychotics|04/10/2016|
43068010602|CE:APY-SGA|Antipsychotics|04/10/2016|
43068010802|CE:APY-SGA|Antipsychotics|04/10/2016|
43068011002|CE:APY-SGA|Antipsychotics|04/10/2016|
43068011202|CE:APY-SGA|Antipsychotics|04/10/2016|
43068011304|CE:APY-SGA|Antipsychotics|04/10/2016|
43386011801|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
43386011801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386011801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386011801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386011801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386011803|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386011803|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386011803|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386011803|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386011803|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
43386035101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035610|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035610|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035610|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035810|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386035810|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386035810|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386035810|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386035810|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386043001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386043001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386043101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386043101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386043101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386043201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386043201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386043201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386043301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386043301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386043301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386043401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386043401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386043401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386043401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386048024|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386048024|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386048026|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386048026|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386048028|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386048028|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386054001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386054001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
43386054101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386054101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386054101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
43386054101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054201|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
43386054201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386054201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386054201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386054301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386054301|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
43386054301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054401|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
43386054401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386054401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386054401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386057001|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386057101|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386057201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386057301|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386057401|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386057501|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
43386068001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386068001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43386068001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43386068001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386068001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386071005|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386071009|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386071105|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386071109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386071205|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386071209|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|02/20/2021
43386076130|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43386076230|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43386086001|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
43386086101|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
43386086201|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
43386087001|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
43386087101|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
43386092060|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386092060|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43386092060|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43386092060|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43547022610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547022610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547022650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547022650|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025110|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547025110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025210|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547025310|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547025310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547025310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547026510|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547026550|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547026610|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547026650|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547026710|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547026750|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547027503|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
43547027509|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
43547027511|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
43547027703|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547027703|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
43547028010|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
43547028011|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
43547028110|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
43547028111|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
43547030203|CE:APY-ARI|Antipsychotics|04/10/2016|
43547030303|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
43547030303|CE:APY-ARI|Antipsychotics|04/10/2016|
43547030403|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
43547030403|CE:APY-ARI|Antipsychotics|04/10/2016|
43547030503|CE:APY-ARI|Antipsychotics|04/10/2016|
43547030503|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
43547030603|CE:APY-ARI|Antipsychotics|04/10/2016|
43547030703|CE:APY-ARI|Antipsychotics|04/10/2016|
43547033003|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547033003|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547033009|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547033009|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547033103|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547033103|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547033109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547033109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547033906|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
43547033906|CE:APY-ARI|Antipsychotics|04/10/2016|
43547033950|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
43547033950|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034006|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
43547034006|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034050|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
43547034050|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034106|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
43547034106|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034150|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
43547034150|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034206|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
43547034206|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034250|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
43547034250|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034306|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034350|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034406|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034450|CE:APY-ARI|Antipsychotics|04/10/2016|
43547034703|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
43547034709|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
43547034711|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
43547034750|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
43547034803|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
43547034809|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
43547034811|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
43547034850|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
43547036009|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
43547036009|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036050|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036050|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
43547036103|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036103|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
43547036109|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
43547036109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036111|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
43547036111|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036203|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547036211|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547037310|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
43547037310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547037310|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
43547037310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547037310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
43547037409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547037409|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
43547037509|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
43547037509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547037550|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
43547037550|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547038450|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547038510|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547038550|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547038609|CE:DRO-FOSI10|Drug Regimen Optimization|01/31/2011|
43547038709|CE:DRO-FOSI20|Drug Regimen Optimization|01/31/2011|
43547038950|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547039050|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
43547039103|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039103|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039203|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039203|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039209|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039209|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039303|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547039309|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039711|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039811|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547039910|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
43547039910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547039910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547039950|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
43547039950|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547039950|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040010|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
43547040010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040011|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040011|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040011|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
43547040050|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040050|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040050|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
43547040510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040610|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547040610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040611|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040611|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547040611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040711|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040711|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547040810|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040810|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040810|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040810|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547040850|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040850|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43547040850|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547040850|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43547042010|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547042050|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547042110|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547042150|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547042210|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547042250|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547043506|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
43547044103|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547044103|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547044203|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43547044203|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547044303|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
43547044303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
43598016405|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016405|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
43598016430|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
43598016430|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016505|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016505|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
43598016530|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
43598016530|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016605|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
43598016605|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016630|CE:APY-SGA|Antipsychotics|04/10/2016|
43598016630|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
43598031330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031430|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031530|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031590|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031630|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031690|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031730|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031830|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031890|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031930|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598031990|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032130|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032190|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032230|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032290|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598032330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598039467|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
43598039567|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
43598040727|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598040733|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598040752|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598049401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
43598049501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
43598049505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
43598050501|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
43598050510|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
43598050530|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
43598050910|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598050930|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598050990|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
43598055430|CE:APY-ARI|Antipsychotics|04/10/2016|
43598055530|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
43598055530|CE:APY-ARI|Antipsychotics|04/10/2016|
43598055630|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
43598055630|CE:APY-ARI|Antipsychotics|04/10/2016|
43598055730|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
43598055730|CE:APY-ARI|Antipsychotics|04/10/2016|
43598055830|CE:APY-ARI|Antipsychotics|04/10/2016|
43598055930|CE:APY-ARI|Antipsychotics|04/10/2016|
43598057860|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
43598057901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598057901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598057901|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598057930|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598057930|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598057930|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058001|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058030|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058030|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058030|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058101|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058130|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058130|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058130|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058201|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058230|CE:SUB-SUBOX|Suboxone|04/23/2013|
43598058230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
43598058310|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058390|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058410|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058430|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058490|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058510|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058530|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058590|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058610|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058630|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598058690|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598065505|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
43598065530|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
43598073330|CE:APY-ARI|Antipsychotics|04/10/2016|
43598073430|CE:APY-ARI|Antipsychotics|04/10/2016|
43598073530|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/31/2021
43598073590|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/31/2021
43598074101|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43598074130|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
43598074210|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074230|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074290|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074305|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074390|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074410|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074430|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074490|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074530|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598074590|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
43598081112|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
43598081115|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
43598082314|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
43598082331|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
43598082335|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
43598089701|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
43598089801|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
43975027710|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975027710|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
43975027810|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
43975027810|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975027910|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975027910|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
43975028010|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975028110|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975028210|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975032203|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
43975032209|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
43975033110|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975033110|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
43975033210|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975033210|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
43975033310|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975033310|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
43975033410|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975033510|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975033610|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
43975034903|CE:APY-SGA|Antipsychotics|04/10/2016|
43975035003|CE:APY-SGA|Antipsychotics|04/10/2016|
43975035103|CE:APY-SGA|Antipsychotics|04/10/2016|
43975035203|CE:APY-SGA|Antipsychotics|04/10/2016|
44087000407|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
44087000407|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44087000507|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
44087000507|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44087000607|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44087100502|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44087100502|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
44087108801|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44087108801|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
44087108801|CE:GRH-NP ZORB|Growth Hormones|01/31/2011|
44087338807|CE:GRH-NP ZORB|Growth Hormones|01/31/2011|
44087338807|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
44087338807|CE:GRH-NP SERO|Growth Hormones|01/31/2011|
44523082501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|03/31/2021
45802002683|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802005705|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802008765|CE:DPP-ALG6|DPP-4 Inhibitors|09/25/2018|
45802008801|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
45802010365|CE:DPP-ALO12|DPP-4 Inhibitors|09/25/2018|
45802011101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802012246|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802012260|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802012265|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802013326|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802014026|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802015065|CE:DPP-ALO25|DPP-4 Inhibitors|09/25/2018|
45802016000|CE:DUP-NSD|Duplicate Therapy|02/05/2013|03/01/2022
45802016972|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802021172|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802023068|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
45802023068|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
45802023089|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
45802023089|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
45802023865|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802024501|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
45802024502|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
45802024503|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
45802026065|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802030465|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802035165|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802036853|CE:IMI-IMIQ5|Imiquimod|07/16/2012|
45802036862|CE:IMI-IMIQ5|Imiquimod|07/16/2012|
45802039000|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802039001|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802039002|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802040265|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802041059|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
45802042578|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802043321|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
45802043321|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
45802043321|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
45802049078|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802049965|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
45802057178|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802062626|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802065065|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802065078|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802065087|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802068028|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802070000|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802070001|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802070002|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
45802072153|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|05/01/2022
45802072162|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|03/12/2021
45802075830|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
45802075930|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
45802088830|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
45802088855|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
45802089726|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802089734|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802091939|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802091987|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45802095226|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802095243|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45802097426|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
45963012523|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45963012524|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
45963030309|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
45963030409|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
45963030509|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
45963047903|CE:GIM-ALO|GI Motility|01/18/2017|
45963048003|CE:GIM-ALO|GI Motility|01/18/2017|
45963055511|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963055550|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963055611|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963055650|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963055711|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963055750|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
45963056508|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056530|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056608|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056630|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056708|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056730|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056808|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963056830|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
45963063301|CE:DUP-STN|Duplicate Therapy|02/04/2016|09/30/2020
45963063301|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|09/30/2020
45963063401|CE:DUP-STN|Duplicate Therapy|02/04/2016|09/30/2020
45963063401|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|09/30/2020
45963063504|CE:DUP-STN|Duplicate Therapy|02/04/2016|03/31/2021
46122001062|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
46122002903|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
46122002904|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
46122002974|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
47335017795|CE:CYC-ILU|Cytokine and CAM Antagonists|06/25/2019|
47335017923|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
47335027723|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
47335030888|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
47335034383|CE:DRO-CERTIR5|Drug Regimen Optimization|01/31/2011|
47335034383|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
47335034483|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
47335053183|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053183|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053183|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053188|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053188|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053188|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053383|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053383|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053383|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053388|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053388|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053388|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053783|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053783|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053783|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053788|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335053788|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335053788|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335053981|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
47335060313|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060313|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060313|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060313|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060318|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060318|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060318|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060318|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060388|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060388|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060388|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060388|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060413|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060413|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060413|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060413|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060418|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060418|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060418|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060418|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060513|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060513|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060513|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060513|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060588|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060588|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060588|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060588|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060688|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060688|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335060688|CE:ALP-ALP|Alprazolam|05/28/2015|
47335060688|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335085983|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335085983|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335085983|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335085983|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335085983|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335086083|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335086083|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335086083|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47335086083|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335086083|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47335086183|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335086183|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47335086183|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47335090218|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090288|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090318|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090388|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090418|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090488|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090518|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090588|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090618|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090688|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090718|CE:APY-SGA|Antipsychotics|04/10/2016|
47335090788|CE:APY-SGA|Antipsychotics|04/10/2016|
47781010444|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781015301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
47781015475|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
47781019601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781019601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781019601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781019601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781019601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781019605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781019605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781019605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781019605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781019605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781020404|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781020504|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781020604|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781020704|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781020804|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781020904|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
47781022901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781022901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781022901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781022901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781022901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781022905|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781022905|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781022905|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781022905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781022905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781023001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781023001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781023005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781023005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781023005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781023063|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023063|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781023063|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781023063|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781023063|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026505|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781026505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781026505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781026505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
47781026505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035503|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035511|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035511|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035511|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035603|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035603|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035603|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035611|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035703|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035703|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035703|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035711|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035803|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035803|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035803|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781035811|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035811|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781035811|CE:SUB-SUBOX|Suboxone|04/23/2013|
47781036801|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|03/31/2021
47781041501|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
47781041501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
47781041601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
47781041601|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
47781041701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
47781041801|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
47781042347|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042347|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042347|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781042347|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47781042347|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
47781042347|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781042447|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47781042447|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
47781042447|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042447|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781042447|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781042447|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042647|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
47781042647|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781042647|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47781042647|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042647|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042647|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781042747|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042747|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781042747|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
47781042747|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781042747|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47781042747|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042847|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
47781042847|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
47781042847|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042847|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
47781042847|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
47781042847|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
47781058568|CE:KET-KETINJ|Ketorolac|05/25/2012|
47781058568|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
49230064331|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
49230064551|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
49348001737|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
49348001737|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
49348002827|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
49348004534|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
49348019609|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
49348054301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
49348063634|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
49348070609|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
49348070610|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
49348086134|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
49348086134|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
49502060561|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
49884001908|CE:LVZ-LOVAZ|Lovaza|07/16/2012|03/31/2021
49884004801|CE:DRO-DMX5|Drug Regimen Optimization|01/31/2011|
49884004801|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884004901|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884004901|CE:DRO-DMX10|Drug Regimen Optimization|01/31/2011|
49884011074|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884011074|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884011074|CE:ALP-ALP|Alprazolam|05/28/2015|
49884011074|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884011174|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884011174|CE:ALP-ALP|Alprazolam|05/28/2015|
49884011174|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884011174|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884017211|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884017211|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884017311|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884017311|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884017411|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884017411|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884017511|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884017511|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884018511|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884018511|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884018601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884021255|CE:APY-ARI|Antipsychotics|04/10/2016|
49884021374|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884021374|CE:ALP-ALP|Alprazolam|05/28/2015|
49884021374|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884021374|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884021474|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884021474|CE:ALP-ALP|Alprazolam|05/28/2015|
49884021474|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884021474|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884024801|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884025011|CE:APY-SGA|Antipsychotics|04/10/2016|
49884025111|CE:APY-SGA|Antipsychotics|04/10/2016|
49884025211|CE:APY-SGA|Antipsychotics|04/10/2016|
49884025311|CE:APY-SGA|Antipsychotics|04/10/2016|
49884027711|CE:APY-SGA|Antipsychotics|04/10/2016|
49884030602|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030602|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030602|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884030602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030702|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030702|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030702|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884030702|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030802|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030802|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030802|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030802|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884030902|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030902|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884030902|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884030902|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884031002|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884031002|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884031002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884031002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
49884031155|CE:DRO-RISODT.5|Drug Regimen Optimization|01/31/2011|
49884031155|CE:APY-ARI|Antipsychotics|04/10/2016|
49884031191|CE:DRO-RISODT.5|Drug Regimen Optimization|01/31/2011|
49884031191|CE:APY-ARI|Antipsychotics|04/10/2016|
49884031555|CE:APY-ARI|Antipsychotics|04/10/2016|
49884031555|CE:DRO-RISODT1|Drug Regimen Optimization|01/31/2011|
49884031591|CE:DRO-RISODT1|Drug Regimen Optimization|01/31/2011|
49884031591|CE:APY-ARI|Antipsychotics|04/10/2016|
49884032055|CE:APY-SGA|Antipsychotics|04/10/2016|
49884032055|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
49884032155|CE:APY-SGA|Antipsychotics|04/10/2016|
49884032155|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
49884032255|CE:APY-SGA|Antipsychotics|04/10/2016|
49884032355|CE:APY-SGA|Antipsychotics|04/10/2016|
49884033301|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884033901|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884034701|CE:APY-FGA|Antipsychotics|04/10/2016|
49884034801|CE:APY-FGA|Antipsychotics|04/10/2016|
49884040191|CE:APY-ARI|Antipsychotics|04/10/2016|
49884040191|CE:DRO-RISODT2|Drug Regimen Optimization|01/31/2011|
49884040291|CE:APY-ARI|Antipsychotics|04/10/2016|
49884040391|CE:APY-ARI|Antipsychotics|04/10/2016|
49884042411|CE:ASN-ALISK150|Aliskiren-Containing Agents|07/16/2012|
49884042511|CE:ASN-ALISK300|Aliskiren-Containing Agents|07/16/2012|
49884042801|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884043001|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884054601|CE:ADD-ERFocali|ADD/ADHD Agents|02/13/2014|
49884054902|CE:LTMC-ZAF|Leukotriene Modifiers - Clinical|12/15/2015|
49884055402|CE:LTMC-ZAF|Leukotriene Modifiers - Clinical|12/15/2015|
49884057411|CE:DUP-ARB|Duplicate Therapy|02/05/2013|01/06/2021
49884057511|CE:DUP-ARB|Duplicate Therapy|02/05/2013|01/06/2021
49884057611|CE:DUP-ARB|Duplicate Therapy|02/05/2013|01/06/2021
49884057711|CE:DUP-ARB|Duplicate Therapy|02/05/2013|01/06/2021
49884065809|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
49884065809|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884065909|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884065909|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
49884066009|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884066009|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
49884066109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884072308|CE:LTMC-ZIL|Leukotriene Modifiers - Clinical|12/15/2015|
49884078709|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884078709|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884078711|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884078711|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884078809|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884078809|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884078811|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884078811|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884079009|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884079009|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884079011|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
49884079011|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
49884081911|CE:GIM-ALO|GI Motility|01/18/2017|
49884082011|CE:GIM-ALO|GI Motility|01/18/2017|
49884083901|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884083901|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
49884084001|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884084001|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
49884084101|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884084101|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
49884084201|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884084301|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884084401|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
49884089811|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884089911|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
49884093547|CE:DUP-NSD|Duplicate Therapy|02/05/2013|03/05/2021
49884098401|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
49884098501|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
50111045901|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111045902|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111045903|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111048201|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111048202|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111048203|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111048301|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111048302|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50111051801|CE:DUP-MLX|Duplicate Therapy|02/05/2013|08/10/2021
50228010901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228010901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228010901|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
50228010905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228010905|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
50228010905|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228010910|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
50228010910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228010910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50228013630|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50228013690|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50228014601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
50228014605|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
50228014610|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
50228017701|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228017705|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228017801|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228017805|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228017901|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228017905|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228018001|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228018005|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228018101|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228018105|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50228033910|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228033930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228033990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228034010|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228034010|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
50228034030|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
50228034030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228034090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228034090|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
50228034110|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228034130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
50228038060|CE:APY-SGA|Antipsychotics|04/10/2016|
50228038160|CE:APY-SGA|Antipsychotics|04/10/2016|
50228038260|CE:APY-SGA|Antipsychotics|04/10/2016|
50228038360|CE:APY-SGA|Antipsychotics|04/10/2016|
50228038460|CE:APY-SGA|Antipsychotics|04/10/2016|
50228042360|CE:RAN-RAN|Ranolazine|05/25/2012|
50228042460|CE:RAN-RAN|Ranolazine|05/25/2012|
50228042730|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
50228042790|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
50228043401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228043405|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228043501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228043505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228043601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228043605|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228046501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228046505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228046601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50228046605|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50242007401|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
50242007501|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
50242007601|CE:GRH-NPGROWTH|Growth Hormones|01/31/2011|
50242013801|CE:CYC-ACTE|Cytokine and CAM Antagonists|03/27/2018|
50242014301|CE:CYC-ACTE|Cytokine and CAM Antagonists|03/27/2018|
50268014411|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014411|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014411|CE:SUB-SUBOX|Suboxone|04/23/2013|
50268014415|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014415|CE:SUB-SUBOX|Suboxone|04/23/2013|
50268014415|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014511|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014511|CE:SUB-SUBOX|Suboxone|04/23/2013|
50268014511|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014515|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50268014515|CE:SUB-SUBOX|Suboxone|04/23/2013|
50268014515|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383004004|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
50383004004|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
50383004224|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
50383004224|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
50383004248|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
50383004248|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
50383004316|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383004316|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383004316|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383004316|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
50383004316|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383007916|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383007916|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383007916|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383007916|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383008716|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
50383008716|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383008716|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383008716|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383008716|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383027201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
50383028793|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383028793|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383028793|CE:SUB-SUBOX|Suboxone|04/23/2013|
50383029493|CE:SUB-SUBOX|Suboxone|04/23/2013|
50383029493|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383029493|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383031147|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
50383070530|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383070530|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
50383070530|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383070530|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383074120|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
50383080116|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
50383080116|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50383080416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50383080416|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383080416|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383080416|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
50383080416|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
50383080416|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383080416|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383092493|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383092493|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
50383092493|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383093093|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
50383093093|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383093093|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096134|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383096134|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096134|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383096134|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50383096134|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096430|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383096430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096430|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50383096504|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096504|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50383096504|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383096504|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096504|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50383096530|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096530|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50383096530|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50383096530|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50383096530|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50419045104|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045204|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045304|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045404|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045504|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045604|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419045904|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419048303|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50419049104|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50458010205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50458010205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458010205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50458010205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458010205|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
50458010205|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
50458030001|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
50458030001|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030006|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
50458030006|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030206|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030206|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
50458030503|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030611|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030611|CE:DRO-RISPM25|Drug Regimen Optimization|01/31/2011|
50458030611|CE:APY-SGA|Antipsychotics|04/10/2016|
50458030711|CE:APY-SGA|Antipsychotics|04/10/2016|
50458030711|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030811|CE:APY-ARI|Antipsychotics|04/10/2016|
50458030811|CE:APY-SGA|Antipsychotics|04/10/2016|
50458030911|CE:APY-SGA|Antipsychotics|04/10/2016|
50458030911|CE:APY-ARI|Antipsychotics|04/10/2016|
50458032001|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
50458032001|CE:APY-ARI|Antipsychotics|04/10/2016|
50458032006|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
50458032006|CE:APY-ARI|Antipsychotics|04/10/2016|
50458033001|CE:APY-ARI|Antipsychotics|04/10/2016|
50458033006|CE:APY-ARI|Antipsychotics|04/10/2016|
50458035001|CE:APY-ARI|Antipsychotics|04/10/2016|
50458035006|CE:APY-ARI|Antipsychotics|04/10/2016|
50458039760|CE:DRO-GALANT8|Drug Regimen Optimization|01/31/2011|08/10/2020
50458055001|CE:APY-SGA|Antipsychotics|04/10/2016|
50458055010|CE:APY-SGA|Antipsychotics|04/10/2016|08/26/2020
50458055101|CE:APY-SGA|Antipsychotics|04/10/2016|
50458055110|CE:APY-SGA|Antipsychotics|04/10/2016|
50458055201|CE:APY-SGA|Antipsychotics|04/10/2016|
50458055210|CE:APY-SGA|Antipsychotics|04/10/2016|
50458055401|CE:APY-SGA|Antipsychotics|04/10/2016|
50458056001|CE:APY-SGA|Antipsychotics|04/10/2016|
50458056101|CE:APY-SGA|Antipsychotics|04/10/2016|
50458056201|CE:APY-SGA|Antipsychotics|04/10/2016|
50458056301|CE:APY-SGA|Antipsychotics|04/10/2016|
50458056401|CE:APY-SGA|Antipsychotics|04/10/2016|
50458057710|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057718|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057760|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057810|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057830|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057890|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057910|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057930|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057989|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458057990|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458058010|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458058030|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458058451|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
50458058501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
50458058501|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
50458058601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
50458058701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
50458058801|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
50458058801|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
50458059560|CE:APY-ARI|Antipsychotics|04/10/2016|08/10/2020
50458059601|CE:APY-ARI|Antipsychotics|04/10/2016|
50458060601|CE:APY-SGA|Antipsychotics|04/10/2016|
50458060701|CE:APY-SGA|Antipsychotics|04/10/2016|
50458060801|CE:APY-SGA|Antipsychotics|04/10/2016|
50458060901|CE:APY-SGA|Antipsychotics|04/10/2016|
50458065060|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50458065060|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458065060|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50458065060|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458065060|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50458065960|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458065960|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50458065960|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50458065960|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50458065960|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50458080501|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
50474071079|CE:CYC-CIMZ|Cytokine and CAM Antagonists|03/27/2018|
50474071081|CE:CYC-CIMZ|Cytokine and CAM Antagonists|03/27/2018|
50742018921|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
50742018921|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
50742019001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50742019010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50742024760|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
50742025601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
50742025601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
50742025601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50742025601|CE:CCA-CARISCPD|Carisoprodol Containing Agents|01/31/2011|
50742025601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
50742025601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50742026001|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
50742026003|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
50742030805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|01/31/2021
50742062001|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
50742063560|CE:APY-SGA|Antipsychotics|04/10/2016|
50742063660|CE:APY-SGA|Antipsychotics|04/10/2016|
50742063760|CE:APY-SGA|Antipsychotics|04/10/2016|
50742063860|CE:APY-SGA|Antipsychotics|04/10/2016|
50742063960|CE:APY-SGA|Antipsychotics|04/10/2016|
50742065601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50742065601|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
50742065601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
50742065728|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50742065784|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50742065828|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50742065884|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
50991021201|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
50991021401|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
50991021401|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
50991021601|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|12/31/2021
50991021601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2021
50991022016|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
50991022016|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50991022016|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
50991022245|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|03/31/2022
50991022245|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|03/31/2022
50991062601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50991062601|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
50991073690|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
50991073890|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|02/28/2021
50991073890|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|02/28/2021
50991074001|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
50991074001|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
50991078290|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50991078290|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
50991078360|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
50991078490|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
50991082616|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
50991082616|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
51079007720|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|09/30/2020
51079007820|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
51079008620|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
51079013020|CE:APY-FGA|Antipsychotics|04/10/2016|
51079014120|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51079014120|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079014120|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079014120|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079016120|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51079016120|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|01/31/2021
51079016120|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|01/31/2021
51079016120|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|01/31/2021
51079016120|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|01/31/2021
51079019703|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
51079020820|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
51079020820|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079020920|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079020920|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
51079021020|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079021020|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
51079021103|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079028804|CE:APY-SGA|Antipsychotics|04/10/2016|
51079037420|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079037420|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079037420|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51079037420|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079037520|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079037520|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079037520|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51079037520|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079043120|CE:APY-FGA|Antipsychotics|04/10/2016|
51079045820|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079045820|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
51079046220|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|09/30/2020
51079046220|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
51079046320|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
51079046320|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|09/30/2020
51079046420|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
51079046520|CE:APY-ARI|Antipsychotics|04/10/2016|09/30/2020
51079048620|CE:APY-FGA|Antipsychotics|04/10/2016|08/31/2020
51079048720|CE:APY-FGA|Antipsychotics|04/10/2016|10/31/2020
51079048820|CE:APY-FGA|Antipsychotics|04/10/2016|12/31/2020
51079051720|CE:APY-FGA|Antipsychotics|04/10/2016|
51079051820|CE:APY-FGA|Antipsychotics|04/10/2016|
51079051920|CE:APY-FGA|Antipsychotics|04/10/2016|
51079056103|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|08/31/2020
51079056103|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|08/31/2020
51079057220|CE:APY-FGA|Antipsychotics|04/10/2016|
51079057320|CE:APY-FGA|Antipsychotics|04/10/2016|
51079057420|CE:APY-FGA|Antipsychotics|04/10/2016|
51079057520|CE:APY-FGA|Antipsychotics|04/10/2016|
51079059720|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51079073320|CE:APY-FGA|Antipsychotics|04/10/2016|
51079073420|CE:APY-FGA|Antipsychotics|04/10/2016|
51079073520|CE:APY-FGA|Antipsychotics|04/10/2016|
51079073620|CE:APY-FGA|Antipsychotics|04/10/2016|
51079074920|CE:APY-SGA|Antipsychotics|04/10/2016|
51079076608|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
51079077420|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|10/31/2020
51079077620|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51079078220|CE:DUP-STN|Duplicate Therapy|02/04/2016|
51079078220|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
51079092120|CE:APY-SGA|Antipsychotics|04/10/2016|
51079092220|CE:APY-SGA|Antipsychotics|04/10/2016|
51079093520|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51079093620|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|01/31/2021
51079093820|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|02/28/2021
51079095720|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|10/31/2020
51079095820|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
51079095920|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
51079099120|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079099120|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51079099120|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51079099120|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51079099120|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51167011301|CE:SYM-SYM|Symdeko|07/17/2018|
51167020001|CE:KAL-KALY|Kalydeco|04/29/2013|
51167030001|CE:KAL-KALY|Kalydeco|04/29/2013|
51167033101|CE:TRK-TRK|Trikafta|02/24/2020|
51167040001|CE:KAL-KALY|Kalydeco|04/29/2013|
51167050002|CE:ORK1-ORK1|Orkambi 100/125|12/04/2016|
51167060001|CE:KAL-KALY|Kalydeco|04/29/2013|
51167066101|CE:SYM-SYM|Symdeko|07/17/2018|
51167070002|CE:ORK1-ORK1|Orkambi 100/125|12/04/2016|
51167080901|CE:ORK-ORK|Orkambi|01/05/2016|
51167090001|CE:ORK1-ORK1|Orkambi 100/125|12/04/2016|
51224000150|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
51224000160|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
51224001050|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
51224001060|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
51224002150|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
51224002160|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
51224012150|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
51224012160|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
51224042510|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
51224042610|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
51248015001|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
51248015003|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
51285004001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51285004702|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51285005002|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51285006390|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51525023403|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51525029403|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51525590101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51525590101|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
51525590101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672136307|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672138508|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672138509|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672207308|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672208808|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
51672209208|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672210208|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672213008|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672213108|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672401601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672401701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672401801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672402701|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672402703|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672402801|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672402803|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672402901|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672402903|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403001|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403003|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403101|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403103|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403203|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403301|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403303|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403401|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403403|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403503|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
51672403601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672404201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404201|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51672404201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404202|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404202|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404202|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51672404202|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404301|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51672404301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404302|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404302|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51672404302|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404302|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51672404401|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51672404501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51672404601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
51672405101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672405104|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672405201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672405204|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672405301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672405304|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51672407008|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672416108|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51672529601|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
51672529701|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
51862006060|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
51862006201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006201|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862006201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006205|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006205|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|11/30/2020
51862006205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006301|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862006305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2021
51862006305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2021
51862006305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2021
51862006305|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|07/31/2021
51862006310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006310|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862006310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
51862006401|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|11/30/2020
51862006405|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|02/28/2021
51862006405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
51862006405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
51862006405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|02/28/2021
51862006410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006410|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862006410|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862006901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862006901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862007001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862007001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862007001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862007001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862018501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
51862018501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862018601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862018601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862018601|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
51862018601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862018701|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
51862018701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862018701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862018801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
51862018801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862018801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862018801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862026301|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|07/31/2020
51862026301|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|07/31/2020
51862026401|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|07/31/2020
51862026501|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|07/31/2020
51862027101|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027105|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027201|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027205|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027301|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027305|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027401|CE:APY-SGA|Antipsychotics|04/10/2016|
51862027405|CE:APY-SGA|Antipsychotics|04/10/2016|
51862031478|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|08/10/2020
51862031478|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
51862031478|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
51862031478|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031478|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031478|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/10/2020
51862031578|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031578|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031578|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|08/10/2020
51862031578|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/10/2020
51862031578|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
51862031578|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
51862031678|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031678|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
51862031678|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
51862031678|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
51862031678|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/10/2020
51862031678|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|08/10/2020
51862031778|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862031778|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862031778|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|06/30/2021
51862031778|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862031778|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|06/30/2021
51862031778|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|06/30/2021
51862033201|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51862033301|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51862033305|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51862033401|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51862033405|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51862034490|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
51862034590|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
51862034690|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
51862053504|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
51862053504|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
51862053504|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51862053516|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
51862053516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51862053516|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
51862058001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
51862058001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
51862058201|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|06/30/2021
51862058201|CE:DUP-OCS|Duplicate Therapy|02/04/2016|06/30/2021
51862058501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862058501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862058501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058505|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058505|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862058505|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862058601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862058601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862058601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|06/30/2021
51862058601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|06/30/2021
51862058605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862058605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|06/30/2021
51862058605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|06/30/2021
51862058605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|06/30/2021
51862058701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862058701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862058701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058705|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862058705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058705|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862058705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862058705|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862060901|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
51862060901|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
51862061001|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
51862061001|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
51862061101|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
51862061201|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
51862061430|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
51862063428|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063428|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862063428|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862063428|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063428|CE:FEN-FENT100|Fentora|09/24/2017|
51862063428|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862063528|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862063528|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862063528|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862063528|CE:FEN-FENT200|Fentora|09/24/2017|
51862063528|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063528|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063628|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862063628|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063628|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862063628|CE:FEN-FENT400|Fentora|09/24/2017|
51862063628|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063628|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862063728|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063728|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862063728|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862063728|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862063728|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063728|CE:FEN-FENT6&8|Fentora|09/24/2017|
51862063828|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51862063828|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51862063828|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063828|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51862063828|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862063828|CE:FEN-FENT6&8|Fentora|09/24/2017|
51862094205|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862094205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094205|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094301|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51862094301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094305|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51862094305|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
51991007301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51991007301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51991007301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51991007301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51991007401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51991007401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51991007405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
51991007405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991007405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
51991007405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
51991033301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991033404|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991047428|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51991061150|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
51991061250|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
51991062328|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
51991064310|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
51991070401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070401|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070405|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070410|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070410|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070501|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070505|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070505|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070510|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070601|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070605|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070605|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070610|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070701|CE:ALP-ALP|Alprazolam|05/28/2015|
51991070701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
51991070705|CE:ALP-ALP|Alprazolam|05/28/2015|
51991071641|CE:APY-ARI|Antipsychotics|04/10/2016|11/30/2020
51991073520|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
51991073532|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
51991077133|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|12/31/2020
51991081403|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991083704|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991083716|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991083801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991083810|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
51991083933|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
51991085301|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
51991085401|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
51991085501|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
51991089333|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|01/31/2021
51991089390|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|01/31/2021
52054051209|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
52054051309|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
52054051409|CE:ADD-ERDEX|ADD/ADHD Agents|02/13/2014|
52244010010|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
52244020010|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
52244030010|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
52244040010|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
52244040410|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/31/2020
52244044910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52244044910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427038290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
52427038390|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
52427043690|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
52427043790|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
52427049401|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
52427069203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069203|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427069211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069211|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427069211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069403|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427069403|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069403|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069411|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069411|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427069411|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069803|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069803|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427069803|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069811|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069811|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427069811|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427071203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427071203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427071203|CE:SUB-SUBOX|Suboxone|04/23/2013|
52427071211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427071211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52427071211|CE:SUB-SUBOX|Suboxone|04/23/2013|
52536050001|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
52536051001|CE:ADD-IRZen|ADD/ADHD Agents|02/13/2014|
52544016460|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
52544016460|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|07/31/2020
52544016460|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|07/31/2020
52544016460|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
52544016460|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/31/2020
52544023912|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
52544047108|CE:DUP-HRT|Duplicate Therapy|02/05/2013|12/31/2020
52544047208|CE:DUP-HRT|Duplicate Therapy|02/05/2013|07/31/2020
52544047308|CE:DUP-HRT|Duplicate Therapy|02/05/2013|07/31/2020
52544062201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/31/2020
52544089660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
52544089660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
52544089660|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/31/2020
52544089660|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|07/31/2020
52544089660|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|07/31/2020
52565000205|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
52817013110|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|11/13/2020
52817016060|CE:APY-SGA|Antipsychotics|04/10/2016|
52817016160|CE:APY-SGA|Antipsychotics|04/10/2016|
52817016260|CE:APY-SGA|Antipsychotics|04/10/2016|
52817016360|CE:APY-SGA|Antipsychotics|04/10/2016|
52817016460|CE:APY-SGA|Antipsychotics|04/10/2016|
52817019100|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
52817019100|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/30/2020
52817019100|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|11/30/2020
52817021010|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
52817021050|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
52817029590|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
52817033010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033010|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
52817033050|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033050|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
52817033050|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033110|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
52817033110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033200|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033200|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
52817033200|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033250|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033250|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
52817033250|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
52856050101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
52856050101|CE:EMF-EMF|Emflaza|09/24/2017|
52856050101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050203|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
52856050203|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050203|CE:EMF-EMF|Emflaza|09/24/2017|
52856050303|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050303|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
52856050303|CE:EMF-EMF|Emflaza|09/24/2017|
52856050403|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050403|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
52856050403|CE:EMF-EMF|Emflaza|09/24/2017|
52856050521|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
52856050521|CE:EMF-EMF|Emflaza|09/24/2017|
52856050521|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050522|CE:EMF-EMF|Emflaza|09/24/2017|
52856050522|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
52856050522|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
53451010101|CE:GAB-HORI|Anticonvulsant Agents (Gabapentin)|02/06/2018|
53451010301|CE:GAB-HORI|Anticonvulsant Agents (Gabapentin)|02/06/2018|
53489014401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
53489014405|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
53489014410|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
53489014801|CE:APY-FGA|Antipsychotics|04/10/2016|
53489014810|CE:APY-FGA|Antipsychotics|04/10/2016|
53489014901|CE:APY-FGA|Antipsychotics|04/10/2016|
53489014910|CE:APY-FGA|Antipsychotics|04/10/2016|
53489015001|CE:APY-FGA|Antipsychotics|04/10/2016|
53489015010|CE:APY-FGA|Antipsychotics|04/10/2016|
53489036801|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
53489036901|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
53489047801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53489047805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53489047901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53489047905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53489050001|CE:APY-FGA|Antipsychotics|04/10/2016|
53489050601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53489064801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53489064801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
53489064801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53489064801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53489065007|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
53489065007|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53489065007|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53489065007|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010101|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
53746010105|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|12/17/2020
53746010110|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
53746010205|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|12/17/2020
53746010210|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
53746010301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
53746010901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746010901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746010901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746010901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010905|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746010905|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746010905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010905|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746010905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746010910|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746010910|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746010910|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746011001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746011001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746011001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746011001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746011005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746011005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746011010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746011010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746011010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746011010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746011701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746011701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746011701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746011701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746014501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746014501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746014501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746014501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746014501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746014501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746014601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746014601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746014601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746014601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746014601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746014601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746019010|CE:DUP-NSD|Duplicate Therapy|02/05/2013|09/30/2022
53746019301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746019401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746019405|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
53746020301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746020301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746020301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746020305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746020305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746020305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746020305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746020401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746020401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746020405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746020405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746020405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746020405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746020405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746061701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746061701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746061701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746061701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746061701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746061705|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|10/09/2020
53746061705|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
53746061705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/09/2020
53746061705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/09/2020
53746061705|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|10/09/2020
53746061710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
53746061710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
53746061710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746061710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
53746061710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
54092025290|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
54092025390|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
54092025490|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
54092025602|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
54092025702|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
54092038101|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
54092038101|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092038301|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
54092038301|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092038501|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
54092038501|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092038701|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092038901|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092039101|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
54092046801|CE:ADD-ERMYD|ADD/ADHD Agents|09/24/2017|
54092047101|CE:ADD-ERMYD|ADD/ADHD Agents|09/24/2017|
54092047401|CE:ADD-ERMYD|ADD/ADHD Agents|09/24/2017|
54092047701|CE:ADD-ERMYD|ADD/ADHD Agents|09/24/2017|
54092051302|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
54092051502|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
54092051702|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
54092051902|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
54092070001|CE:ENZ-ELA|Enzymes|11/20/2019|
54123011430|CE:SUB-SUBOX|Suboxone|04/23/2013|
54123090730|CE:SUB-SUBOX|Suboxone|04/23/2013|
54123091430|CE:SUB-SUBOX|Suboxone|04/23/2013|
54123091430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
54123091430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
54123092930|CE:SUB-SUBOX|Suboxone|04/23/2013|
54123095730|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
54123095730|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
54123095730|CE:SUB-SUBOX|Suboxone|04/23/2013|
54123098630|CE:SUB-SUBOX|Suboxone|04/23/2013|
54458088116|CE:DUP-STN|Duplicate Therapy|02/04/2016|09/01/2020
54458088116|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|09/01/2020
54766089403|CE:GIM-ALO|GI Motility|01/18/2017|
54766089503|CE:GIM-ALO|GI Motility|01/18/2017|
54838011540|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838011540|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
54838011540|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838011740|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
54838011770|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
54838011780|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
54838013340|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
54838013340|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838013540|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838013570|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838013580|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838013640|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
54838013640|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838013640|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838013670|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
54838013670|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838013670|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838020940|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838020940|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
54838020970|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
54838020970|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838020980|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
54838020980|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
54838050140|CE:APY-FGA|Antipsychotics|04/10/2016|
54838050280|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838055240|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838055680|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
54838055840|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54838057059|CE:APY-ARI|Antipsychotics|04/10/2016|
54838057280|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
54879000308|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
54879000308|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
55111012105|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
55111012105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012190|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
55111012205|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
55111012205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012290|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
55111012305|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012305|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
55111012390|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
55111012390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012405|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111012490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111015701|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
55111015730|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
55111015801|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
55111015810|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
55111015830|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
55111016305|CE:APY-SGA|Antipsychotics|04/10/2016|
55111016305|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
55111016330|CE:APY-SGA|Antipsychotics|04/10/2016|
55111016330|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
55111016705|CE:APY-SGA|Antipsychotics|04/10/2016|
55111016730|CE:APY-SGA|Antipsychotics|04/10/2016|
55111016805|CE:APY-SGA|Antipsychotics|04/10/2016|
55111016830|CE:APY-SGA|Antipsychotics|04/10/2016|
55111017001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111017005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111019705|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
55111019705|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019730|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
55111019730|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019790|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
55111019790|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019805|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
55111019830|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
55111019830|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019890|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019890|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
55111019905|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
55111019905|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019930|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019930|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
55111019990|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111019990|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
55111020005|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111020005|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
55111020030|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
55111020030|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111020090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111020090|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
55111022905|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
55111022905|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111022990|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111022990|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
55111023005|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111023005|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
55111023090|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
55111023090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111023105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111023105|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
55111023190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111023190|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
55111025660|CE:APY-SGA|Antipsychotics|04/10/2016|
55111025760|CE:APY-SGA|Antipsychotics|04/10/2016|
55111025860|CE:APY-SGA|Antipsychotics|04/10/2016|
55111025960|CE:APY-SGA|Antipsychotics|04/10/2016|
55111026281|CE:APY-SGA|Antipsychotics|04/10/2016|
55111026281|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
55111026381|CE:APY-SGA|Antipsychotics|04/10/2016|
55111026381|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
55111026481|CE:APY-SGA|Antipsychotics|04/10/2016|
55111026581|CE:APY-SGA|Antipsychotics|04/10/2016|
55111026805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111026830|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111026890|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111027405|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111027490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
55111028960|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111032890|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
55111032990|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
55111033290|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
55111035605|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
55111035610|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
55111036031|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
55111039830|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
55111039890|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
55111047801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55111047901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55111049230|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
55111051930|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111052030|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111052130|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111052230|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111052830|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111053301|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
55111053305|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
55111055131|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
55111056330|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111056430|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
55111061701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55111061901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55111062560|CE:LTMC-ZAF|Leukotriene Modifiers - Clinical|12/15/2015|
55111062660|CE:LTMC-ZAF|Leukotriene Modifiers - Clinical|12/15/2015|
55111062930|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55111065001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55111065001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55111067802|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111067810|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111067902|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111067910|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111068002|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111068010|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111068102|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111068110|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
55111068201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111068205|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111068301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111068305|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111068401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111068405|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111069990|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
55111070160|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
55111072510|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
55111072530|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
55111072590|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
55111076303|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
55111078401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
55111079818|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
55111079818|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
55111079836|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
55111079836|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
55111079924|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
55111079924|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
55253080130|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
55253080130|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
55253080190|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
55253080190|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
55253080230|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
55253080230|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
55253080290|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
55253080290|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
55292010401|CE:ADD-IRMETHAM|ADD/ADHD Agents|02/13/2014|
55292030401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55292030401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55292030401|CE:ASH-CLORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
55292030401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55513000204|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513000304|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513000404|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513000504|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513000601|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513002104|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513002304|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513002504|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513002704|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513002801|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513003201|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513005704|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513011101|CE:ESP-ARA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513012601|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513012610|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513013760|CE:CYC-OTEZ|Cytokine and CAM Antagonists|03/27/2018|
55513014401|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513014410|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513014801|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513014810|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513026701|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513026710|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513028301|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513028310|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513036955|CE:CYC-OTEZSP|Cytokine and CAM Antagonists|11/20/2019|
55513036955|CE:CYC-OTEZ|Cytokine and CAM Antagonists|03/27/2018|
55513047801|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55513047810|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
55566220000|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
55566230000|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
55566260000|CE:DES-DESMO|Desmopressin|05/25/2012|
55566270000|CE:DES-DESMO|Desmopressin|05/25/2012|
55700014730|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700014730|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700014730|CE:SUB-SUBOX|Suboxone|04/23/2013|
55700030230|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
55700030230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700030230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700030330|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700030330|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
55700030330|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
55724021121|CE:TIM-EUC|Topical Immunomodulators ( Elidel & Protopic)|06/06/2017|
57237000201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57237000205|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57237000299|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57237000705|CE:DRO-MIRTA7.5|Drug Regimen Optimization|01/31/2011|
57237000730|CE:DRO-MIRTA7.5|Drug Regimen Optimization|01/31/2011|
57237000805|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
57237000830|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
57237001106|CE:DRO-MIRODT15|Drug Regimen Optimization|01/31/2011|
57237005060|CE:DRO-GALANT8|Drug Regimen Optimization|01/31/2011|
57237008901|CE:DRO-TRANDOL1|Drug Regimen Optimization|01/31/2011|
57237009001|CE:DRO-TRANDOL2|Drug Regimen Optimization|01/31/2011|
57237010801|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
57237010901|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
57237011901|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237011999|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012001|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012099|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012101|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012199|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012201|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012299|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012301|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012399|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012401|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012499|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012601|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237012701|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
57237015430|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
57237015430|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
57237015490|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
57237015490|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
57237015530|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
57237015530|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
57237015590|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
57237015590|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
57237015701|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
57237015801|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
57237015901|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
57237016130|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
57237016190|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
57237016199|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
57237016805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237016805|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
57237016890|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237016890|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
57237016990|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
57237016990|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237016999|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237016999|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
57237017090|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
57237017090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237017099|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237017099|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
57237017105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237017130|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237017190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
57237017301|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
57237021230|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
57237021290|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
57237021330|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
57237021390|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
57237021760|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237021860|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237021905|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237021930|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237021990|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022005|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022030|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022090|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022105|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022130|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022190|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
57237022201|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
57237022230|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
57237022301|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
57237022305|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
57237022401|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
57237022405|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
57237023901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
57237024001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
57237026601|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
57237026601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57237026601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664005513|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
57664005518|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
57664005599|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
57664005613|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
57664005618|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
57664005699|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
57664010788|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
57664010818|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
57664010888|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
57664010988|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
57664012613|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664012613|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664012613|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664012613|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664012613|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664012688|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664012688|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664012688|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664012688|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664012688|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664013388|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
57664013488|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
57664017013|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017013|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664017013|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017013|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664017013|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664017088|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664017088|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664017088|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017088|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664017088|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017613|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017613|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017613|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664017613|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664017613|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664017688|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664017688|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664017688|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664017688|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664017688|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664018788|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664018788|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664018788|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664018788|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664018788|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664022388|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664022388|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664022388|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664022388|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664022388|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664022488|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664022488|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664022488|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664022488|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664022488|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664022888|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
57664022988|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
57664023088|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
57664024188|CE:APY-SGA|Antipsychotics|04/10/2016|
57664034588|CE:APY-SGA|Antipsychotics|04/10/2016|
57664034713|CE:APY-SGA|Antipsychotics|04/10/2016|
57664034788|CE:APY-SGA|Antipsychotics|04/10/2016|
57664037688|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
57664037708|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664037708|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037708|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664037708|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664037708|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037713|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664037713|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037713|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664037713|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037713|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664037718|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664037718|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664037718|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037718|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664037718|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664037888|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
57664037988|CE:ADD-IRFOC|ADD/ADHD Agents|02/13/2014|
57664050818|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
57664053713|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664053713|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664053713|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664053713|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664053713|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664053718|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664053718|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664053718|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664053718|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664053718|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664053788|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
57664053788|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664053788|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
57664053788|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
57664053788|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664066383|CE:DRO-CARVCR10|Drug Regimen Optimization|01/31/2011|
57664066483|CE:DRO-CARVCR20|Drug Regimen Optimization|01/31/2011|
57664066583|CE:DRO-CARVCR40|Drug Regimen Optimization|01/31/2011|
57664075583|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075683|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
57664075683|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075699|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075699|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
57664075783|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075799|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075883|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664075883|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075899|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075899|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664075983|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664075983|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075999|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664075999|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664076083|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664076083|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664076099|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664076099|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077283|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077299|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077383|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077399|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077483|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077499|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077583|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664077599|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664078586|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
57664078586|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664078586|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664078586|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
57664079683|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079683|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079699|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079699|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079783|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079783|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079799|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079799|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079883|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079883|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079899|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079899|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079983|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664079983|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079999|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664079999|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664080083|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664080083|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57664080099|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
57664080099|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
57665000201|CE:ENZ-ARE|Enzymes|11/20/2019|
57844010501|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844011001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844011201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844011501|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844011701|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844012001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57844013001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
57894006002|CE:CYC-STEL|Cytokine and CAM Antagonists|03/27/2018|
57894006003|CE:CYC-STEL|Cytokine and CAM Antagonists|03/27/2018|
57894006103|CE:CYC-STEL|Cytokine and CAM Antagonists|03/27/2018|
57894007001|CE:CYC-SIMP|Cytokine and CAM Antagonists|03/27/2018|
57894007002|CE:CYC-SIMP|Cytokine and CAM Antagonists|03/27/2018|
57894007101|CE:CYC-SIMP|Cytokine and CAM Antagonists|03/27/2018|
57894007102|CE:CYC-SIMP|Cytokine and CAM Antagonists|03/27/2018|
57894035001|CE:CYC-SIMP|Cytokine and CAM Antagonists|03/27/2018|
57894064001|CE:CYC-TREM|Cytokine and CAM Antagonists|03/27/2018|
57894064011|CE:CYC-TREM|Cytokine and CAM Antagonists|03/27/2018|
58406001004|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406002104|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406003204|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406004401|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406004404|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406042534|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|
58406043501|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|03/01/2022
58406043504|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|03/01/2022
58406044504|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|04/01/2022
58406045501|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|10/01/2021
58406045504|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|10/01/2021
58406045601|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|12/01/2021
58406045604|CE:CYC-ENBR|Cytokine and CAM Antagonists|03/27/2018|12/01/2021
58407062530|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58407062530|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
58468004001|CE:ENZ-FAB|Enzymes|11/20/2019|
58468004101|CE:ENZ-FAB|Enzymes|11/20/2019|
58468007001|CE:ENZ-ALD|Enzymes|11/20/2019|
58468016001|CE:ENZ-LUM|Enzymes|11/20/2019|
58468016002|CE:ENZ-LUM|Enzymes|11/20/2019|
58605040101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|08/10/2020
58605040101|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|08/10/2020
58605042301|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|08/10/2020
58605042301|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|08/10/2020
58605042301|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|08/10/2020
58657050004|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
58657050004|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
58657050004|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657050004|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657050004|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
58657050016|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
58657050016|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
58657050016|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
58657050016|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657050016|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657052804|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
58657052816|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
58657053530|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|11/30/2020
58657062001|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|02/28/2021
58657062050|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|02/28/2021
58657062101|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/31/2021
58657062150|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|02/28/2021
58657062201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|02/28/2021
58657062250|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|11/30/2020
58657062301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|12/31/2020
58657062350|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|12/31/2020
58657062401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/31/2021
58657062450|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|02/28/2021
58657064501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064501|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
58657064501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064510|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
58657064550|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064550|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
58657064550|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
58657070001|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070101|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070201|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070301|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070310|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070401|CE:APY-FGA|Antipsychotics|04/10/2016|
58657070501|CE:APY-FGA|Antipsychotics|04/10/2016|
58809019860|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809019860|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|
58809022360|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809022360|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809048550|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809050130|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
58809055508|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809064330|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809065150|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809072904|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809072904|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809074050|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809075050|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
58809085008|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809099901|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
58809099901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59011025630|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|12/31/2020
59011027160|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027160|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027160|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027160|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027160|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027260|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027260|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027260|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027260|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027260|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027360|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027360|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027360|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027360|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027360|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027460|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027460|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027460|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027460|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027460|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027560|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027560|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027560|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027560|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027560|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027660|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027660|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027660|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027760|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011027760|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011027760|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011027760|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011027760|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011041010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011041010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011041010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011041010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011041010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011041010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011041510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011041510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011041510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011041510|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011041510|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011041510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011042010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011042010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011042010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011042010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011042010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011042010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011043010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011043010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011043010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011043010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011043010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011043010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011044010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011044010|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011044010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011044010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011044010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011044010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011046010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011046010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011046010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011046010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011046010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011046010|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011048010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011048010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011048010|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011048010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011048010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011048010|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
59011075004|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011075004|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011075004|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011075004|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075004|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075104|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011075104|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075104|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075104|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011075104|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011075204|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59011075204|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075204|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011075204|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075204|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011075704|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075704|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011075704|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011075704|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075804|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59011075804|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59011075804|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59011075804|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59148000613|CE:APY-ARI|Antipsychotics|04/10/2016|
59148000713|CE:APY-ARI|Antipsychotics|04/10/2016|
59148000713|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
59148000813|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
59148000813|CE:APY-ARI|Antipsychotics|04/10/2016|
59148000913|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
59148000913|CE:APY-ARI|Antipsychotics|04/10/2016|
59148001013|CE:APY-ARI|Antipsychotics|04/10/2016|
59148001113|CE:APY-ARI|Antipsychotics|04/10/2016|
59148001871|CE:APY-ARI|Antipsychotics|04/10/2016|
59148001871|CE:APY-SGA|Antipsychotics|04/10/2016|
59148001971|CE:APY-SGA|Antipsychotics|04/10/2016|
59148001971|CE:APY-ARI|Antipsychotics|04/10/2016|
59148002985|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003085|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003085|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
59148003185|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003185|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
59148003285|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003285|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
59148003385|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003485|CE:APY-ARI|Antipsychotics|04/10/2016|
59148003513|CE:APY-SGA|Antipsychotics|04/10/2016|
59148003613|CE:APY-SGA|Antipsychotics|04/10/2016|
59148003713|CE:APY-SGA|Antipsychotics|04/10/2016|
59148003813|CE:APY-SGA|Antipsychotics|04/10/2016|
59148003913|CE:APY-SGA|Antipsychotics|04/10/2016|
59148004013|CE:APY-SGA|Antipsychotics|04/10/2016|
59148004580|CE:APY-SGA|Antipsychotics|04/10/2016|
59148004580|CE:APY-ARI|Antipsychotics|04/10/2016|
59148007280|CE:APY-SGA|Antipsychotics|04/10/2016|
59148007280|CE:APY-ARI|Antipsychotics|04/10/2016|
59310030240|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
59310030480|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
59310057922|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
59310058020|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
59385001201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001201|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001230|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001401|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001430|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001601|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385001630|CE:SUB-SUBOX|Suboxone|04/23/2013|
59385001630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59385002160|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002160|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002160|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59385002260|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59385002260|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002260|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002360|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002360|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59385002360|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002460|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002460|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002560|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002560|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59385002560|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002660|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002660|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59385002760|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
59385002760|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
59385002760|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
59417010110|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010210|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010310|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010410|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010510|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010610|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417010710|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417011501|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417011601|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417011701|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417011801|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417011901|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59417012001|CE:ADD-ERVYV|ADD/ADHD Agents|02/13/2014|
59572063106|CE:CYC-OTEZ|Cytokine and CAM Antagonists|03/27/2018|10/31/2022
59572063255|CE:CYC-OTEZSP|Cytokine and CAM Antagonists|11/20/2019|08/31/2022
59572063255|CE:CYC-OTEZ|Cytokine and CAM Antagonists|03/27/2018|08/31/2022
59617001502|CE:ALE-ORA|Allergen Extracts (Clinical)|09/01/2015|
59630075050|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
59630075550|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
59651000101|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
59651000130|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
59651000205|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
59651000290|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
59651001890|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
59651003212|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59651003247|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59651004730|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
59651011055|CE:APY-ARI|Antipsychotics|04/10/2016|
59651026830|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
59651026901|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
59651026905|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
59676030201|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676030301|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676030401|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676031001|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676031002|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676031204|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676032004|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59676034001|CE:ESP-ESA|Erythropoiesis Stimulating Proteins|09/24/2013|
59746000103|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746000103|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746000106|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746000106|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746000204|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746000204|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746000314|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746000314|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746001032|CE:APY-ARI|Antipsychotics|04/10/2016|
59746001032|CE:DRO-RISODT.5|Drug Regimen Optimization|01/31/2011|
59746001504|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746001504|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746002022|CE:APY-ARI|Antipsychotics|04/10/2016|
59746002022|CE:DRO-RISODT1|Drug Regimen Optimization|01/31/2011|
59746003022|CE:DRO-RISODT2|Drug Regimen Optimization|01/31/2011|
59746003022|CE:APY-ARI|Antipsychotics|04/10/2016|
59746004022|CE:APY-ARI|Antipsychotics|04/10/2016|
59746005022|CE:APY-ARI|Antipsychotics|04/10/2016|
59746012106|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746012110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746012206|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746012210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746017106|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017106|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017110|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017110|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017206|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017206|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017210|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017210|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017306|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017306|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017310|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017310|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017506|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017506|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017509|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59746017509|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59746017706|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
59746017706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746017706|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746017710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746017710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746017710|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
59746021106|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
59746021106|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746021106|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746021110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746021110|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
59746021110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59746027901|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
59746028001|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
59746028390|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|11/01/2020
59746028532|CE:DRO-CERTIR5|Drug Regimen Optimization|01/31/2011|
59746028532|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746028632|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
59746030632|CE:APY-SGA|Antipsychotics|04/10/2016|
59746030632|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
59746030732|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
59746030732|CE:APY-SGA|Antipsychotics|04/10/2016|
59746030832|CE:APY-SGA|Antipsychotics|04/10/2016|
59746030932|CE:APY-SGA|Antipsychotics|04/10/2016|
59746032930|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
59746032990|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
59746033310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033310|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
59746033390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033390|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
59746033410|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033410|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
59746033430|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
59746033430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033490|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
59746033490|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033590|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033730|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
59746033730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746033730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033790|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746033790|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
59746033790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746033830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033890|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746033890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746033930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746033990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746035830|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|11/01/2020
59746035890|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|11/01/2020
59746035930|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|11/01/2020
59746035990|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|11/01/2020
59746036030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746036190|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
59746036190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746036290|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
59746036290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746036390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746037960|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59746038206|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746038210|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59746038306|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|
59746038310|CE:DRO-TERAZO1|Drug Regimen Optimization|01/31/2011|
59746038506|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|
59746038510|CE:DRO-TERAZO5|Drug Regimen Optimization|01/31/2011|
59746044730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746044730|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
59746044790|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
59746044790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746044830|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
59746044830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746044890|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
59746044890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746044930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746044990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
59746070501|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|11/01/2020
59746070501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59746070501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59746070505|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|11/01/2020
59746070505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59746070505|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59746070510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59746070510|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|11/01/2020
59746070510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|11/01/2020
59762002801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762002802|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762002901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762003301|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
59762004701|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
59762004702|CE:DRO-TOLTLA2|Drug Regimen Optimization|01/31/2011|
59762004901|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762004901|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762005001|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762005001|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762005101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762005101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762005701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762005701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762005701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762005701|CE:ALP-ALP|Alprazolam|05/28/2015|
59762005901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762005901|CE:ALP-ALP|Alprazolam|05/28/2015|
59762005901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762005901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006601|CE:ALP-ALP|Alprazolam|05/28/2015|
59762006601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006801|CE:ALP-ALP|Alprazolam|05/28/2015|
59762006801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762006801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762007301|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762007301|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762007401|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762007401|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762007501|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762007501|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762014001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762014501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762015501|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
59762015501|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015502|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
59762015502|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015601|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015601|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
59762015602|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
59762015602|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015701|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015701|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
59762015702|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015702|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
59762015801|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762015802|CE:DUP-STN|Duplicate Therapy|02/04/2016|
59762022001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59762022201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59762022301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59762054001|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
59762054101|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
59762054102|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
59762151501|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762151501|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151601|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762151601|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151603|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762151603|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151701|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762151701|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151703|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762151703|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151802|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
59762151802|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
59762200101|CE:APY-SGA|Antipsychotics|04/10/2016|
59762200201|CE:APY-SGA|Antipsychotics|04/10/2016|
59762200301|CE:APY-SGA|Antipsychotics|04/10/2016|
59762200401|CE:APY-SGA|Antipsychotics|04/10/2016|
59762205801|CE:SDF-REVSUSP|Sildenafil (Revatio)|09/01/2015|
59762231006|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
59762232006|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
59762234006|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
59762371704|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
59762371704|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371704|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371704|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371709|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
59762371709|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371709|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371709|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371803|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
59762371803|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371803|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371803|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371804|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
59762371804|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371804|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371804|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371809|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371809|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
59762371809|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371809|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371901|CE:ALP-ALP|Alprazolam|05/28/2015|
59762371903|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371903|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371903|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371903|CE:ALP-ALP|Alprazolam|05/28/2015|
59762371904|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371904|CE:ALP-ALP|Alprazolam|05/28/2015|
59762371904|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762371904|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372001|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372003|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372003|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372003|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372003|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372004|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372004|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372004|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372004|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372101|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372103|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372103|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372103|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372103|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372104|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372104|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372104|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372104|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372201|CE:ALP-ALP|Alprazolam|05/28/2015|
59762372201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372203|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372203|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372203|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
59762372203|CE:ALP-ALP|Alprazolam|05/28/2015|
59762444002|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762444002|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762444003|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
59762444003|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
59762501401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
59762502501|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/14/2021
59762505001|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
59762600201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
59762634701|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
59762644301|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
59762644302|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
59762644303|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
59762671001|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762671101|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762671201|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762672001|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762672101|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762672201|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762672301|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762673001|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762673101|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762673201|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59762673301|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
59922063101|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
60429058611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058611|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058630|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058633|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058633|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058633|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058711|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058730|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058730|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058730|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058733|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60429058733|CE:SUB-SUBOX|Suboxone|04/23/2013|
60429058733|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432015004|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432015016|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432021208|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
60432021208|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
60432024516|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432024516|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60432024516|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60432024516|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432027504|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
60432027504|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
60432027504|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432027516|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
60432027516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432027516|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
60432045516|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
60432045516|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60432045516|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60432045516|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432045516|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432046608|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
60432046608|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
60432060416|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
60432060416|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
60432060416|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
60432060416|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
60432060416|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432060616|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60432060616|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
60432060616|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432060616|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60432060616|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432060616|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432060616|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
60432060816|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
60432060816|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432070605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432070605|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60432070605|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60432070605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60432070605|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60432083704|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
60432083704|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432083704|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
60432083716|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60432083716|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
60432083716|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
60505003901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
60505004001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
60505004101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
60505006500|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
60505006501|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
60505006502|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
60505008301|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
60505008302|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
60505008304|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
60505009300|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
60505009301|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
60505009400|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
60505009401|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
60505009500|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
60505009501|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
60505009505|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
60505009701|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
60505009702|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
60505009704|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
60505010201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
60505011201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505011208|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505011301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505011308|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505011401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505011405|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505014500|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
60505014501|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
60505014502|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
60505014701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505014708|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505016805|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
60505016805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505016809|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505016809|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
60505016907|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
60505016907|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505016909|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
60505016909|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505017007|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505017007|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
60505017009|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
60505017009|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505020801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505024701|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
60505024708|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
60505025701|CE:DES-DESMO|Desmopressin|05/25/2012|
60505025801|CE:DES-DESMO|Desmopressin|05/25/2012|
60505026101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505026201|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|08/07/2021
60505026301|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505026401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505039905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
60505040405|CE:APY-ARI|Antipsychotics|04/10/2016|
60505079100|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079104|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079200|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079204|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079300|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079304|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079400|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079404|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079501|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079504|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079600|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079604|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079800|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505079804|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
60505081301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60505081301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505081301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505081301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505081301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505083305|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505084805|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505131603|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
60505132305|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505132309|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505251801|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
60505251804|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
60505251808|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
60505251901|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
60505251904|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
60505251908|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
60505252603|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
60505252603|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
60505252703|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
60505252703|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
60505252806|CE:APY-SGA|Antipsychotics|04/10/2016|
60505252906|CE:APY-SGA|Antipsychotics|04/10/2016|
60505253006|CE:APY-SGA|Antipsychotics|04/10/2016|
60505253106|CE:APY-SGA|Antipsychotics|04/10/2016|
60505254306|CE:DRO-GALANT8|Drug Regimen Optimization|01/31/2011|
60505255101|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505255105|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505255201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505255205|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
60505257808|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
60505257808|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505257809|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
60505257809|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505257908|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505257908|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
60505257909|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505257909|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
60505258008|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
60505258008|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505258009|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505258009|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
60505263301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505263308|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505264401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60505264401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505264401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505264401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505264401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505264405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505264405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60505264405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505264405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505264405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505265601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505265605|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505265701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505265705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505267108|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505267109|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505267303|CE:APY-ARI|Antipsychotics|04/10/2016|
60505267303|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
60505267403|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
60505267403|CE:APY-ARI|Antipsychotics|04/10/2016|
60505267503|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
60505267503|CE:APY-ARI|Antipsychotics|04/10/2016|
60505267603|CE:APY-ARI|Antipsychotics|04/10/2016|
60505267703|CE:APY-ARI|Antipsychotics|04/10/2016|
60505278001|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
60505278008|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
60505278101|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
60505278108|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
60505283003|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283103|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283203|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283303|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283403|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283503|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505283603|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505307503|CE:APY-ARI|Antipsychotics|04/10/2016|
60505311003|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311003|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
60505311008|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
60505311008|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311103|CE:APY-SGA|Antipsychotics|04/10/2016|04/02/2021
60505311103|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|04/02/2021
60505311108|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
60505311108|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311203|CE:APY-SGA|Antipsychotics|04/10/2016|04/02/2021
60505311203|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|04/02/2021
60505311208|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311208|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
60505311303|CE:APY-SGA|Antipsychotics|04/10/2016|04/02/2021
60505311303|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|04/02/2021
60505311308|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
60505311308|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311403|CE:APY-SGA|Antipsychotics|04/10/2016|
60505311408|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313001|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313008|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313201|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313208|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313301|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313308|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313501|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313508|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313706|CE:APY-SGA|Antipsychotics|04/10/2016|
60505313901|CE:APY-SGA|Antipsychotics|04/10/2016|
60505314003|CE:APY-SGA|Antipsychotics|04/10/2016|
60505314008|CE:APY-SGA|Antipsychotics|04/10/2016|
60505317007|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
60505327500|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
60505327500|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327503|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
60505327503|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327600|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
60505327600|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327603|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327603|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
60505327700|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327703|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327800|CE:APY-SGA|Antipsychotics|04/10/2016|
60505327803|CE:APY-SGA|Antipsychotics|04/10/2016|
60505340909|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505341109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|07/30/2020
60505360303|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505360303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505360309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505360309|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505360403|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505360403|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505366303|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
60505366403|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|10/31/2020
60505366803|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
60505367303|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
60505367803|CE:DRO-CARVCR10|Drug Regimen Optimization|01/31/2011|
60505367903|CE:DRO-CARVCR20|Drug Regimen Optimization|01/31/2011|
60505368003|CE:DRO-CARVCR40|Drug Regimen Optimization|01/31/2011|
60505371309|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
60505380709|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505380709|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505380809|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505380809|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505380909|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505380909|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60505384706|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
60505384706|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
60505384801|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
60505384801|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
60505384805|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
60505384805|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
60505384901|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
60505384901|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
60505384905|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
60505384905|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
60505388207|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
60505388307|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
60505392701|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505392801|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505392901|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505393001|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
60505395203|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|11/01/2020
60505397206|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505397206|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
60505397206|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505397306|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505397306|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
60505397306|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505437703|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
60505450209|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505450209|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
60505450309|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505450309|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
60505450409|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
60505450409|CE:DUP-STN|Duplicate Therapy|02/04/2016|
60505451703|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
60505451803|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
60505458203|CE:DUP-ARB|Duplicate Therapy|02/05/2013|04/02/2021
60505458303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|04/02/2021
60505458403|CE:DUP-ARB|Duplicate Therapy|02/05/2013|07/31/2020
60505458503|CE:DUP-ARB|Duplicate Therapy|02/05/2013|06/10/2021
60505465203|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505465303|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505465303|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
60505465309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505465309|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
60505465403|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505465409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60505470203|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
60505470209|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
60505471303|CE:DRO-CARVCR10|Drug Regimen Optimization|01/31/2011|
60505471403|CE:DRO-CARVCR20|Drug Regimen Optimization|01/31/2011|
60505471503|CE:DRO-CARVCR40|Drug Regimen Optimization|01/31/2011|
60505700600|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700600|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700600|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700600|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700600|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700600|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700602|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700602|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700602|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700602|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700602|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700700|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700700|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700700|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700700|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700700|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700700|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700702|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700702|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700702|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700702|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700702|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700702|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700800|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700800|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700800|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700800|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700800|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700800|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700802|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700802|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700802|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700802|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700802|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700802|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700900|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700900|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700900|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700900|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505700900|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700900|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700902|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700902|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505700902|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505700902|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505700902|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505700902|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505701002|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505701002|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505701002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505701002|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505701002|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505701002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708102|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505708102|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505708102|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708102|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708102|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505708102|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505708202|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505708202|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708202|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505708202|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505708202|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505708202|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708302|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505708302|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505708302|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708302|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505708302|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708302|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505708402|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
60505708402|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60505708402|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60505708402|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60505708402|CE:DUR-DURAG|Duragesic (Fentanyl Transdermal)|01/31/2011|
60505708402|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60574411301|CE:SYN-SYN14N|Palivizumab (Synagis)|01/31/2011|
60574411301|CE:SYN-SYNAGIS|Palivizumab (Synagis)|01/31/2011|
60574411301|CE:SYN-SYN14R|Palivizumab (Synagis)|01/31/2011|
60574411401|CE:SYN-SYN14N|Palivizumab (Synagis)|01/31/2011|
60574411401|CE:SYN-SYN14R|Palivizumab (Synagis)|01/31/2011|
60574411401|CE:SYN-SYNAGIS|Palivizumab (Synagis)|01/31/2011|
60631004030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60631008030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60631041230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
60631041230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
60687048111|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687048111|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
60687048111|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687048121|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687048121|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
60687048121|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687049211|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
60687049211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687049211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687049221|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
60687049221|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60687049221|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60793013601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60793013601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60793041130|CE:DUP-NSD|Duplicate Therapy|02/05/2013|05/13/2021
60793043020|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043020|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043020|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043020|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60793043020|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043120|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043120|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043120|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60793043120|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043120|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043320|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043320|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043320|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043320|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043320|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60793043420|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043420|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043420|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043420|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60793043420|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043520|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043520|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60793043520|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043520|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043520|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043720|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
60793043720|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043720|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60793043720|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
60793043720|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
60951060270|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951060270|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60951060270|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951060270|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60951060270|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60951060285|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60951060285|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60951060285|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951060285|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60951060285|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951070070|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60951070070|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951070070|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60951070070|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60951070070|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951071270|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
60951071270|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
60951071270|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
60951071270|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
60951071270|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
61442010201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010210|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010260|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010305|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010310|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442010360|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
61442012601|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
61442012601|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
61442012601|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
61442012610|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
61442012610|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
61442012610|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
61442012701|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
61442012701|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
61442012710|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
61442012710|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
61442014101|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014101|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
61442014110|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014110|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
61442014160|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|08/01/2020
61442014160|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/01/2020
61442014201|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014201|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
61442014210|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014210|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
61442014260|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|08/01/2020
61442014260|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/01/2020
61442014301|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014310|CE:DUP-STN|Duplicate Therapy|02/04/2016|
61442014360|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/01/2020
61442045101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
61442045101|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
61442045101|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
61570007201|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
61570007301|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
61570007401|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
61570011001|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
61570011101|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
61570011201|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
61874007560|CE:GIM-VIB|GI Motility|02/06/2018|
61874010060|CE:GIM-VIB|GI Motility|02/06/2018|
61874011520|CE:APY-SGA|Antipsychotics|04/10/2016|
61874011530|CE:APY-SGA|Antipsychotics|04/10/2016|
61874013020|CE:APY-SGA|Antipsychotics|04/10/2016|
61874013030|CE:APY-SGA|Antipsychotics|04/10/2016|
61874014530|CE:APY-SGA|Antipsychotics|04/10/2016|
61874016030|CE:APY-SGA|Antipsychotics|04/10/2016|
61874017008|CE:APY-SGA|Antipsychotics|04/10/2016|
61958100301|CE:RAN-RAN|Ranolazine|05/25/2012|
61958100401|CE:RAN-RAN|Ranolazine|05/25/2012|
61958150101|CE:HCT-HEPC|Hepatitis C Treatment|01/31/2011|
61958150101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
61958180101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
61958220101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
61958240101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
62037072501|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62037072501|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
62037072601|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62037072701|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62037073401|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
62037073401|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62037082501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
62037082675|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
62135019122|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
62135019222|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
62175011432|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
62175011437|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
62175011832|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
62175011837|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
62175011843|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
62175018046|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
62175020432|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175020443|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175020446|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175020532|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175020543|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175020546|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175021032|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175021043|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175021046|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
62175026037|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
62175026043|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
62175026055|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
62175027037|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
62175027041|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
62175031037|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
62175031037|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62175031137|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62175031137|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
62175031237|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62175031337|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
62175032046|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
62175045232|CE:SUB-SUBOX|Suboxone|04/23/2013|
62175045232|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62175045232|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62175045832|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62175045832|CE:SUB-SUBOX|Suboxone|04/23/2013|
62175045832|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62175048537|CE:DRO-VPM100|Drug Regimen Optimization|01/31/2011|
62175057037|CE:DRO-VPM100|Drug Regimen Optimization|01/31/2011|
62175082032|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
62175082043|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
62175082046|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
62175089043|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
62175089043|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089046|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089046|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
62175089143|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
62175089143|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089146|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
62175089146|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089241|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
62175089241|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089246|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
62175089246|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089741|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62175089746|CE:DUP-STN|Duplicate Therapy|02/04/2016|
62332000931|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
62332001931|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332001931|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332002031|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332002031|CE:ASH-CMOXAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332002730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002730|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
62332002790|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
62332002790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002791|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
62332002791|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002830|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
62332002890|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
62332002890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002891|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
62332002891|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332002991|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004130|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
62332004130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004190|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
62332004230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004230|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
62332004271|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
62332004271|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004290|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
62332004330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004371|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004490|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004571|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004571|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
62332004590|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
62332004590|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004671|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
62332004671|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004690|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
62332004690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004771|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332004830|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
62332004890|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
62332004890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004890|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332004891|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
62332004891|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004891|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332004930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332004990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332004991|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332004991|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005091|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005091|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332005290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332005290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332006030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332006090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332007971|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332007971|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332007990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332007990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008071|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008071|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008171|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008171|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008271|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008271|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008371|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008371|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008390|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332008730|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
62332008730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008830|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
62332008830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332008930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332009230|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62332009290|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62332009291|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62332009730|CE:APY-ARI|Antipsychotics|04/10/2016|
62332009731|CE:APY-ARI|Antipsychotics|04/10/2016|
62332009830|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
62332009830|CE:APY-ARI|Antipsychotics|04/10/2016|
62332009831|CE:APY-ARI|Antipsychotics|04/10/2016|
62332009831|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
62332009930|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
62332009930|CE:APY-ARI|Antipsychotics|04/10/2016|
62332009931|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
62332009931|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010030|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010030|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
62332010031|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010031|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
62332010130|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010131|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010230|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010231|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010330|CE:APY-ARI|Antipsychotics|04/10/2016|
62332010430|CE:APY-ARI|Antipsychotics|04/10/2016|
62332011531|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332011631|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332013130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332013230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332013230|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
62332013290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332013290|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
62332013330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332013390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332014060|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014060|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014131|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014131|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014171|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014171|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014231|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014231|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014271|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014271|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014291|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014291|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014360|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
62332014360|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
62332014930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332014930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332014990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332014990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332015030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332015030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332015090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332015090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332015130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332015130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332015190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332015190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332019230|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
62332019290|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
62332020530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020590|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332020930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332020930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332021030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62332021130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332021530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332034130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332034130|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
62332034190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332034190|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
62332034290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332034290|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
62332034330|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
62332034330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332034390|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
62332034390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62332036406|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036406|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036406|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332036406|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036506|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036506|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036506|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036506|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332036606|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036606|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332036606|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036606|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036706|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332036706|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036706|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036806|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036806|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332036806|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332036806|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332037931|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332037931|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332037931|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332037931|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038031|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038031|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038031|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038031|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038071|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038071|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038071|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038071|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038130|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038130|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038130|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038130|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038231|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038231|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038231|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038231|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038271|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
62332038271|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038271|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038271|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62332038530|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
62332038530|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
62332038590|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
62332038590|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
62332038630|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
62332038630|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
62332038690|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
62332038690|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
62332042631|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
62332042671|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
62332042731|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
62332042771|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
62542030104|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62542030104|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
62542030104|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62542030104|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
62542030104|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62542030104|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62542030117|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62542030117|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62542030117|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
62542030117|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62542030117|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62542030117|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
62559011107|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
62559011107|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
62559011111|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
62559011111|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
62559013807|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
62559013807|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
62559015116|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559015116|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559015116|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559015116|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559015116|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559016701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559016701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559016701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559016701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559016701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559017001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559017001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017001|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559017001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559017005|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559017005|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559017005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017005|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559017005|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559017101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559017101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559017101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017105|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
62559017105|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
62559017105|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
62559017105|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559017105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62559025001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
62559025101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
62559064030|CE:DRO-CARD4|Drug Regimen Optimization|01/31/2011|
62559064030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559064130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559064130|CE:DRO-CARD8|Drug Regimen Optimization|01/31/2011|
62559064230|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
62559064230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559064290|CE:DRO-CARD16|Drug Regimen Optimization|01/31/2011|
62559064290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559064330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559064390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559065090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559065090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559065190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559065190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559065290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559065290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559066090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559066090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559066190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559066190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559066290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62559066290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
62559070030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070090|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070130|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070190|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070230|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070290|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559070390|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
62559079001|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|12/31/2021
62559079001|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|12/31/2021
62559079101|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|12/31/2021
62559079101|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|12/31/2021
62756013702|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
62756020201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
62756020203|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
62756020401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
62756020403|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
62756036888|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62756036988|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62756037088|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
62756044018|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62756044081|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62756044083|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
62756044602|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756044602|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
62756044602|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756044604|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
62756044604|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756044604|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756044605|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
62756044605|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756044605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756045983|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756045983|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
62756045983|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756046083|CE:STX-STX|Subutex (buprenorphine)|12/05/2014|
62756046083|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756046083|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756055118|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
62756055118|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055183|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055183|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
62756055188|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055188|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
62756055218|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055218|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
62756055283|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
62756055283|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055288|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
62756055288|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055318|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055318|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
62756055383|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
62756055383|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055388|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
62756055388|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055418|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055418|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
62756055483|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055483|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
62756055488|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
62756055488|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055518|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055583|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055588|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055618|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055683|CE:APY-SGA|Antipsychotics|04/10/2016|
62756055688|CE:APY-SGA|Antipsychotics|04/10/2016|
62756075164|CE:APY-SGA|Antipsychotics|04/10/2016|
62756075164|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
62756075464|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
62756075464|CE:APY-SGA|Antipsychotics|04/10/2016|
62756075564|CE:APY-SGA|Antipsychotics|04/10/2016|
62756075764|CE:APY-SGA|Antipsychotics|04/10/2016|
62756096983|CE:SUB-SUBOX|Suboxone|04/23/2013|
62756096983|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756096983|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756097083|CE:SUB-SUBOX|Suboxone|04/23/2013|
62756097083|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62756097083|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
62856024530|CE:DRO-DONEZ5|Drug Regimen Optimization|01/31/2011|
63004871001|CE:HPA-HPA|HP Acthar|03/08/2016|
63090010030|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
63304068301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63304068301|CE:OXC-LD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
63304068301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63304068301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63304068301|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
63304068301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63304068401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63304068401|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
63304068401|CE:OXC-HD OXY|Oxycontin (Narcotic Analgesic)|01/31/2011|
63304068401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63304068401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63304068401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63402019030|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63402019103|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63402019110|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/10/2020
63402019303|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63402019310|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63402030230|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030401|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030410|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030430|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030630|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030801|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030810|CE:APY-SGA|Antipsychotics|04/10/2016|
63402030830|CE:APY-SGA|Antipsychotics|04/10/2016|
63402031230|CE:APY-SGA|Antipsychotics|04/10/2016|
63402051001|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
63402067530|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
63402068106|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
63402068160|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
63402091130|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
63402091164|CE:DUP-LABA|Duplicate Therapy|02/04/2016|
63459010130|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
63459010130|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
63459020130|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
63459020130|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
63459020530|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
63459021530|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
63459022030|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
63459022530|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
63459050230|CE:ACT-ACTIQ200|Actiq Lozenges|01/31/2011|
63459050230|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459050230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050230|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459050230|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459050430|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050430|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050430|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459050430|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459050430|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
63459050430|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459050630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050630|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459050630|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459050630|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459050630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050630|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
63459050830|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459050830|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
63459050830|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459050830|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459050830|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459050830|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459051230|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459051230|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
63459051230|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459051230|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459051230|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459051230|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459051630|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459051630|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459051630|CE:ACT-ACTIQ|Actiq Lozenges|01/31/2011|
63459051630|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459051630|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459051630|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054128|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054128|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054128|CE:FEN-FENT100|Fentora|09/24/2017|
63459054128|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459054128|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054128|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459054228|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054228|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459054228|CE:FEN-FENT200|Fentora|09/24/2017|
63459054228|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054228|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459054228|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054428|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054428|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459054428|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054428|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054428|CE:FEN-FENT400|Fentora|09/24/2017|
63459054428|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459054628|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054628|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054628|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054628|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459054628|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459054628|CE:FEN-FENT6&8|Fentora|09/24/2017|
63459054828|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63459054828|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054828|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459054828|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63459054828|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63459054828|CE:FEN-FENT6&8|Fentora|09/24/2017|
63459070060|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459070060|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459070060|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
63459070160|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
63459070160|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63459070160|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062370|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062370|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63481062370|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062370|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63481062370|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63481062385|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062385|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63481062385|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63481062385|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63481062385|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062770|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062770|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63481062770|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63481062770|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062770|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63481062870|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63481062870|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062870|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63481062870|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062870|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63481062970|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
63481062970|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
63481062970|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
63481062970|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481062970|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63481068447|CE:DUP-NSD|Duplicate Therapy|02/05/2013|04/30/2022
63739000333|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739000333|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63739000333|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739000333|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739000532|CE:APY-SGA|Antipsychotics|04/10/2016|
63739002910|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
63739004910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739004910|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|08/07/2020
63739004910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739007310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739007310|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63739007310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739007310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739012510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739012510|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63739012510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739012510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739012810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
63739021310|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
63739023610|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
63739028110|CE:DUP-STN|Duplicate Therapy|02/04/2016|
63739028110|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
63739035510|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|12/01/2020
63739035810|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
63739040310|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739048310|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63739048610|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63739049910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739049910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739049910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739049910|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/07/2020
63739050010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050010|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/07/2020
63739050010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739050110|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|08/07/2020
63739050832|CE:APY-SGA|Antipsychotics|04/10/2016|
63739051810|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
63739051810|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
63739051910|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
63739051910|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
63739052610|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63739053110|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
63739053110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739053110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739054833|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
63739056010|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
63739057010|CE:DUP-STN|Duplicate Therapy|02/04/2016|
63739057010|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
63739057110|CE:DUP-STN|Duplicate Therapy|02/04/2016|
63739057110|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
63739057210|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
63739057210|CE:DUP-STN|Duplicate Therapy|02/04/2016|
63739057310|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
63739057310|CE:DUP-STN|Duplicate Therapy|02/04/2016|
63739059110|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
63739064410|CE:ALP-ALP|Alprazolam|05/28/2015|08/07/2020
63739064410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739064410|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739064410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739066510|CE:APY-SGA|Antipsychotics|04/10/2016|
63739066632|CE:APY-SGA|Antipsychotics|04/10/2016|
63739066910|CE:ALP-ALP|Alprazolam|05/28/2015|08/07/2020
63739066910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739066910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739066910|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739067201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739067210|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739067310|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
63739067310|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
63739067410|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739067410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739067410|CE:ALP-ALP|Alprazolam|05/28/2015|08/07/2020
63739067410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/07/2020
63739067710|CE:APY-SGA|Antipsychotics|04/10/2016|
63739068401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739068410|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739068610|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
63739068610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
63739069101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739069110|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63739069810|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
63739070110|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
63739070110|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
63739070110|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
63739070910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
63739070910|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/26/2020
63739070910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/26/2020
63739070910|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/26/2020
63739070910|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/26/2020
63739087710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
63739087710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739087710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739087710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
63739088810|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
63739096310|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
63739098410|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
63739098832|CE:APY-SGA|Antipsychotics|04/10/2016|
63824000832|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824000832|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824000834|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824000834|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824000850|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824000850|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824001966|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824001966|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
63824001966|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824001966|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
63824002335|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824002335|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824002336|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824002336|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824002346|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824002346|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824004124|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824004124|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824005632|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824005632|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824005632|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
63824005634|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824005634|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824005634|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
63824005718|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824005718|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824005736|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824005736|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824007235|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824007235|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
63824007235|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824007236|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
63824007236|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824007236|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824007246|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824007246|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824007246|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
63824017163|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824017163|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017163|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017165|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017165|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824017165|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017365|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824017365|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017365|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017563|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017563|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017563|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824017565|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824017565|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017565|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017765|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824017765|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
63824017765|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824021366|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
63824021366|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824021366|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
63824021366|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
63824025412|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
63824025612|CE:DXO-DEXDDCHD|Dextromethorphan Overutilization|07/16/2012|
63824025612|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824028267|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
63824050066|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63824060064|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63868008701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63868015130|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
63868015410|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63868032550|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63868046501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63868046550|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63868061132|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
63868075940|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
63868082354|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64011024702|CE:MAK-MAK|Makena|06/12/2015|05/31/2021
64011030103|CE:MAK-MAK|Makena|06/12/2015|
64376060501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|12/04/2020
64376061216|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|02/13/2021
64376061240|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|02/13/2021
64376064301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376064301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064305|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064305|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064305|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376064305|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064305|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376064801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064801|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064805|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376064805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064805|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064805|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376064901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064905|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
64376064905|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64376064905|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064905|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64376064905|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64376065716|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/30/2020
64376065716|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|08/30/2020
64376065716|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|08/30/2020
64376065740|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|10/31/2020
64376065740|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|10/31/2020
64376065740|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|10/31/2020
64380071206|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
64380071207|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
64380071306|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
64380071307|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
64380076111|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
64380079506|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64380079508|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64380080706|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380080707|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380080806|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380080807|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380080906|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380080907|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380084206|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380084306|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380084307|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
64380086706|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380086707|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380086806|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380086807|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380086906|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380086907|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
64380093504|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
64380093505|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
64380093508|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
64543004404|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
64543004416|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
64543009790|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
64543009790|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64543009790|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
64543010504|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64543010504|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
64543010504|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
64543010504|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
64543010516|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
64543010516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64543010516|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
64543010516|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
64597030160|CE:NUE-NUE|Nuedexta|05/02/2017|
64720013010|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
64720013210|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
64720013510|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
64720013610|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
64764008060|CE:GIM-LUB|GI Motility|01/18/2017|
64764012103|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764012303|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764012403|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764012530|CE:DPP-ALO12|DPP-4 Inhibitors|09/25/2018|
64764024060|CE:GIM-LUB|GI Motility|01/18/2017|
64764025030|CE:DPP-ALO25|DPP-4 Inhibitors|09/25/2018|
64764025103|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764025303|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764025403|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764030230|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
64764030430|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
64764033560|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764033760|CE:DPP-DPPC|DPP-4 Inhibitors|09/25/2018|
64764051030|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|09/30/2020
64764054130|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
64764062530|CE:DPP-ALG6|DPP-4 Inhibitors|09/25/2018|
64764080510|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
64764080530|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
64896069501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069513|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069513|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069513|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069513|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069513|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069613|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069613|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069613|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069613|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069701|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069713|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069713|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069713|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069713|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069713|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069801|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069801|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069801|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069813|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069813|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069813|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069813|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069813|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069901|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069913|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896069913|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896069913|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896069913|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896069913|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896070101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896070101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896070101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896070101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896070101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896070113|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
64896070113|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
64896070113|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64896070113|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
64896070113|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64980016901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/30/2020
64980016905|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/31/2020
64980019401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|09/30/2023
64980019501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|11/30/2022
64980019601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|11/30/2023
64980020612|CE:LTMC-ZIL|Leukotriene Modifiers - Clinical|12/15/2015|
64980020901|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
64980022101|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
64980022201|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
64980022301|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
64980027903|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
64980028001|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
64980028005|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
64980028010|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
64980029001|CE:APY-FGA|Antipsychotics|04/10/2016|
64980029101|CE:APY-FGA|Antipsychotics|04/10/2016|
64980029201|CE:APY-FGA|Antipsychotics|04/10/2016|
64980029301|CE:APY-FGA|Antipsychotics|04/10/2016|
64980037303|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037403|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037503|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037603|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037703|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037803|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980037903|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
64980045303|CE:GIM-ALO|GI Motility|01/18/2017|
64980045403|CE:GIM-ALO|GI Motility|01/18/2017|
64980047201|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64980047201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
64980050448|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
64980050924|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
64980050924|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
65162003310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162003310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162003310|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162003310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162003310|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162003311|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|03/23/2021
65162003311|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/23/2021
65162003311|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|03/23/2021
65162003311|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162003311|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|03/23/2021
65162003416|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
65162004710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162004710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162004710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162004710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162004750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162004750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162004750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004810|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004810|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162004810|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004810|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162004810|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162004910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004910|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162004910|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162004910|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162004910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004950|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004950|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162004950|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162004950|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162004950|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162005010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005010|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162005010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005010|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162005010|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162005110|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162005110|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162005110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005110|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162005150|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005150|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162005150|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162005150|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162005150|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162005703|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
65162005710|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
65162010110|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010111|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010150|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010210|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010211|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010250|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010310|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162010350|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162011510|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162011510|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162011510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011510|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162011510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011511|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162011511|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011511|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162011511|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162011511|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011550|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162011550|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011550|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162011550|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162011550|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162018810|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162018811|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162018850|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162018910|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162018911|CE:DUP-NSD|Duplicate Therapy|02/05/2013|12/10/2020
65162018950|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162019010|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162019011|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162019050|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162020710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162020710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162020710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162020710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162020710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162020750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162020750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162020750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162020750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162020750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162022621|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162022623|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162023109|CE:DRO-MPHER18|Drug Regimen Optimization|01/31/2011|
65162023109|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
65162023309|CE:DRO-MPHER27|Drug Regimen Optimization|01/31/2011|
65162023309|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
65162023509|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
65162023709|CE:ADD-ERCONCER|ADD/ADHD Agents|02/13/2014|
65162024803|CE:GIM-ALO|GI Motility|01/18/2017|
65162024903|CE:GIM-ALO|GI Motility|01/18/2017|
65162028003|CE:APY-SGA|Antipsychotics|04/10/2016|
65162028103|CE:APY-SGA|Antipsychotics|04/10/2016|
65162028203|CE:APY-SGA|Antipsychotics|04/10/2016|
65162028303|CE:APY-SGA|Antipsychotics|04/10/2016|
65162032109|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
65162035109|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
65162037110|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
65162037150|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
65162041503|CE:SUB-SUBOX|Suboxone|04/23/2013|
65162041503|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162041503|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162041603|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162041603|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162041603|CE:SUB-SUBOX|Suboxone|04/23/2013|
65162043606|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162043806|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162044110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162044111|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162044150|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|01/13/2021
65162044210|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162044211|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162044250|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|10/09/2020
65162046410|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046450|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046510|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046550|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046609|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046610|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162046650|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162050603|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162050606|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162050609|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162050650|CE:DUP-NSD|Duplicate Therapy|02/05/2013|01/24/2021
65162052110|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
65162052111|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
65162052210|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
65162055310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055610|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65162055610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055650|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055650|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65162055650|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055710|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65162055710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162055750|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65162055750|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162059020|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|01/13/2021
65162061710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162061710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162061710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162061710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162061710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162061711|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162061711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162061711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162061711|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162061711|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162061750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162061750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162061750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162061750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162061750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062710|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162062710|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062710|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162062710|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162062711|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062711|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162062711|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062711|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162062711|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162062750|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65162062750|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062750|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162062750|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65162062750|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65162063609|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
65162067384|CE:APY-ARI|Antipsychotics|04/10/2016|
65162067684|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162068090|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
65162068090|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
65162068090|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
65162068090|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
65162068090|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
65162068784|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162068784|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162068784|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65162068784|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65162069890|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65162074510|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
65162075510|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
65162075550|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
65162076110|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076111|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076210|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076211|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076310|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076311|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076410|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076411|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076510|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076511|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076610|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076611|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076710|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076711|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076810|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076811|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076910|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162076911|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65162077810|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
65162077810|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
65162083366|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162089374|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089603|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089609|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089703|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
65162089703|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089709|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
65162089709|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089803|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
65162089803|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089809|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089809|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
65162089903|CE:APY-ARI|Antipsychotics|04/10/2016|
65162089903|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
65162089909|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
65162089909|CE:APY-ARI|Antipsychotics|04/10/2016|
65162090103|CE:APY-ARI|Antipsychotics|04/10/2016|
65162090109|CE:APY-ARI|Antipsychotics|04/10/2016|
65162090203|CE:APY-ARI|Antipsychotics|04/10/2016|
65162090209|CE:APY-ARI|Antipsychotics|04/10/2016|
65162091174|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65162098908|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162099208|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162099308|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162099508|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65162099708|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
65224085009|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65597010130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597010330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597010330|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
65597010430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597010530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597010530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597010630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597010630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597010730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597010730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011430|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597011530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597011630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597011630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597011730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597011830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65597011830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65597020130|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65597020230|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65597020290|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65597020330|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65597020390|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
65597030110|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|05/02/2021
65597030110|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|05/02/2021
65597030110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030110|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65597030110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/14/2021
65597030210|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65597030210|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|04/14/2021
65597030210|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/14/2021
65597030210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/14/2021
65597030310|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|05/02/2021
65597030310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030310|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|05/02/2021
65597030310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65597030410|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|05/02/2021
65597030410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/02/2021
65597030410|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|05/02/2021
65597030410|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65649015090|CE:REL-REL|Relistor|09/24/2013|
65649030103|CE:RIF-XIF200|Rifaximin (Xifaxan)|01/31/2011|
65649030302|CE:RIF-XIF550|Rifaximin (Xifaxan)|01/31/2011|
65649031112|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65649055103|CE:REL-REL|Relistor|09/24/2013|
65649055204|CE:REL-REL|Relistor|09/24/2013|
65757040103|CE:APY-SGA|Antipsychotics|04/10/2016|
65757040203|CE:APY-SGA|Antipsychotics|04/10/2016|
65757040303|CE:APY-SGA|Antipsychotics|04/10/2016|
65757040403|CE:APY-SGA|Antipsychotics|04/10/2016|
65757050003|CE:APY-SGA|Antipsychotics|04/10/2016|
65862000501|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
65862000505|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
65862000601|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
65862000605|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
65862001101|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
65862001105|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
65862001130|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
65862001201|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
65862001205|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
65862001230|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
65862002106|CE:DRO-MIRODT15|Drug Regimen Optimization|01/31/2011|
65862003130|CE:DRO-MIRTZA15|Drug Regimen Optimization|01/31/2011|
65862005090|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
65862005090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005130|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005130|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
65862005190|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
65862005190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005199|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
65862005199|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005230|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005230|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
65862005290|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
65862005290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005299|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
65862005299|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005330|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
65862005330|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005390|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
65862005399|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
65862005399|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005430|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862005499|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862009701|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
65862009701|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
65862009701|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862009705|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862009705|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
65862009705|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
65862013399|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862013401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862013499|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862015505|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
65862015530|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
65862015599|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
65862015801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862015801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862015801|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
65862015901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862016001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862016190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862016290|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862016390|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862019105|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862019105|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862019105|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
65862019801|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862019805|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862019899|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862019901|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862019905|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862019999|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862020001|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862020005|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862020190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020190|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
65862020199|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020199|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
65862020230|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
65862020230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020290|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
65862020290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020299|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
65862020299|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862020399|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862021401|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862021501|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862029390|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
65862029390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862029490|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
65862029490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862029590|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
65862029590|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862029630|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862029690|CE:DUP-STN|Duplicate Therapy|02/04/2016|
65862030801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862030901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862037301|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
65862037305|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
65862037401|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
65862037405|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
65862045460|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045460|CE:ALP-ALP|Alprazolam|05/28/2015|
65862045460|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045460|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045560|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045560|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045560|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045560|CE:ALP-ALP|Alprazolam|05/28/2015|
65862045660|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045660|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045660|CE:ALP-ALP|Alprazolam|05/28/2015|
65862045660|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045760|CE:ALP-ALP|Alprazolam|05/28/2015|
65862045760|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045760|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862045760|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862046830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862046830|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
65862046830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046890|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
65862046890|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862046899|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046899|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862046899|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
65862046930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862046990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862046999|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862046999|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862047030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862047030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862047090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862047090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862047099|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862047099|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862047401|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
65862047501|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
65862047505|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
65862047601|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
65862047605|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
65862048901|CE:APY-SGA|Antipsychotics|04/10/2016|
65862049001|CE:APY-SGA|Antipsychotics|04/10/2016|
65862049101|CE:APY-SGA|Antipsychotics|04/10/2016|
65862049301|CE:APY-SGA|Antipsychotics|04/10/2016|
65862049460|CE:APY-SGA|Antipsychotics|04/10/2016|
65862049501|CE:APY-SGA|Antipsychotics|04/10/2016|
65862051205|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862051290|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862051305|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862051405|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862051501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65862051601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65862052205|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65862052301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862052305|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862052401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862052405|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
65862052518|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862052560|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862052618|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862052660|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
65862052701|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
65862052730|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
65862052790|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
65862052799|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
65862052801|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
65862052830|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
65862052890|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
65862052899|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
65862054799|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862054799|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862054890|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862054890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862054899|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862054899|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862054990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862054990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862054999|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862054999|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862055005|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862055005|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862055090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862055090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862055105|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862055105|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862055190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862055190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862055990|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
65862056130|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056130|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
65862056199|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
65862056199|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056230|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
65862056230|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056299|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
65862056299|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056330|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056330|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
65862056399|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
65862056399|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056430|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
65862056430|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056499|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
65862056499|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056530|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056599|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056630|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056699|CE:APY-SGA|Antipsychotics|04/10/2016|
65862056790|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
65862056890|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
65862057030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862057190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862057190|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
65862057290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862057290|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
65862057390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862057490|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
65862059401|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
65862059499|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
65862060101|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
65862060101|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
65862060130|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
65862060130|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
65862060201|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
65862060201|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
65862060230|CE:MOD-MOD|Modafinil (Provigil)|11/06/2012|
65862060230|CE:MOD-MOD|Modafinil (Provigil)|11/08/2012|
65862065603|CE:APY-SGA|Antipsychotics|04/10/2016|
65862065603|CE:DRO-OLAODT5|Drug Regimen Optimization|01/31/2011|
65862065703|CE:APY-SGA|Antipsychotics|04/10/2016|
65862065703|CE:DRO-OLAODT10|Drug Regimen Optimization|01/31/2011|
65862065803|CE:APY-SGA|Antipsychotics|04/10/2016|
65862065903|CE:APY-SGA|Antipsychotics|04/10/2016|
65862066105|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066130|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066205|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
65862066205|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066230|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066230|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
65862066305|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066305|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
65862066330|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
65862066330|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066405|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
65862066405|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066430|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066430|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
65862066505|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066530|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066605|CE:APY-ARI|Antipsychotics|04/10/2016|
65862066630|CE:APY-ARI|Antipsychotics|04/10/2016|
65862067001|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
65862067101|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
65862067201|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
65862067601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067601|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067605|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067605|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067699|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067699|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067699|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067699|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067701|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067705|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067799|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067799|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067799|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067799|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067801|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067805|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067805|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067805|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067805|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067899|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067899|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067899|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067899|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067901|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862067901|CE:ALP-ALP|Alprazolam|05/28/2015|
65862067901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862068890|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
65862070260|CE:APY-SGA|Antipsychotics|04/10/2016|
65862070360|CE:APY-SGA|Antipsychotics|04/10/2016|
65862070460|CE:APY-SGA|Antipsychotics|04/10/2016|
65862070560|CE:APY-SGA|Antipsychotics|04/10/2016|
65862073730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862073830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862073930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074230|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
65862074230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074290|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
65862074290|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862074390|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862077930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862077930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862077990|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862077990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862078030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862078030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862078090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862078090|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862078130|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862078130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862078190|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862078190|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862078330|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
65862078390|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
65862080530|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
65862080630|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
65862080730|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
65862083430|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862083430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862083530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862083530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862083630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862083630|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862083730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862083730|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862083830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862083830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862084401|CE:APY-SGA|Antipsychotics|04/10/2016|
65862084501|CE:APY-SGA|Antipsychotics|04/10/2016|
65862084601|CE:APY-SGA|Antipsychotics|04/10/2016|
65862084605|CE:APY-SGA|Antipsychotics|04/10/2016|
65862084701|CE:APY-SGA|Antipsychotics|04/10/2016|
65862085430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862085530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862085630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862085730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862086130|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|
65862086703|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
65862086703|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862086803|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
65862086803|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862086903|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862087360|CE:APY-SGA|Antipsychotics|04/10/2016|
65862087460|CE:APY-SGA|Antipsychotics|04/10/2016|
65862087560|CE:APY-SGA|Antipsychotics|04/10/2016|
65862087660|CE:APY-SGA|Antipsychotics|04/10/2016|
65862087760|CE:APY-SGA|Antipsychotics|04/10/2016|
65862088060|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
65862088830|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
65862088901|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
65862088905|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
65862090760|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862090760|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
65862090801|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
65862090801|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862090901|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
65862090901|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862091060|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
65862091060|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
65862092201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862092201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65862092201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65862092201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65862092201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862092205|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
65862092205|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862092205|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
65862092205|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
65862092205|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
65862092836|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
65862094324|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
65862094424|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
65862094524|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
65862096701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862096730|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862096801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862096901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
65862097603|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862097603|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862097703|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862097703|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862097803|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
65862097803|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
65862099830|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
66302046760|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
66490065020|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
66582031131|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031154|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031231|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031254|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031331|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031354|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031531|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66582031554|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
66658010260|CE:ENZ-NOR|Enzymes|11/20/2019|
66658010560|CE:ENZ-NOR|Enzymes|11/20/2019|
66658011060|CE:ENZ-NOR|Enzymes|11/20/2019|
66658012060|CE:ENZ-NOR|Enzymes|11/20/2019|
66658020490|CE:ENZ-NOR|Enzymes|11/20/2019|
66658023407|CE:CYC-KINE|Cytokine and CAM Antagonists|03/27/2018|
66689002304|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
66689002304|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002304|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002304|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
66689002304|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
66689002316|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002316|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002316|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
66689002316|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
66689002316|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
66689002530|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002530|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689002530|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
66689002530|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
66689033316|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
66689040316|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66689040316|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
66689040316|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
66689040316|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
66689040316|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
66869010490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
66869020490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
66869040490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
66993001968|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
66993002127|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
66993002227|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
66993002327|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
66993003883|CE:MAK-MAK|Makena|06/12/2015|
66993004030|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004130|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004230|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004330|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004430|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004530|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993004630|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
66993006785|CE:DRO-PNZ20|Drug Regimen Optimization|01/31/2011|
66993014130|CE:ASN-ALISK150|Aliskiren-Containing Agents|07/16/2012|
66993014230|CE:ASN-ALISK300|Aliskiren-Containing Agents|07/16/2012|
66993035957|CE:ADD-IRPROC|ADD/ADHD Agents|02/13/2014|
66993042285|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
66993042385|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
66993042485|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
66993048532|CE:LTMC-ZIL|Leukotriene Modifiers - Clinical|12/15/2015|
66993058497|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
66993058597|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
66993058697|CE:DUP-SALFL|Duplicate Therapy|02/05/2013|
66993059402|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993059402|CE:DRO-APHXL5|Drug Regimen Optimization|01/31/2011|
66993059502|CE:DRO-APHXL10|Drug Regimen Optimization|01/31/2011|
66993059502|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993059602|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993059602|CE:DRO-APHXK15|Drug Regimen Optimization|01/31/2011|
66993059702|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993059802|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993059902|CE:ADD-ERADDERA|ADD/ADHD Agents|02/13/2014|
66993066102|CE:DUP-RXF|Duplicate Therapy|02/04/2016|08/10/2020
66993066130|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
66993066188|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
66993068030|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
66993068030|CE:APY-SGA|Antipsychotics|04/10/2016|
66993068130|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
66993068130|CE:APY-SGA|Antipsychotics|04/10/2016|
66993068230|CE:APY-SGA|Antipsychotics|04/10/2016|
66993068230|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
66993068330|CE:APY-SGA|Antipsychotics|04/10/2016|
66993068330|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
66993068430|CE:APY-SGA|Antipsychotics|04/10/2016|
66993068530|CE:APY-SGA|Antipsychotics|04/10/2016|
66993082130|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
66993082230|CE:TZD-PIOGLIT|Hypoglycemics  TZD|01/31/2011|
66993084462|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
66993084462|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
66993084562|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
66993084562|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
66993084662|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
66993084662|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
67253065110|CE:PTU-PTU|Propylthiouracil|04/18/2011|
67253090010|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090010|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090010|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090010|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090011|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090011|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090011|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090011|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090050|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090050|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090050|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090050|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090110|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090110|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090111|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090111|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090111|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090111|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090150|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090150|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090150|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090150|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090210|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090211|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090211|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090211|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090211|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090250|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090250|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090250|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090250|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090310|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090310|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090350|CE:ALP-ALP|Alprazolam|05/28/2015|10/08/2020
67253090350|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090350|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67253090350|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/08/2020
67386042101|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
67386042201|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
67405057510|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405057550|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405057596|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405057710|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405057750|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405067110|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405067150|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67405067196|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/26/2020
67457012410|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
67457058210|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
67457058304|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
67457058406|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
67457058508|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
67457059406|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
67457096701|CE:MAK-MAK|Makena|06/12/2015|
67877011601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
67877011601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
67877011601|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
67877011601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877011601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
67877011601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014601|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877014601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014605|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877014605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014605|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014701|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014701|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877014705|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014705|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014705|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014705|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877014801|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014801|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014801|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014801|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877014930|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014930|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014930|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
67877014930|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
67877019705|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
67877019710|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
67877019790|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
67877019805|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
67877019810|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
67877019890|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
67877022201|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022205|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022210|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022301|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022305|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022310|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022405|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877022410|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877024201|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024210|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024601|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024610|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024710|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024760|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024801|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024810|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024901|CE:APY-SGA|Antipsychotics|04/10/2016|
67877024910|CE:APY-SGA|Antipsychotics|04/10/2016|
67877025001|CE:APY-SGA|Antipsychotics|04/10/2016|
67877025010|CE:APY-SGA|Antipsychotics|04/10/2016|
67877031901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877031905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032030|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032050|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032130|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877032150|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
67877041530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877041690|CE:DRO-VALSA80|Drug Regimen Optimization|01/31/2011|
67877041690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877041790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877041790|CE:DRO-VALSA160|Drug Regimen Optimization|01/31/2011|
67877041890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877042801|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877042805|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877042901|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877042905|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
67877043003|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043005|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043101|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
67877043101|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043103|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043103|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
67877043105|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043105|CE:DRO-ARIPI5|Drug Regimen Optimization|01/31/2011|
67877043201|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043201|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
67877043203|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043203|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
67877043205|CE:DRO-ARIPI10|Drug Regimen Optimization|01/31/2011|
67877043205|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043301|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043301|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
67877043303|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043303|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
67877043305|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043305|CE:DRO-ARIPI15|Drug Regimen Optimization|01/31/2011|
67877043403|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043405|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043501|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043503|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043505|CE:APY-ARI|Antipsychotics|04/10/2016|
67877043990|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877043990|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
67877044005|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
67877044005|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877044090|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
67877044090|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877044190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877044190|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
67877044230|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877044290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877044530|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877044630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877044630|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
67877044690|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
67877044690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877044730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877044790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877047750|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
67877047810|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
67877047830|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
67877047890|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
67877048230|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
67877048230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877048284|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877048284|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
67877048330|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877048330|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
67877048384|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877048384|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
67877048430|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877048484|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877050130|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877050230|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
67877050730|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877050790|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877050830|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877050890|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877050930|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877050990|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877051030|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877051090|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
67877051105|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
67877051105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051190|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
67877051190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051210|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
67877051210|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051290|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
67877051390|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
67877051390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051405|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877051490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
67877052730|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
67877052790|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
67877057301|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
67877057305|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
67877057401|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
67877057501|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
67877057505|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
68001000400|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68001000400|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68001000501|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68001000501|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68001000600|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/28/2021
68001000603|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/28/2021
68001000700|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|01/15/2021
68001000703|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|04/30/2021
68001010500|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
68001010503|CE:DRO-DIVAL250|Drug Regimen Optimization|01/31/2011|
68001011104|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
68001011105|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
68001013606|CE:APY-SGA|Antipsychotics|04/10/2016|
68001013706|CE:APY-SGA|Antipsychotics|04/10/2016|07/13/2021
68001013806|CE:APY-SGA|Antipsychotics|04/10/2016|
68001013906|CE:APY-SGA|Antipsychotics|04/10/2016|06/30/2021
68001014004|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|03/20/2021
68001014200|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|03/04/2021
68001014203|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|03/04/2021
68001014300|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|01/15/2021
68001014303|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|01/15/2021
68001015800|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
68001016100|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68001016200|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68001016208|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68001016300|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68001018000|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018008|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018100|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018103|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018200|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018203|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018300|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018303|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018306|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018400|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018408|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018500|CE:APY-SGA|Antipsychotics|04/10/2016|
68001018508|CE:APY-SGA|Antipsychotics|04/10/2016|
68001019500|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
68001019600|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
68001019603|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
68001023106|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001023206|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001027900|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028000|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028006|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028008|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028100|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028103|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028106|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001028108|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68001031400|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68001031400|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
68001031408|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|07/31/2020
68001031408|CE:DUP-STN|Duplicate Therapy|02/04/2016|07/31/2020
68001031500|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68001031500|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68001031508|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68001031508|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68001031600|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68001031608|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68001032203|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68001032204|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68001032205|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68001032500|CE:DES-DESMO|Desmopressin|05/25/2012|
68001032600|CE:DES-DESMO|Desmopressin|05/25/2012|
68001032700|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|11/26/2020
68001032703|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
68001032800|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|10/08/2020
68001032803|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|12/31/2020
68001036103|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
68001036105|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
68001036305|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
68001038700|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68001038703|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68001038800|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68001038803|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68001041100|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68001041103|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68001041200|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68001041203|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68001042800|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
68001042900|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
68001043000|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68001043003|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68025004610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68025004610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68025004710|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68025004710|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68025006530|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68025006630|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68025006730|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68047012016|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68047012016|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
68047012916|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
68047012916|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
68047012916|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68047014316|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
68047014316|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
68047014316|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
68047014316|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68047018516|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
68047018516|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68047018616|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68047018616|CE:DXO-DEXO|Dextromethorphan Overutilization|07/16/2012|
68047018616|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
68047018616|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
68047070221|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68047070221|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68047070235|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68047070235|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68047070251|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68047070251|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68134020116|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68135002001|CE:ENZ-NAG|Enzymes|11/20/2019|
68135010001|CE:ENZ-VIM|Enzymes|11/20/2019|
68180010102|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010102|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010202|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010202|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010209|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010209|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010302|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010302|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010309|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010402|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010402|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010409|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010502|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180010502|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010509|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180010509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180013415|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
68180013501|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
68180013701|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
68180015301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68180015302|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68180018506|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68180019306|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019306|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180019406|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019406|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180019506|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019506|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180019606|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019706|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019806|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180019906|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021506|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180021506|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
68180021506|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021509|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180021509|CE:DRO-LORS12.5|Drug Regimen Optimization|01/31/2011|
68180021606|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180021606|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021609|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180021609|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021706|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021706|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180021709|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180021709|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180022101|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
68180022103|CE:DRO-NIASA500|Drug Regimen Optimization|01/31/2011|
68180031902|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68180031906|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68180031909|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68180032201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68180032301|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68180032401|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68180033107|CE:APY-SGA|Antipsychotics|04/10/2016|
68180033207|CE:APY-SGA|Antipsychotics|04/10/2016|
68180033307|CE:APY-SGA|Antipsychotics|04/10/2016|
68180033407|CE:APY-SGA|Antipsychotics|04/10/2016|
68180035103|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
68180035106|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
68180035109|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
68180035202|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
68180035205|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
68180035206|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
68180035209|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
68180035407|CE:RAN-RAN|Ranolazine|05/25/2012|07/31/2021
68180035507|CE:RAN-RAN|Ranolazine|05/25/2012|07/31/2021
68180037603|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180037603|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
68180037703|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68180037703|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180037803|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180039507|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039507|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180039601|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180039601|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039602|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180039602|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039701|CE:DUP-COXC|Duplicate Therapy|02/04/2016|01/16/2021
68180039701|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|01/16/2021
68180039702|CE:DUP-COXC|Duplicate Therapy|02/04/2016|02/24/2021
68180039702|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|02/24/2021
68180039807|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180039807|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039901|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180039901|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039902|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
68180039902|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180040858|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|08/28/2021
68180040958|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|08/28/2021
68180041006|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041006|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
68180041009|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
68180041009|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041106|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
68180041106|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041109|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
68180041206|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041209|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041306|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041306|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180041309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041309|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180041406|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041406|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180041409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180041409|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180044501|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044503|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044601|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044603|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044701|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044703|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044801|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044802|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044901|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044902|CE:APY-SGA|Antipsychotics|04/10/2016|
68180044907|CE:APY-SGA|Antipsychotics|04/10/2016|
68180045001|CE:APY-SGA|Antipsychotics|04/10/2016|
68180045002|CE:APY-SGA|Antipsychotics|04/10/2016|
68180046403|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
68180046403|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046406|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046406|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
68180046409|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
68180046409|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046503|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046506|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046509|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046701|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046701|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
68180046703|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
68180046703|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046707|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046707|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|
68180046801|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046801|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68180046803|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046803|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68180046805|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68180046805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046807|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046807|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68180046901|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046903|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046905|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180046907|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047801|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
68180047801|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047802|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047802|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
68180047803|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
68180047803|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047901|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047901|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
68180047902|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047902|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
68180047903|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180047903|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
68180048502|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048502|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68180048509|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048509|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68180048602|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68180048602|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048609|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68180048609|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048702|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68180048702|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048709|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048709|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68180048802|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180048809|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68180049001|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
68180049101|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
68180050101|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68180050101|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
68180050101|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180050103|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
68180050103|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68180050103|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180050201|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68180050201|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180050203|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68180050203|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68180051801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180051802|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180051830|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180051901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180051902|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180051930|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180052001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180052002|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180052030|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180053801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68180056601|CE:DRO-TRANDOL1|Drug Regimen Optimization|01/31/2011|
68180056701|CE:DRO-TRANDOL2|Drug Regimen Optimization|01/31/2011|
68180056907|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
68180057107|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
68180057207|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
68180057307|CE:MOD-ARM|Modafinil (Provigil)|02/06/2018|
68180058901|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
68180058902|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
68180058909|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
68180059001|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68180059002|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68180059009|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68180060607|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
68180061207|CE:APY-SGA|Antipsychotics|04/10/2016|
68180061307|CE:APY-SGA|Antipsychotics|04/10/2016|
68180061407|CE:APY-SGA|Antipsychotics|04/10/2016|
68180061507|CE:APY-SGA|Antipsychotics|04/10/2016|
68180061607|CE:APY-SGA|Antipsychotics|04/10/2016|
68180064706|CE:DRO-PRX12.5|Drug Regimen Optimization|01/31/2011|
68180069706|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180069706|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68180069706|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
68180069706|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68180069706|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180069806|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68180069806|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68180069806|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180069806|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180069806|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
68180069906|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68180069906|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180069906|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68180071909|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
68180072003|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
68180072009|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
68180076406|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180076506|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180076606|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180076706|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077106|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077106|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077109|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077109|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077206|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077206|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077209|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077209|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077306|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077306|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077309|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077309|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077406|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077406|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077409|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077409|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077506|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077506|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077509|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68180077509|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68180077901|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68180078001|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68180081942|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
68180082046|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
68180082147|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
68180082709|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180082713|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180082809|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180082813|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180082913|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180083013|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68180091407|CE:SDF-REVATIO|Sildenafil (Revatio)|01/31/2011|
68308002003|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68308002003|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308002003|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308002003|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68308011201|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
68308011201|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/31/2020
68308011201|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/31/2020
68308011201|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
68308011201|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/31/2020
68308011501|CE:ADD-IRMETHAM|ADD/ADHD Agents|02/13/2014|
68308014501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308014501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68308014501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68308014501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68308014501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308047547|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308047547|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68308047547|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68308047547|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308047547|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68308048047|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308048047|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68308048047|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68308048047|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308048047|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68308050547|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
68308050547|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/10/2020
68308050547|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/10/2020
68308050547|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/10/2020
68308050547|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/10/2020
68308084101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
68308084101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|07/31/2020
68308084101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|07/31/2020
68308084101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/31/2020
68308084101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/31/2020
68308084501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68308084501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68308084501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68308084501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68308084501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382001901|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
68382003406|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
68382003410|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
68382003416|CE:DRO-VENL37.5|Drug Regimen Optimization|01/31/2011|
68382003506|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
68382003510|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
68382003516|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
68382004001|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68382004101|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68382004110|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68382004201|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
68382005001|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68382005001|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68382005001|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
68382005005|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68382005005|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
68382005005|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68382005101|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68382005101|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68382005105|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
68382005105|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
68382007005|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007005|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68382007016|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68382007016|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007105|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007105|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68382007116|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68382007116|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007205|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68382007216|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68382007216|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68382007901|CE:APY-FGA|Antipsychotics|04/10/2016|
68382007910|CE:APY-FGA|Antipsychotics|04/10/2016|
68382008001|CE:APY-FGA|Antipsychotics|04/10/2016|
68382008101|CE:APY-FGA|Antipsychotics|04/10/2016|
68382009705|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
68382009706|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
68382009710|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
68382009716|CE:DRO-PRX10|Drug Regimen Optimization|01/31/2011|
68382009801|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
68382009805|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
68382009806|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
68382009810|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
68382009816|CE:DRO-PRX20|Drug Regimen Optimization|01/31/2011|
68382011205|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011205|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
68382011214|CE:DRO-RISP0.25|Drug Regimen Optimization|01/31/2011|
68382011214|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011305|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011305|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
68382011314|CE:DRO-RISP0.5|Drug Regimen Optimization|01/31/2011|
68382011314|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011405|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
68382011405|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011414|CE:DRO-RISP1|Drug Regimen Optimization|01/31/2011|
68382011414|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011505|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
68382011505|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011514|CE:DRO-RISP2|Drug Regimen Optimization|01/31/2011|
68382011514|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011605|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011614|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011705|CE:APY-ARI|Antipsychotics|04/10/2016|
68382011714|CE:APY-ARI|Antipsychotics|04/10/2016|
68382012105|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
68382012116|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
68382012205|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
68382012216|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
68382013506|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013506|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
68382013510|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013510|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
68382013516|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013516|CE:DRO-LORSA25|Drug Regimen Optimization|01/31/2011|
68382013606|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013606|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68382013610|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013610|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68382013616|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013616|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68382013706|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013710|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382013716|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382014406|CE:DRO-RAMI1.25|Drug Regimen Optimization|01/31/2011|
68382014501|CE:DRO-RAMI2.50|Drug Regimen Optimization|01/31/2011|
68382014601|CE:DRO-RAMI5.00|Drug Regimen Optimization|01/31/2011|
68382020401|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68382020405|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68382020501|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68382020505|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68382024701|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
68382024705|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
68382025501|CE:DRO-OXYBU5|Drug Regimen Optimization|01/31/2011|
68382027101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68382027114|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68382027201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68382027301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68382027314|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68382031901|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382031901|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382031901|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382031901|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68382031901|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68382031910|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382031910|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68382031910|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382031910|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382031910|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68382033401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382033401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382033401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68382033401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382033401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68382033405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382033405|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
68382033405|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382033405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68382033405|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
68382033506|CE:DRO-GLIP2.5|Drug Regimen Optimization|01/31/2011|
68382033601|CE:DRO-GLIP5|Drug Regimen Optimization|01/31/2011|
68382035305|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68382035306|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68382035316|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
68382041101|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
68382041205|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
68382047178|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382047178|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
68382047278|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382047278|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
68382047378|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68382054306|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
68382054310|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
68382072116|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
68382072216|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
68382078301|CE:DRO-DOXA1|Drug Regimen Optimization|01/31/2011|
68382078401|CE:DRO-DOXA2|Drug Regimen Optimization|01/31/2011|
68382078501|CE:DRO-DOXA4|Drug Regimen Optimization|01/31/2011|
68382079301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/31/2021
68382079301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382079301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|10/31/2021
68382079301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/31/2021
68382079301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|10/31/2021
68382079401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|04/30/2021
68382079401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/30/2021
68382079401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382079401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
68382079401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
68382079501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/31/2021
68382079501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|05/31/2021
68382079501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|05/31/2021
68382079501|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|05/31/2021
68382079501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382079601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
68382079601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/30/2021
68382079601|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/30/2021
68382079601|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68382079601|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|04/30/2021
68382079701|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
68382079701|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
68382079701|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/31/2020
68382079701|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/31/2020
68382079701|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/31/2020
68382085601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68382085605|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68382085701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68382085705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68382091601|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68382091601|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68382091634|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68382091634|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68382091711|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68382091711|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68382091818|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68382091818|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68382091911|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
68382091911|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
68382095001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095101|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095201|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095501|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68382095601|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
68462011233|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462012601|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68462012605|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68462012701|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68462012705|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
68462017801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462017805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/10/2020
68462017901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462017905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462018801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462018805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462018901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462018905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462019001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462019005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462019030|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462019505|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68462019505|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019590|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019590|CE:DRO-PRAVA10|Drug Regimen Optimization|01/31/2011|
68462019605|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68462019605|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019690|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019690|CE:DRO-PRAVA20|Drug Regimen Optimization|01/31/2011|
68462019705|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019705|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68462019790|CE:DRO-PRAVA40|Drug Regimen Optimization|01/31/2011|
68462019790|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019805|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019890|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462019913|CE:DRO-TELMI20|Drug Regimen Optimization|01/31/2011|
68462019913|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462020013|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462020013|CE:DRO-TELMI40|Drug Regimen Optimization|01/31/2011|
68462020113|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462020401|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68462020401|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|04/01/2021
68462020401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462020401|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/01/2021
68462020401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462023301|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
68462023401|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
68462026190|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462026190|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
68462026290|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462026290|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
68462026390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462026390|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
68462026430|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68462026530|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462026630|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462026730|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462026830|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462026930|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462027030|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462027130|CE:ADD-NSADHD|ADD/ADHD Agents|02/13/2014|
68462027501|CE:DES-DESMO|Desmopressin|05/25/2012|
68462027601|CE:DES-DESMO|Desmopressin|05/25/2012|
68462030201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462030205|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462031960|CE:RAN-RAN|Ranolazine|05/25/2012|
68462032060|CE:RAN-RAN|Ranolazine|05/25/2012|
68462032130|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
68462032230|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
68462032290|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
68462032330|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
68462032430|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
68462032501|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462032560|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462032590|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462034690|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
68462034737|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68462034737|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462034737|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462034737|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/01/2021
68462035594|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462035601|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
68462035801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|03/13/2021
68462035805|CE:DUP-NSD|Duplicate Therapy|02/05/2013|01/31/2021
68462035901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|02/10/2021
68462035905|CE:DUP-NSD|Duplicate Therapy|02/05/2013|02/10/2021
68462038001|CE:DUP-MLX|Duplicate Therapy|02/05/2013|
68462038201|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68462038301|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68462038401|CE:ASH-SEDHYP19|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68462038630|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
68462038690|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
68462039501|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
68462039530|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
68462039590|CE:DRO-OMP10|Drug Regimen Optimization|01/31/2011|
68462039601|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
68462039610|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
68462039630|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
68462039690|CE:DRO-OMP20|Drug Regimen Optimization|01/31/2011|
68462040601|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462040610|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68462043630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462043730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462043730|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
68462043790|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
68462043790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462043830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462043890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462053435|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462053465|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462053494|CE:TIM-PRO|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462053670|CE:IMI-IMIQ5|Imiquimod|07/16/2012|
68462055401|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68462055501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68462056630|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056690|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056730|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056790|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056890|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462056990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68462058340|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462058385|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462058458|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462058476|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462058576|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
68462060935|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462060965|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462060994|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68462065629|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462065684|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462065729|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462065784|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462065790|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462071171|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462071188|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68462072401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68462072401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68462072501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68462072501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68462080001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462080001|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462080001|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|04/01/2021
68462080001|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68462080001|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/01/2021
68462080101|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462080101|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|04/01/2021
68462080101|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/01/2021
68462080101|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|04/01/2021
68462080101|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
68462080101|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|04/01/2021
68546017060|CE:VMAT-DEU|VMAT2 Inhibitors|09/25/2018|
68546017160|CE:VMAT-DEU|VMAT2 Inhibitors|09/25/2018|
68546017260|CE:VMAT-DEU|VMAT2 Inhibitors|09/25/2018|
68645045854|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|06/30/2021
68645045854|CE:DUP-STN|Duplicate Therapy|02/04/2016|06/30/2021
68645045954|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|06/30/2021
68645045954|CE:DUP-STN|Duplicate Therapy|02/04/2016|06/30/2021
68645046054|CE:DUP-STN|Duplicate Therapy|02/04/2016|04/30/2021
68645046054|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|04/30/2021
68645046154|CE:DUP-STN|Duplicate Therapy|02/04/2016|04/30/2021
68645047054|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
68645047054|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645048054|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|06/30/2022
68645048054|CE:DUP-STN|Duplicate Therapy|02/04/2016|06/30/2022
68645048154|CE:DUP-STN|Duplicate Therapy|02/04/2016|06/30/2022
68645048154|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|06/30/2022
68645048354|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|08/31/2020
68645048354|CE:DUP-STN|Duplicate Therapy|02/04/2016|08/31/2020
68645049454|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68645049454|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68645049554|CE:DUP-STN|Duplicate Therapy|02/04/2016|06/30/2022
68645051054|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68645051254|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
68645051554|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
68645051790|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
68645051790|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68645051790|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68645051890|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68645051890|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
68645051890|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
68645051954|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
68645052154|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
68645052254|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
68645052754|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645052754|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
68645055654|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68645055754|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68645055854|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68645056354|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68645056690|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645056690|CE:DRO-LOVA20|Drug Regimen Optimization|01/31/2011|
68645056790|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645056854|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|05/31/2022
68645056854|CE:DUP-STN|Duplicate Therapy|02/04/2016|05/31/2022
68645056954|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
68645057054|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
68645057690|CE:DRO-LOVA10|Drug Regimen Optimization|01/31/2011|09/30/2020
68645057690|CE:DUP-STN|Duplicate Therapy|02/04/2016|09/30/2020
68645058654|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
68645058654|CE:DRO-LORSA50|Drug Regimen Optimization|01/31/2011|
68645058854|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
68645059154|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
68645059154|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645059254|CE:DUP-STN|Duplicate Therapy|02/04/2016|
68645059254|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
68682010301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
68682010510|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
68682010830|CE:DRO-NFP30|Drug Regimen Optimization|01/31/2011|
68682011001|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68682011102|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68682011203|CE:TIM-TIM|Topical Immunomodulators ( Elidel & Protopic)|01/31/2011|
68682027275|CE:IMI-IMIQ|Imiquimod|07/16/2012|
68682042112|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
68682042225|CE:VMAT-TET|VMAT2 Inhibitors|09/25/2018|
68682065020|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68682065220|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68682065520|CE:ASH-CLO/DIAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
68727010001|CE:XYR-XYR|Xyrem|02/17/2011|
68727035001|CE:CNS-SOL|CNS Stimulants|04/14/2020|
68727035101|CE:CNS-SOL|CNS Stimulants|04/14/2020|
68968017203|CE:APY-SGA|Antipsychotics|04/10/2016|
68968017303|CE:APY-SGA|Antipsychotics|04/10/2016|
68968017403|CE:APY-SGA|Antipsychotics|04/10/2016|
68968051408|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968052508|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968341008|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968342508|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968343708|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968345008|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968347508|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
68968555203|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
68968555203|CE:DRO-MPHPA10|Drug Regimen Optimization|01/31/2011|
68968555303|CE:DRO-MPHPA15|Drug Regimen Optimization|01/31/2011|
68968555303|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
68968555403|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
68968555503|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
69097012605|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
69097012615|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
69097012705|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
69097012715|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
69097014260|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
69097015807|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097015807|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015807|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
69097015812|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015812|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
69097015812|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097015815|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
69097015815|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015815|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097015907|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097015907|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015912|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015912|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097015915|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
69097015915|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097017353|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
69097017364|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
69097025902|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
69097031887|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
69097031953|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
69097031987|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
69097032187|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
69097042107|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
69097042107|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097042112|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
69097042112|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097042207|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
69097042207|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097042212|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097042212|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
69097042303|CE:COX-CELEBREX|COX-2 Inhibitors|01/31/2011|
69097042303|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
69097043102|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|
69097043105|CE:DRO-DARI7.5|Drug Regimen Optimization|01/31/2011|
69097052444|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097081107|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081112|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081207|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081212|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081307|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081312|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081507|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097081512|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69097082207|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
69097082212|CE:DRO-CTP10|Drug Regimen Optimization|01/31/2011|
69097082307|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
69097082312|CE:DRO-CTP20|Drug Regimen Optimization|01/31/2011|
69097082502|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
69097082507|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
69097082515|CE:DUP-RXF|Duplicate Therapy|02/04/2016|
69097082805|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097082905|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097083105|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097083302|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
69097083305|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
69097083312|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
69097083402|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
69097083412|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
69097083605|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
69097083615|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
69097083705|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
69097083715|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
69097084507|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084507|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084507|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
69097084607|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
69097084607|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084607|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084615|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
69097084615|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084615|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69097084705|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
69097084805|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
69097085107|CE:DUP-NSD|Duplicate Therapy|02/05/2013|05/31/2021
69097085207|CE:DUP-NSD|Duplicate Therapy|02/05/2013|09/30/2021
69097085307|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097085407|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097085412|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097085507|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097085512|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097085605|CE:DRO-FOSI10|Drug Regimen Optimization|01/31/2011|
69097085705|CE:DRO-FOSI20|Drug Regimen Optimization|01/31/2011|
69097086283|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
69097087502|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
69097087505|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
69097087512|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
69097094405|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
69097094405|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094415|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094415|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
69097094505|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094505|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
69097094512|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094512|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
69097094605|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094605|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
69097094615|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094615|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
69097094705|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097094712|CE:DUP-STN|Duplicate Therapy|02/04/2016|
69097096507|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097096512|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097096607|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097096612|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69097096807|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097096812|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097096907|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097096912|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097097107|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69097097112|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69117002801|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
69117002802|CE:DRO-FLP2.5|Drug Regimen Optimization|01/31/2011|
69117002901|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
69117002902|CE:DRO-FLP5|Drug Regimen Optimization|01/31/2011|
69238105401|CE:APY-FGA|Antipsychotics|04/10/2016|
69238105601|CE:APY-FGA|Antipsychotics|04/10/2016|
69238105801|CE:APY-FGA|Antipsychotics|04/10/2016|
69238106001|CE:APY-FGA|Antipsychotics|04/10/2016|
69238106201|CE:APY-FGA|Antipsychotics|04/10/2016|
69238110105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|05/31/2022
69238112001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69238112005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|08/10/2020
69238115503|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
69238115603|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
69238115609|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|10/17/2020
69238115703|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
69238115709|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|10/17/2020
69238115803|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|
69238115809|CE:DUP-STNCBO|Duplicate Therapy|02/05/2013|10/17/2020
69238120302|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
69238120302|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120302|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69238120302|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120402|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120402|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120402|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
69238120502|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69238120502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238120502|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
69238125206|CE:DUP-HRT|Duplicate Therapy|02/05/2013|12/17/2020
69238130803|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|08/03/2021
69238130809|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|08/03/2021
69238134201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69238134301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69238142606|CE:ADD-KAPVAY|ADD/ADHD Agents|02/13/2014|
69238150502|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|
69238150502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238150502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238156301|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
69238156301|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
69238156401|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
69238156401|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
69238157401|CE:SDF-REVSUSP|Sildenafil (Revatio)|09/01/2015|
69238179701|CE:MAK-MAK|Makena|06/12/2015|
69238199301|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69238199301|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69238199301|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238199301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69238199301|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69315013001|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315013010|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315013101|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315013110|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315015501|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315015510|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69315024812|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69315024812|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315024812|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69315024812|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69315024812|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315024848|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69315024848|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315024848|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69315024848|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315024848|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69315090401|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090401|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090405|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090405|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090410|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090410|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090410|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090410|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090501|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090501|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090505|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090505|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090505|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090505|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090510|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090510|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090510|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090510|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090601|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090601|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090601|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090601|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090605|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090605|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090605|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090605|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69315090610|CE:ASH-LORAZ|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
69315090610|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69339013501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69339013510|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69344010101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69367011901|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367011901|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
69367011903|CE:DRO-IRBE75|Drug Regimen Optimization|01/31/2011|
69367011903|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367012001|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367012001|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
69367012003|CE:DRO-IRBE150|Drug Regimen Optimization|01/31/2011|
69367012003|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367012101|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367012103|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
69367012204|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367012207|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367012304|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367012307|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367013104|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013106|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013204|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013206|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013304|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013306|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013404|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013406|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013504|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367013506|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
69367018408|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
69367018530|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367018650|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367018730|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367019760|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
69367019760|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367019890|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
69367019890|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
69367019901|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
69367019901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367021901|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367021905|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367021910|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
69367023809|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367023903|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
69367023909|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
69367024101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69367024105|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69367024201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69367024205|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69367024601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367024610|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69367025330|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69452010513|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010519|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010532|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010613|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010619|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010713|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452010719|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
69452014320|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
69452014330|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
69452014420|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
69452014430|CE:CCC-CCCC|Cough and Cold Agents - Clinical|12/15/2015|
69452017522|CE:LVZ-LOVAZ|Lovaza|07/16/2012|
69452022720|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
69452022820|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
69543010710|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69543010730|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|09/27/2020
69543010750|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69543013610|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013610|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013610|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69543013610|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543013610|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543013611|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013611|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013611|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543013611|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69543013611|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543013650|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69543013650|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013650|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543013650|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543013650|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025116|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025116|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025116|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025116|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543025116|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543025204|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025204|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543025204|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025204|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543025204|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025216|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025216|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025216|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543025216|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025216|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543025304|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025304|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543025304|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543025304|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025304|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025316|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543025316|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025316|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543025316|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543025316|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543027616|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543027616|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
69543027616|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69543027616|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543027616|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543038030|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038030|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
69543038090|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038090|CE:DRO-OLANZ2.5|Drug Regimen Optimization|01/31/2011|
69543038130|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
69543038130|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038190|CE:DRO-OLANZ5|Drug Regimen Optimization|01/31/2011|
69543038190|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038230|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
69543038230|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038290|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038290|CE:DRO-OLANZ7.5|Drug Regimen Optimization|01/31/2011|
69543038330|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038330|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
69543038390|CE:DRO-OLANZ10|Drug Regimen Optimization|01/31/2011|
69543038390|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038430|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038490|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038530|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038590|CE:APY-SGA|Antipsychotics|04/10/2016|
69543038810|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69543038810|CE:KET-KET|Ketorolac|05/25/2012|
69543041210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543041210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69543041210|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
69543041210|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
69543042510|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69543042610|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69584011110|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
69584011110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584011110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584011190|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584011190|CE:CCA-LDCARIS|Carisoprodol Containing Agents|01/31/2011|
69584011190|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061110|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061110|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061150|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061150|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061250|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69584061250|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
69639010101|CE:AEM-ANTIEME|Antiemetics  Oral|01/31/2011|
69784010201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
69784050001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69784050101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69784055001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
69809012605|CE:APY-SGA|Antipsychotics|04/10/2016|
69809012705|CE:APY-SGA|Antipsychotics|04/10/2016|
69865024002|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|07/30/2020
69865024002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/30/2020
69865024002|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|07/30/2020
69865024002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|07/30/2020
69865024002|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|07/30/2020
69865024502|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/05/2020
69865024502|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/05/2020
69865024502|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/05/2020
69865024502|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/05/2020
69865024502|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/05/2020
69865025002|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|08/31/2020
69865025002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
69865025002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|08/31/2020
69865025002|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|08/31/2020
69865025002|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|08/31/2020
69865026002|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/03/2020
69865026002|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|10/03/2020
69865026002|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|10/03/2020
69865026002|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|10/03/2020
69865026002|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69865026501|CE:OPC-MEDL|Opioid Policy Criteria|09/01/2020|09/30/2020
69865026501|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
69865026501|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
69865026501|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|09/30/2020
69865026501|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|09/30/2020
69918010101|CE:DES-DESMO|Desmopressin|05/25/2012|
69918020101|CE:DES-DESMO|Desmopressin|05/25/2012|
69918089910|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
69918090110|CE:DES-DESMOINJ|Desmopressin|05/25/2012|
70000000101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000000301|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000000401|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000000401|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000000402|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000000402|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000000601|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000000701|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
70000000701|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000003201|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
70000003202|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
70000003203|CE:DRO-EMP20|Drug Regimen Optimization|01/31/2011|
70000004201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000012801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|08/10/2020
70000013101|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
70000013101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000013101|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000013101|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
70000013301|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|05/14/2021
70000013301|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|05/14/2021
70000013402|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|08/10/2020
70000013602|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000013603|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000014201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000014401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000016001|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000016001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000016002|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000016002|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000016201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000016202|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000017103|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017502|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017503|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017504|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017505|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017602|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000017603|CE:DUP-NSD|Duplicate Therapy|02/05/2013|04/03/2021
70000018101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000018801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|01/07/2021
70000018801|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|01/07/2021
70000018901|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000018901|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
70000018901|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
70000018901|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000019101|CE:DXO-DEXVCHLD|Dextromethorphan Overutilization|07/16/2012|
70000019102|CE:DXO-DEXVCHLD|Dextromethorphan Overutilization|07/16/2012|
70000019501|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000019501|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000019501|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
70000020102|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000020103|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000020702|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021302|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021303|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021304|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021306|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000021501|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000024001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000024401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000024502|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000025101|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000025901|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000026101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000026302|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000026401|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000027802|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
70000027802|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000028701|CE:DXO-DEXAA|Dextromethorphan Overutilization|07/16/2012|
70000028901|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|
70000029101|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000029201|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000029801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000029901|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000029902|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000030101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000030101|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
70000030201|CE:DXO-DEXI|Dextromethorphan Overutilization|07/16/2012|
70000030201|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000030201|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000030801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000030802|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000031901|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000031901|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
70000031902|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000031902|CE:DXO-DEXQ|Dextromethorphan Overutilization|07/16/2012|
70000032401|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
70000032401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036001|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000036002|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000036003|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70000036101|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036102|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036103|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036104|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000036202|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000037201|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
70000037201|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000037202|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000037202|CE:DXO-DEXW|Dextromethorphan Overutilization|07/16/2012|
70000038001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000038002|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000038003|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000038004|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000038701|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000038701|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
70000038701|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
70000038701|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000038702|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000038702|CE:DXO-DEXQCHLD|Dextromethorphan Overutilization|07/16/2012|
70000038702|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000038702|CE:DXO-DEXN|Dextromethorphan Overutilization|07/16/2012|
70000039201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|01/30/2021
70000041401|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|12/04/2020
70000041402|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|11/21/2020
70000041403|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|12/13/2020
70000042701|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|
70000042702|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|
70000045201|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000045202|CE:CCC-CCCA|Cough and Cold Agents - Clinical|12/15/2015|
70000045301|CE:DXO-DEXVCHLD|Dextromethorphan Overutilization|07/16/2012|
70000046701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000047301|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000047401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000047402|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000047901|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000047901|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000047902|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000047902|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000049101|CE:CCC-CCCD|Cough and Cold Agents - Clinical|12/15/2015|
70000049101|CE:DXO-DEXY|Dextromethorphan Overutilization|07/16/2012|
70000049101|CE:CCC-CCCB|Cough and Cold Agents - Clinical|12/15/2015|
70000049201|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000050401|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000051501|CE:DXO-DEXDD|Dextromethorphan Overutilization|07/16/2012|
70000051601|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|
70000051602|CE:DXO-DEXBB|Dextromethorphan Overutilization|07/16/2012|
70000051801|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70000052701|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70010001201|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70010001201|CE:DRO-MPHER10|Drug Regimen Optimization|01/31/2011|
70010001301|CE:DRO-MPHER20|Drug Regimen Optimization|01/31/2011|
70010001301|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70010001401|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70010001501|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70010001603|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70010004001|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
70010004001|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
70010004101|CE:ADD-IRAMPH|ADD/ADHD Agents|02/13/2014|
70010004101|CE:ADD-IREVT|ADD/ADHD Agents|12/18/2019|
70010075401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010075401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010075405|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010075405|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010077001|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010077001|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010077005|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70010077005|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70165000530|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165001030|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165001530|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165002030|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165002530|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165003030|CE:ADD-ERADZ|ADD/ADHD Agents|01/26/2017|
70165010030|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
70165010030|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70165020030|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
70165020030|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70165030030|CE:ADD-LAMETHYL|ADD/ADHD Agents|02/13/2014|
70165030030|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
70194000330|CE:GIM-TRU|GI Motility|02/06/2018|
70199001401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70199001401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
70199001401|CE:CYB-CYCLOBEN|Cyclobenzaprine|01/31/2011|
70362070239|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|08/26/2020
70362070239|CE:DUP-OCS|Duplicate Therapy|02/04/2016|08/26/2020
70362073030|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|08/26/2020
70370104001|CE:VMAT-ING|VMAT2 Inhibitors|09/25/2018|02/25/2021
70370108001|CE:VMAT-ING|VMAT2 Inhibitors|09/25/2018|
70370204001|CE:VMAT-ING|VMAT2 Inhibitors|09/25/2018|
70377000112|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
70377000112|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000114|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000114|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
70377000115|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000115|CE:DRO-SIMVA5|Drug Regimen Optimization|01/31/2011|
70377000212|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
70377000212|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000214|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000214|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
70377000215|CE:DRO-SIMVA10|Drug Regimen Optimization|01/31/2011|
70377000215|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000312|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
70377000312|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000314|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000314|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
70377000315|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000315|CE:DRO-SIMVA20|Drug Regimen Optimization|01/31/2011|
70377000412|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
70377000412|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000414|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
70377000414|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000415|CE:DRO-SIMVA40|Drug Regimen Optimization|01/31/2011|
70377000415|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000512|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000514|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000515|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000612|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000612|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
70377000613|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000613|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
70377000712|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
70377000712|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000713|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
70377000713|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000812|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
70377000812|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000813|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
70377000813|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000911|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000912|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377000913|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002711|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002711|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
70377002713|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
70377002713|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002811|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
70377002811|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002813|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
70377002813|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002911|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
70377002911|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002913|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377002913|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
70377003012|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70377003014|CE:DUP-STN|Duplicate Therapy|02/04/2016|
70408014634|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70408014634|CE:PRT-PROMETH|Promethazine Utilization|01/31/2011|
70436000506|CE:DRO-GALANT8|Drug Regimen Optimization|01/31/2011|
70436001002|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
70436001004|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
70436001006|CE:DRO-BUPR150|Drug Regimen Optimization|01/31/2011|
70436009006|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
70436009106|CE:LTMC-MON|Leukotriene Modifiers - Clinical|12/15/2015|
70515071101|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
70515071201|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
70709000060|CE:ENZ-NOR|Enzymes|11/20/2019|
70709000260|CE:ENZ-NOR|Enzymes|11/20/2019|
70709000560|CE:ENZ-NOR|Enzymes|11/20/2019|
70710111001|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70710112901|CE:APY-FGA|Antipsychotics|04/10/2016|
70710113001|CE:APY-FGA|Antipsychotics|04/10/2016|
70710113101|CE:APY-FGA|Antipsychotics|04/10/2016|
70710113201|CE:APY-FGA|Antipsychotics|04/10/2016|
70710113301|CE:APY-FGA|Antipsychotics|04/10/2016|
70710116701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70710116801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70710134401|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
70710134403|CE:ASH-RAMELT|Anxiolytics  Sedatives and Hypnotics|01/31/2011|
70710151506|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70710151509|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70710151606|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70710151609|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70710151706|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70710151709|CE:DUP-ANTCAG|Duplicate Therapy|02/05/2013|
70748021507|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70748021607|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
70752010112|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
70756070360|CE:RAN-RAN|Ranolazine|05/25/2012|
70756070460|CE:RAN-RAN|Ranolazine|05/25/2012|
70756080630|CE:DRO-LPZ15|Drug Regimen Optimization|01/31/2011|
70756080830|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
70756080930|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
70756080930|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
70756080990|CE:DRO-OLMES20|Drug Regimen Optimization|01/31/2011|
70756080990|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
70756081030|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
70756081090|CE:DUP-ARB|Duplicate Therapy|02/05/2013|
70839011230|CE:ASN-ALISK150|Aliskiren-Containing Agents|07/16/2012|
70839011230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70839012530|CE:ASN-ALISK150|Aliskiren-Containing Agents|07/16/2012|
70839012530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70839015030|CE:ASN-ALISK150|Aliskiren-Containing Agents|07/16/2012|
70839030030|CE:ASN-ALISK300|Aliskiren-Containing Agents|07/16/2012|
70839031230|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70839031230|CE:ASN-ALISK300|Aliskiren-Containing Agents|07/16/2012|
70839032530|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
70839032530|CE:ASN-ALISK300|Aliskiren-Containing Agents|07/16/2012|
70954001410|CE:APY-FGA|Antipsychotics|04/10/2016|
70954001510|CE:APY-FGA|Antipsychotics|04/10/2016|
70954001610|CE:APY-FGA|Antipsychotics|04/10/2016|
70954001710|CE:APY-FGA|Antipsychotics|04/10/2016|
70954005710|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954005710|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954005810|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954005810|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954005820|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954005820|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954005910|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954005910|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954005920|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954005920|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954006010|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954006010|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954006020|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954006020|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954006030|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954006030|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954006110|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
70954006110|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
70954016810|CE:SDF-REVSUSP|Sildenafil (Revatio)|09/01/2015|
71093011104|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093011105|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093011204|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093011205|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012004|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012005|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012104|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012105|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012204|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093012205|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
71093013602|CE:APY-SGA|Antipsychotics|04/10/2016|
71093013702|CE:APY-SGA|Antipsychotics|04/10/2016|
71093013802|CE:APY-SGA|Antipsychotics|04/10/2016|
71093013902|CE:APY-SGA|Antipsychotics|04/10/2016|
71225010401|CE:MAK-MAK|Makena|06/12/2015|
71225010501|CE:MAK-MAK|Makena|06/12/2015|
71376020103|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
71376020203|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
71376020303|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
71376020403|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
71376020503|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
71717010210|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|08/31/2020
71717010250|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|08/31/2020
71717010310|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|08/31/2020
71717010350|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|08/31/2020
71930001912|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930001912|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930001912|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930001912|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930001912|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930001952|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930001952|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930001952|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930001952|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930001952|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002012|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002012|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002012|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002012|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002012|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002052|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002052|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002052|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002052|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002052|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002112|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002112|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002112|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002112|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002112|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002152|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002152|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002152|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002152|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002152|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002243|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002243|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002243|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002243|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002243|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002330|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002330|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930002330|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002330|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002452|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
71930002552|CE:ADD-IRMETHYL|ADD/ADHD Agents|02/13/2014|
71930002743|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002743|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930002743|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930002743|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930002743|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004212|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004212|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004212|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004212|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004212|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004252|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004252|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004252|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004252|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004252|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004312|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004312|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004312|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004312|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004312|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004352|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004352|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004352|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004352|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004352|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004412|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004412|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004412|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004412|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004412|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004452|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004452|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004452|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004452|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004452|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004512|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004512|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004512|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004512|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004512|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004552|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004552|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004552|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004552|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004552|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004612|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004612|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004612|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004612|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004612|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004652|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004652|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004652|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004652|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004652|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004712|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004712|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004712|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004712|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004712|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004752|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930004752|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930004752|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930004752|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930004752|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005412|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005412|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005412|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005412|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930005412|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005452|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930005452|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005452|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005452|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005452|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005512|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005512|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005512|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930005512|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005512|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005552|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930005552|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005552|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005552|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005552|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005612|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005612|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005612|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005612|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
71930005612|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005652|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005652|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
71930005652|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
71930005652|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
71930005652|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
72060014230|CE:APY-SGA|Antipsychotics|04/10/2016|
72205000290|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|01/31/2022
72205000290|CE:DUP-STN|Duplicate Therapy|02/04/2016|01/31/2022
72205000299|CE:DUP-STN|Duplicate Therapy|02/04/2016|01/31/2022
72205000299|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|01/31/2022
72205000390|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
72205000390|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000399|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000399|CE:DRO-ROSUV10|Drug Regimen Optimization|01/31/2011|
72205000490|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000490|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
72205000499|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000499|CE:DRO-ROSUV20|Drug Regimen Optimization|01/31/2011|
72205000530|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000590|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205000599|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002030|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
72205002090|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
72205002205|CE:DRO-ATORV10|Drug Regimen Optimization|01/31/2011|
72205002205|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002305|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002305|CE:DRO-ATORV20|Drug Regimen Optimization|01/31/2011|
72205002405|CE:DRO-ATORV40|Drug Regimen Optimization|01/31/2011|
72205002405|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002505|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002790|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
72205002790|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002799|CE:DUP-STN|Duplicate Therapy|02/04/2016|
72205002799|CE:DRO-ROSUV5|Drug Regimen Optimization|01/31/2011|
72245019303|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
72245019303|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
72245019303|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
72245019303|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
72245019303|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
72245019310|CE:OPO-OOVU|Opiate Overutilization|11/05/2013|
72245019310|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
72245019310|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
72245019310|CE:MED-MED|Morphine Equivalent Dosing|01/09/2018|09/01/2020
72245019310|CE:OPC-MEDS|Opioid Policy Criteria|09/01/2020|
72485010125|CE:DUP-ANTHIS|Duplicate Therapy|02/05/2013|
72495020105|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
72495020210|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
72511075001|CE:PCS-REP|PCSK9 Inhibitors|01/04/2017|
72511076002|CE:PCS-REP|PCSK9 Inhibitors|01/04/2017|
72511077001|CE:PCS-REP|PCSK9 Inhibitors|01/04/2017|
72578006414|CE:RAN-RAN|Ranolazine|05/25/2012|
72578006514|CE:RAN-RAN|Ranolazine|05/25/2012|
72606000901|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
72606000902|CE:DRO-SOLAF5|Drug Regimen Optimization|01/31/2011|
72626260101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
72626270101|CE:HCA-HEPC|Hepatitis C Agents  Clinical|01/23/2015|
72647033101|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
72647033101|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
72647033104|CE:DUP-OCS|Duplicate Therapy|02/04/2016|
72647033104|CE:DUP-OCRT|Duplicate Therapy|02/05/2013|
72733590102|CE:PCS-PRA|PCSK9 Inhibitors|01/04/2017|
72733590202|CE:PCS-PRA|PCSK9 Inhibitors|01/04/2017|
72786010101|CE:SCA-SCA|Sickle Cell Agents|09/08/2020|
72912052530|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
72912053530|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
72912054530|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
72912055530|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
72912057030|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
72912058530|CE:ADD-ERCOT|ADD/ADHD Agents|09/24/2017|
75834012929|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
75834013029|CE:DUP-HRT|Duplicate Therapy|02/05/2013|
75834020501|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
75834020601|CE:DUP-MGL|Duplicate Therapy|02/05/2013|
75834021730|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
75834021790|CE:DRO-VENL75|Drug Regimen Optimization|01/31/2011|
75987001003|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
75987003004|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
75987003104|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
75987004005|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
76204020001|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204020025|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204020030|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204020060|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204060005|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
76204060012|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
76204060030|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
76204060060|CE:DUP-LABAC|Duplicate Therapy|02/04/2016|
76204070001|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204070025|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204080001|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204080025|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204090001|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76204090025|CE:DUP-SABA|Duplicate Therapy|02/05/2013|
76282015201|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
76282015201|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
76282015201|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
76282015210|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
76282015210|CE:DRO-MELOX7.5|Drug Regimen Optimization|01/31/2011|
76282015210|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
76282015301|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
76282015301|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
76282015310|CE:COX-MOBIC|COX-2 Inhibitors|01/31/2011|
76282015310|CE:DUP-COXC|Duplicate Therapy|02/04/2016|
76282020010|CE:DRO-FOSI10|Drug Regimen Optimization|01/31/2011|
76282020090|CE:DRO-FOSI10|Drug Regimen Optimization|01/31/2011|
76282020110|CE:DRO-FOSI20|Drug Regimen Optimization|01/31/2011|
76282020190|CE:DRO-FOSI20|Drug Regimen Optimization|01/31/2011|
76282021201|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
76282021205|CE:DRO-SRL25|Drug Regimen Optimization|01/31/2011|
76282021301|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
76282021305|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
76282021330|CE:DRO-SRL50|Drug Regimen Optimization|01/31/2011|
76282023710|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
76282023790|CE:DRO-AMLOD2.5|Drug Regimen Optimization|01/31/2011|
76282023810|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
76282023890|CE:DRO-AMLOD5|Drug Regimen Optimization|01/31/2011|
76282024910|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
76282024930|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
76282024990|CE:DRO-ETP5|Drug Regimen Optimization|01/31/2011|
76282025010|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
76282025090|CE:DRO-ETP10|Drug Regimen Optimization|01/31/2011|
76282025701|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
76282025801|CE:DUP-NSD|Duplicate Therapy|02/05/2013|
76282037702|CE:FOS-FOSRENOL|Fosrenol (Lanthanum Carbonate)|01/31/2011|
76282040501|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282040505|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282040590|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282040601|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282040605|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282040690|CE:GAB-GABA|Anticonvulsant Agents (Gabapentin)|01/31/2011|
76282044601|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044605|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044610|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044690|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044701|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044705|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044710|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044790|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044801|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044805|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044810|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282044890|CE:DUP-TZDTS|Duplicate Therapy|02/05/2013|
76282064038|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
76282064138|CE:DUP-CRTROD|Duplicate Therapy|02/05/2013|
76385012301|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012301|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012350|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012350|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012401|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012401|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012450|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76385012450|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|
76439030210|CE:NTR-BMR|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/14/2021
76439030210|CE:NTR-OBM|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/14/2021
76439030210|CE:NTR-OBE|New Trilogy Edit (opiates/benzos/muscle relaxants)|03/26/2017|04/14/2021
99207027028|CE:IMI-IMIQ|Imiquimod|07/16/2012|